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A induction of MHC-I-restricted CTL response and protection in
murine model, 210, 456
serotypes 1 to 5, inverted terminal repetition sequences, comparison
AcNPV, see Autographa californica nuclear polyhedrosis virus (swine), 212, 237
Acquired immunodeficiency syndrome subgroup B, membrane protein E3–20.5K, containing O-linked and
progression in SIV-infected macaques, association with replication, complex N-linked oligosaccharides, characterization (human),
tropism, and cytopathic properties of variant virus population, 210, 335
207, 528 subgroup B and E, hexon genes, sequence comparison (human),
Acyclovir 212, 232
treated CD4 cells, HIV-1 spread, protection by Tat-inducible HSV-1 subgroup C, productive infection, metabolism of small cellular RNA
thymidine kinase gene expression, 206, 495 species during, 206, 100
Acylation subgroup D
Marburg virus glycoprotein, 208, 289 fiber genes, characterization, 206, 564
Adeno-associated viruses immunological variant strains AD9/Hx and Ad15/Hx, hexon and
linear duplex DNA replication in vitro, minimum origin requirements, fiber sequences, comparison, 213, 313
209, 692 type 1, early region 3-encoded 11K protein, characterization (mouse),
Rep78 protein, covalent linkage to viral DNA in preformed virion, 208, 457
214, 360 type 2, protease encapsidation and activity, effect of proline 137
rep protein, inhibition of cellular and simian virus 40 DNA replication, mutation, 209, 167
207, 246 type 3
type 2 pathogenesis and immunogenicity in cotton rat (bovine), 213, 131
common ancestral origin with goose and muscovy duck parvovi- subgroup B, E3 region-encoded 20.5-K protein, role in viral replica-
ruses, 212, 562 tion (human), 208, 226
homology with goose parvovirus, 210, 283
type 5
rep gene, sequence elements required for suppression of herpes
helper-independent vectors, foreign gene expression by, analysis
simplex virus-induced DNA amplification, 206, 254
with firefly luciferase and bacterial b-galactosidase genes as
Adenosine deaminase
reporters (human), 210, 226
double-stranded RNA-specific, induction by interferon-a and IFN-g
temperature-sensitive DNA polymerase, biochemical characteriza-
in human cells, 210, 508
tion, 205, 364; erratum, 207, 342
Adenoviruses
type 12, early region 1B 54K protein, quaternary structure, examina-21-kDa and 54-kDa E1B proteins, distinct modulation of p53 activity
tion under denaturing and nondenaturing conditions, 207, 255in transcription and cell cycle regulation, 212, 543
type Ad35p and Ad34a, fiber gene organization and hemagglutinatingE1A gene
capacity, comparison, 206, 686associated regions affecting MHC class I expression and suscep-
VAi RNA, binding activity of full-length and R-domain forms of inter-tibility to cytotoxic T lymphocytes, identification, 211, 268
feron-inducible RNA-dependent protein kinase R: determinationautoregulation, phenotypic determinants: variable region between
of dissociation constants, 206, 511conserved coding domains 2 and 3, 213, 666
African cassava mosaic virusexpression, induced susceptibility to NK cell killing in human cells,
recombinants, strand nicking within conserved nonanucleotide motifeffects of adenovirus infection versus immortalization, 210, 421
during initiation of rolling circle DNA replication, 206, 707early region 1, transformed human cells, high p53 levels in, effect
African horse sickness viruson MDM2 expression, 210, 323
and other orbiviruses, nonstructural NS2 proteins, structure andencoded single-stranded DNA-binding protein, mutations altering ac-
ssRNA-binding ability, comparison, 209, 624cumulation of early and late viral RNAs, identification, 212, 91
serotype 2, capsid protein VP2 linear neutralization domain, identifi-entry into host cells, role of protease, 213, 494
cation, 210, 391homologues for 100K hexon assembly, 33K, pVIII, and fiber genes,
African swine fever virussequence (ovine), 209, 400
IAP homologue, identification as late structural polypeptide, 214, 670phylogenetic inferences from analysis of VA RNA genes (human,
infected Vero cells, replication of transfected plasmid DNA in, 207,simian), 207, 32
392recombinant, expressing transmissible gastroenteritis coronavirus
mutants resistant to phosphonoacetic acid, functional and molecularspike protein, induction of antibodies against TGEV, 213, 503
characterization, 214, 72replication-deficient vectors, in measles virus nucleocapsid protein:
p17 structural protein gene, mapping and sequencing, 206, 1140
strain BA71V, complete nucleotide sequence analysis, 208, 249
Aggregation
1 Boldface numbers indicate appropriate volume; lightface numbers vesicular stomatitis virus matrix protein, reversibility and mediation
by nucleation sites, role in viral assembly, 206, 28indicate pagination.
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AIDS, see Acquired immunodeficiency syndrome reverse transcriptase region, 212, 58
Alfalfa mosaic virus HTLV type II proteins produced by spliced mRNAs, 209, 445
coat protein human adenovirus
N-terminal basic amino acids, role in infection initiation, 208, 405 subgenus B and E hexon polypeptides, 212, 232
role in regulation of plus and minus RNA synthesis, implications type 3 subgroup B 20.5-K protein, 208, 226
for viral life cycle, 208, 583 human hepatitis B virus core and precore in wild-type and naturally
replicase-mediated resistance in transformed tobacco plants, 207, occurring mutants, 212, 151
467 human respiratory syncytial virus
RNA-dependent RNA polymerase, interaction with template, effect G proteins groups A and B, 209, 70
of oxidation of vicinal hydroxyl groups of template, 213, 650 phosphoprotein P, 205, 93; erratum, 209, 284
subgenomic RNA synthesis in vivo, sequences controlling, character- infectious pancreatic necrosis virus major structural protein VP2,
ization, 212, 663 214, 40
Alphaherpesvirus, see also specific virus La Crosse virus and other Bunyaviridae L proteins, 206, 742
S component genes, Marek’s disease virus ORFs homologous to, lactate dehydrogenase-elevating virus
nucleotide sequences, 206, 324 ORF 2, 5, and 6 proteins, 212, 512
Amino acids strains P and C ORF 1a and 1B, 209, 637
amino-terminal basic residues, brome mosaic virus coat protein, bio- Leishmania RNA virus, 212, 84
logical significance, 211, 42 lettuce infectious yellows virus RNA 1 and RNA 2 proteins, 208, 99
critical, identification in foot-and-mouth disease virus leader protein, luteovirus readthrough and virion protein N and C domains, 206,
213, 140 1129
Sindbis virus E2 protein, conferring resistance to release inhibition lyssavirus nucleoprotein, 209, 526
in low-ionic-strength medium, identification, 210, 237 Melolontha melolontha entomopoxvirus fusolin, 208, 427
Amino acid sequence molluscum contagiosum virus DNA-dependent RNA polymerase 22-
AcNPV chitinase, 212, 673 kDa and 147-kDa subunits and poly(A) polymerase, 210, 471
adenovirus subgenus D nucleoprotein interactor-1, 206, 116
fiber polypeptides, 206, 564 orf virus topoisomerase type I, 206, 203
immunological variant strain, hexon and fiber sequences, 213, 313 Orgyia pseudotsugata nuclear polyhedrosis virus
African swine fever virus alpha-like DNA polymerases, 214, 72
lef-1 gene, 207, 417
bacteriophage P2 proteins involved in baseplate assembly, 213, 109
LEF-3, 210, 372
barley mild mosaic virus capsid protein from fungally and mechani-
ovine adenovirus homologues for 100K hexon assembly, 33K, pVIII,
cally transmitted isolates, 212, 383
and fiber proteins, 209, 400
Bombyx mori nuclear polyhedrosis virus pol gene, 206, 435
ovine pestivirus autoprotease and nucleocapsid proteins, 209, 200
bovine herpesvirus type 1 and 5 glycoprotein D, 206, 242
peste des petits ruminants virus nucleoprotein, 208, 776
bovine herpesvirus type 1 UL1, UL2, UL3, and UL3.5 predicted prod-
pneumonia virus of mice attachment glycoprotein, 207, 240ucts, 213, 28
potato mop-top virus RNA3, 206, 701bovine lentivirus surface envelope protein, 212, 728
PP7 phage maturation and coat proteins and replicase, 206, 611bovine viral diarrhea virus2– 125c and -125nc p125 polypeptide, 212,
Prunus necrotic ringspot virus PE-5 isolate coat protein, 208, 349259
rabbitpox virus 35-kDa major secreted protein, 206, 591caprine arthritis–encephalitis virus provirus/visna virus envelope,
replicase of cocksfoot mottle virus and related sobemoviruses, 207,variation, 209, 297
566capripoxvirus HindIII Q2 fragment encoding G protein-coupled chem-
rotavirusokine receptor homolog, 209, 207
NSP3, 207, 327carmovirus segments with motifs encoded by RNA-directed RNA
VP8* (bovine, chicken, pigeon, turkey), 210, 231polymerase genes, 207, 312
simian immunodeficiency virusChoristoneura fumiferana nuclear polyhedrosis virus DNA polymer-
env clones, 212, 458ase, 209, 538
envelope proviral variants, 207, 528citrus tristeza virus RNA genome, 208, 511
simian parvovirus putative nonstructural and capsid proteins, 210,coxsackie A virus capsid protein VP4–VP2 and RNA polymerase,
314212, 30
simian retrovirus SRV-Pc, 207, 292C-terminal, bacteriophage T3 packaging enzyme large subunit, 211,
Sphenodon endogenous virus, 210, 206516
subterranean clover stunt virus ORFs, 207, 354Cydia pomonella granulosis virus transposon TCl4.7/MCp5, 207, 369
Theiler’s virus leader and capsid protein coding regions from neurovi-Diadromus pulchellus reovirus double-stranded RNA genome seg-
rulent strains, 214, 550ment translation products, 210, 109
transmissible gastroenteritis virus ORF 16 divergent region, 206, 817Ectocarpus siliculosus virus gp1, 206, 520
virulent bovine viral diarrhea virus type 2 large ORF, 212, 39Epstein–Barr virus BDLF3 ORF-encoded gp150, 209, 108
Amino-terminusfeline coronavirus ORF7a/7b transcription unit proteins: viruses of
fragments of capsid polypeptides, production, interference with repli-different biotypes, 212, 622
cation of double-stranded RNA viruses, 214, 215flaviviruses: TYU, SRE, and CFA viruses, 206, 1133
maize dwarf mosaic virus coat protein, inhibition of viral transmissionGL protein of equine arteritis virus, 214, 690
by aphid, 213, 676goose parvovirus nonstructural and capsid proteins, 210, 283
Amniotic fluidshantavirus protein sequences isolated in California
embryonated egg, and chorioallantoic membrane cells, selection ofM and S sequences (deer mouse), 206, 973
different variants of influenza A viruses (chicken), 211, 302partial M and S sequences (deer mouse), 206, 963
AnnouncementsHIV-1
envelope V3 domains in subtype D, G, and A/D recombinant, 209, International Conference on Receptor-Regulated Calcium Influx, Pa-
cific Grove, California, May 1995, 206, 783136
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Virus Assembly Symposium, Marrakech, Morocco, April 1995, 206, sensitivity to HIV-1 Vpu protein-induced degradation, role of alpha-
helix structure in CD4 proximal cytoplasmic region, 209, 615784
Antibodies, see also Monoclonal antibodies surface expression, downregulation by HIV-1 Nef protein, role of
anti-idiotypic, induction of papillomavirus-neutralizing antibodies, CD4 lck-binding domain, 207, 338
210, 292 transgenic rabbit, apoptosis of lymphocytes, effect of HIV-1 (hu-
and CD8/ cells, effector functions in resolution of rotavirus infection man), 213, 450
and protection against reinfection in mouse, 214, 387 CD26, recombinant, interaction potential with glutathione S-trans-
cucumber mosaic virus, production from synthetic phage display ferase-tagged HIV-1 gp120, 208, 142
library, 214, 235 CD46, role in presentation of measles virus nucleoprotein to NP-
to foot-and-mouth disease virus major antigenic sites, reactivity to specific murine and MHC class I-restricted CTLs, effects of viral
synthetic peptides of VP1 G-H loop (swine), 210, 120 inactivation, 212, 255
to hepatitis C virus E2 protein hypervariable region 1 in human sera, core, hepatitis B virus, mutations in hepatomas, accumulation in T-
blockage of viral attachment to tissue culture cells, 208, 653 cell epitopes, 212, 151
to HTLV-II external envelope protein, rapid generation by growth of diffused-form early, EA-D, Epstein–Barr virus, functional analysis,
mouse plasmacytomas in SCID mouse, 214, 680 211, 593
in immunological characterization of Ty1 virus-like particle, 207, 59 envelope, p37K, vaccinia virus, biochemical analysis, 213, 19
in indirect immunofluorescence analysis of intracellular localization Fas, apoptotic, encoding gene, activation upon influenza virus infec-
of HSV-1 ribonucleotide reductase subunits during infection of tion, role of spontaneously produced b-interferon, 209, 288
cultured cells, 213, 615 large surface, hepatitis B virus, associated promoter, SP1-binding
neutralizing, in macaques infected with SIV isolates, measurement site on, characterization, 208, 399
with CD4-expressing macaque cell line, 213, 386 large T
parvovirus B19 neutralizing, induction in rabbit by peptides derived JC virus, phosphorylation domains, biochemical characterization,
from minor capsid protein unique region, 206, 626 212, 295
postattachment neutralization of papillomaviruses, 207, 136 polyomavirus, mediation of intrachromosomal recombination, 206,
rotavirus, long-term production after single oral murine rotavirus im- 227
munization in neonatal mouse, 211, 474 MHC class I
transmissible gastroenteritis virus, induction by recombinant adeno- expression and susceptibility to cytotoxic T lymphocytes, adenovi-
virus expressing TGEV spike protein, 213, 503 rus E1A regions affecting, identification, 211, 268
transmissible gastroenteritis virus major structural proteins, T helper H-2KB-restricted CTL clone, simian virus 40 large T antigen minimal
cells collaborating in in vitro synthesis, elicitation by viral nu- recognition epitope, identification, 208, 159
cleoprotein epitope, 212, 746
restricted measles virus nucleoprotein presentation to NP-specific
Antibody-forming cells
CTLs, role of CD46 and effects of viral inactivation, 212, 255
response to Sendai virus infection, kinetics in different anatomical
MHC class II, detection on Epstein–Barr virus by infection of CR2-
locations (mouse), 207, 287
transfected epithelial cells, 213, 147
Antibody responses
middle-T, polyomavirus, associated domains, role in viral-mediated
to HIV-1, induction in mouse by DNAs expressing HIV-1 Env and
oncogenic transformation, 208, 26
noninfectious HIV-1 particles, 209, 147
Antiviral drugs, see also specific drugAntigenic determinants, see Epitopes
Ro 31–5140, herpes simplex virus type 2 DNA polymerase- andAntigenic drift
thymidine kinase-inhibiting, synergistic effects of ganglionic in-effect on recognition of influenza A virus hemagglutinin epitope by
fections, 206, 263neutralizing monoclonal antibody, 212, 526
Ro 31–8959, HIV-1 mutant with decreased sensitivity to, character-Antigenicity
ization, 206, 527hepatitis B virus small envelope proteins lacking cysteines in major
Aphid transmissionantigenic region, 211, 535
barley yellow dwarf luteovirus, efficiency, role of virion-associatedrespiratory syncytial virus group A and B, G proteins to G protein-
readthrough protein, 206, 954specific monoclonal antibodies, 209, 70
maize dwarf mosaic virus, inhibition by N-terminus of MDMV coatrotavirus, effect of VP7 glycosylation and genetic context, 209, 80
protein, 213, 676Antigenic sites
Apoptosislocalization on receptor-binding domain of human adenovirus type
induction by AcNPV in Spodoptera littoralis cells, 209, 5192 fiber, 214, 110
lymphocytes from human CD4 transgenic and normal rabbit, effectAntigenic variation
of HIV-1, 213, 450between glycoprotein C of respiratory bovine herpesvirus 1 and neu-
tobacco mosaic virus-mediated, role of serine/threonine proteinrovirulent BHV-5, molecular basis, 213, 558
phosphatase, 207, 460Kunjin virus isolates, 206, 49
1-b-D-Arabinofuranosylcytosine, see CytarabineAntigen presentation
Arachidonic acidmeasles virus nucleoprotein to MHC class I-restricted CTLs, role of
and prostaglandin E2, release from HIV-infected mononuclear phago-CD46 and effects of viral inactivation, 212, 255
cytes, relationship with viral replication and TNF-a and IL-2Antigens, see also Immunogens; Nuclear antigens; Superantigens
production, 208, 590CD4
Astrocytes–HIV-1 gp120 covalently crosslinked complexes, monoclonal anti-
activation in spinal cord of mouse chronically infected with neuro-bodies raised against, identification of complex-dependent
trophic coronavirus, 213, 482gp120 epitope, 211, 583
2–5A synthetaseHIV-1 Nef-mediated downregulation, relationship to Nef-enhanced
encoding gene, induction by interferon-g, mechanism, 211, 113viral propagation in vitro, 212, 451
Attenuationinteraction with HIV-1 gp120 V3 loop-derived multibranched pep-
tide construct, inhibitory effect on viral infection, 206, 457 channel catfish herpesvirus by thymidine kinase gene deletion, effect
on infectivity, 209, 658membrane, role in HIV-1 entry in choriocarcinoma cells, 208, 784
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disease, implications of effect of defective interfering RNA on accu- tail sheath and tail tube genes, nucleotide sequencing, 212, 218
mulation of tomato bushy stunt virus proteins, 211, 324 coliphage lO, initiator protein, protection from proteolysis in assem-
human respiratory syncytial virus cold-passaged strain, associated bly of replication complex in vivo, 207, 179
mutations in F and L gene, identification, 208, 478 Cp-1, left early region coding for terminal protein and DNA polymer-
Aura virus ase, nucleotide sequence and transcription (Streptococcus
organizational and sequence similarity with Sindbis virus, 208, 621 pneumoniae), 211, 21
Autographa californica nuclear polyhedrosis virus l, in vitro DNA packaging, defined system for, 211, 367
25K protein, biosynthesis and localization in infected Sf9 cells, 208, P2, genes involved in baseplate assembly, sequences, 213, 109
279 f6
fourth instar Trichoplusia ni orally inoculated with, developmental
acquisition of fourth genomic segment, 212, 204
resistance in, 209, 384
dsRNAgenome, chitinase gene in, identification and characterization, 212,
in in vitro packaging and replication system, polymerase activity,673
211, 320homologous region 1a, requirement for DNA replication, and tran-
in vitro transcription, effects of purine nucleoside triphosphatesscriptional enhancer function, 208, 742
and calcium, 207, 400IE1 protein
reduced-size genomic segments, packaging of multiple copies,expression during viral infection in Sf9 cells, 209, 99
212, 213tsB821 temperature-sensitive mutant, altered transactivation and
f29DNA-binding activities, 209, 90
assembly, inhibition by antisense oligonucleotides targeting viralinfected Sf cells
pRNA essential for DNA packaging, 211, 568expression of T  4 Nudaurelia capensis v virus capsid protein in
insect cells and capsid protein assembly and mRNA processing, Bacillus subtilis
207, 89 holin gene dual translational start motif, evolutionary conserva-
p6.9, cytochalasin D-induced proteolysis, 207, 1 tion, 206, 479
passage through midgut epithelium of Spodoptera exigua larva, 208, transcription regulation: expression of viral promoters through-
328 out infection cycle, 207, 23
pathogenesis in Trichoplusia ni and Heliothis virescens larvae, com- DNA packaging, role of circularly permuted viral pRNA, 207, 442
parison, 209, 561 ssRNA, PP7, Pseudomonas aeruginosa-derived, nucleotide se-
pk2 gene encoding truncated protein kinase homolog, expression quence: relationship to coliphages and conservation of regula-
and functional analysis, 206, 314 tory RNA structure, 206, 611
–Sf9 cell expression system, in assembly of SIV virus-like particles synthetic display library, in production of cucumber mosaic cucumo-
containing envelope proteins, 214, 50 virus antibodies, 214, 235
strain E2, genome, as target DNA in assay for movement of lepidop-
T3, packaging protein prohead-binding domain, fine structure, analy-
teran transposon IFP2 in insect cells, 211, 397 sis with hexapeptide analog, 211, 516
wild-type, induction of apoptosis in Spodoptera littoralis cells, 209,
T7
519
mature DNA, single-stranded breaks in, 211, 329Avian erythroblastosis virus
packaged DNA, specific nonproductive cleavage in vivo, 210, 409v-erbB protein, Shc protein binding site, identification, 206, 269
RNA polymerase, recombinant vaccinia virus encoding, construc-Avian infectious bronchitis virus
tion and transient expression in mammalian cells, 210, 202ORF 1a-encoded 87-kDa polypeptide, identification, expression, and
and vaccinia virus, polymerases, and Ebola virus polymerase, edit-processing, 208, 48
ing of Ebola virus glycoprotein mRNA, 214, 421Avian leukosis virus
temperate Streptococcus thermophilus, characterization and geneticbased packaging cell lines, for contaminant defective virus produc-
relationship to lytic phages, 212, 632tion, analysis, 209, 671
TP901–1, lactococcal temperate, major proteins, virion positions andAvian myeloblastosis virus
relationships, 212, 595v-myb oncogene, weak transcriptional activation-induced transfor-
mation of QT6 fibroblasts, 208, 467 Baculoviruses, see also specific baculovirus
Avian reovirus expression of peste des petits ruminants virus nucleoprotein for
strain RAM-1, sC protein-induced syncytia formation after expression serological diagnosis, 208, 776
in COS-7 cells, 208, 678 Barley mild mosaic virus
Avian sarcoma leukemia virus fungally and mechanically transmitted isolates, characterization, 212,
protease, linked to adjacent Gag polyprotein, enzymatic activity, 214, 383
439 Barley yellow dwarf virus
efficiency of aphid transmission, role of virion-associated read-
B through protein, 206, 954
PAV serotype, RNA replication, gene products and cis-acting ele-Bacillus subtilis
ments involved in, identification, 212, 186phage f29
B cellsholin gene dual translational start motif, evolutionary conservation,
Epstein–Barr virus-carrying, expression of complementary-strand206, 479
transcripts from BamHI-A region of EBV genome, 208, 180transcription regulation: expression of viral promoters throughout
Epstein–Barr virus ZEBRA protein latency function, restoration, 211,infection cycle, 207, 23
64Bacteria, see specific bacteria
linear epitopes, and immunodominant regions, gE envelope proteinBacteriophages
of varicella–zoster virus, identification, 214, 531coliphage 186
tail fiber genes, DNA sequence and evidence for common ancestor from patients with high viral load, cellular tropism of HTLV-II, 206,
1126of dsDNA phage fiber genes, 212, 128
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Bean golden mosaic virus nonneurovirulent BHV-1 and neurovirulent BHV-5 strains, glycopro-
teins C, antigenic variation between, molecular basis, 213, 558BL1 and BR1 genes, virus and host-specific adaptations, 214, 330
complementable and noncomplementable host adaptation defects, type 1
genomic 30-kb region exhibiting colinear gene arrangement with212, 263
replication-associated protein AC1, NTP-binding domain, mutational HSV UL21 to UL4 genes, nucleotide sequence, 210, 100
glycoprotein B and C, heparin binding, 209, 230analysis, 211, 1
Beet curly top virus glycoprotein D
modulatory function in viral entry, 207, 429DNA replication, strain-specific determinants, 206, 904
genetic analysis: role of L2 and L3 genes in viral pathogenesis, 206, neutralizing epitopes, fine mapping with type-specific mAb and
sequence comparison with BHV-5 gD, 206, 2421044
Beet necrotic yellow vein virus glycoprotein H, synthesis and processing, 206, 651
major tegument protein VP8, role in infection and immunity, 206,accumulation of RNA 2 in cis and coat protein in trans, regulation
by small cysteine-rich protein P14, 210, 73 413
UL1–UL3.5 ORFs, 3*-coterminal gene cluster, identification andBeet western yellows luteovirus
capsid proteins, recombinant baculovirus-produced, assembly into transcriptional analysis, 213, 28
UL39, UL38, and UL37 homologues, sequence analysis, and ex-virion-like particles in Bombyx mori cells and larvae, 213, 204
1-Benzyloxymethyl-5-ethyl-6-(a-pyridylthio)uracil pression studies of ribonucleotide reductase subunits UL40 and
UL39, 212, 734HIV-1 resistance to, generation by reverse transcriptase mutations
at multiple sites, 210, 186 type 4, replication in vitro, effect of DNA synthesis dependence on
S phase of cell cycle, 213, 328Biosensors
in kinetic and functional mapping of viral epitopes, 213, 462 Bovine immunodeficiency virus
long terminal repeat, identification of cis-acting regulatory elements,Biotypes
feline coronaviruses, ORF7a/7b transcription unit, comparative se- 209, 604
surface envelope gene, identification of hypervariable and conservedquence analysis, 212, 622
BK virus regions, 212, 728
Bovine lentivirus, see Bovine immunodeficiency virusproductive infection in urinary tract tumors, effect of DNA re-
arrangements, 214, 273 Bovine leukemia virus
genomic RNA, packaging in vivo, essential RNA stem–loop structure,Black Creek Canal virus
genetic and serologic analyses, and association with human disease identification, 211, 434
induced leukemogenesisand infection in cotton rat, 210, 482
Blueberry scorch carlavirus associated LTR and env proviral variation in vivo, 206, 769
relationship to p53 tumor-suppressor gene mutations in cattle and223-kDa protein, autocatalytic processing by papain-like proteinase,
207, 127 sheep, 209, 676
transactivator Tax, interaction with bZip proteins, 214, 207Bluetongue virus
chimeric VP3 molecules, synthesis and interactions with VP7 protein Bovine papillomavirus
maintenance at high copy number in transformed mouse cell lines,to assemble into virus core-like particles, 214, 593
and other orbiviruses, nonstructural NS2 proteins, structure and 213, 526
type 1ssRNA-binding ability, comparison, 209, 624
serotype 1, core particle, crystallization and preliminary x-ray analy- E1 replication protein, required domains for origin-specific DNA
binding and interaction with E2 transactivator, 211, 385sis, 210, 217
serotype 17, homotypic and heterotypic neutralization determinants, postattachment neutralization by monoclonal and polyclonal anti-
bodies, 207, 136209, 263
U.S. serotypes, RNA-directed RNA polymerase, sequence analysis type 4
cattle infection by, prevention by vaccination with N-terminus ofand antigenic epitope mapping, 214, 280
Bombyx mori nuclear polyhedrosis virus L2, 211, 204
E7 protein, T-cell responses during infection and epitope mapping,DNA polymerase gene, nucleotide sequence and transcriptional
analysis, 206, 435 206, 504
virions and virus-like particles, fate after infection of cultured cells,recombinant, beet western yellows luteovirus capsid proteins pro-
duced by, assembly into virion-like particles in Bombyx mori 214, 167
Bovine viral diarrhea viruscells and larvae, 213, 204
Bone genotype 1 and 2, genetic recombination, effects on onset of postvac-
cinal mucosal disease, 212, 259tumorigenesis, enhancement by Akv murine leukemia virus in hMT-
c-fos-LTR transgenic mouse, 206, 85 genotype 2, virulent, nucleotide sequencing and detection of large
genomic insertion in noncytopathic BVDV, 212, 39Bone marrow
stromal cells, susceptibility to HIV-1 infection (human), 208, 779 resistant MDBK mutant cell line, viral entry-blocking, isolation, 208,
565Border disease virus
isolates, characterization: evidence for more than three species translation initiation, role of internal ribosome entry site in 5* noncod-
ing region, 206, 750within genus pestivirus, 209, 200
Borna disease virus Brain
lymphocyte-tropic SIV persistent infection (rhesus monkey), 213, 600cell-culture-attenuated, pathogenicity and immune response after in-
oculation in weanling rat, 206, 426 SSPE-affected tissue, and wild-type measles virus, derived L genes,
nucleotide sequence comparison, 208, 795coding strategy, minireview, 210, 1
Bovine adenovirus type 3 Broad bean mottle virus
defective-interfering RNAs in, de novo generation, 212, 574pathogenesis and immunogenicity in cotton rat, 213, 131
Bovine herpesvirus Brome mosaic virus
coat protein, N-terminal basic residues, biological significance, 211,DNA, latently transcribed regions, altered dinucleotide content, impli-
cations for latent RNA expression and DNA structure, 209, 358 42
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genetic RNA recombination, facilitation by foreign complementary Casein kinase II
sequences, 208, 370 cellular, role in phosphorylation of measles virus P protein, 211, 218
helicase-like and polymerase-like proteins, interaction, biochemical mediated phosphorylation of human respiratory syncytial virus phos-
and genetic analysis, 214, 59 phoprotein P
RNA-2, plus-strand promoter, interaction with host proteins, 214, 638 role in transcriptional activity, 205, 104; erratum, 209, 284
systemic infection, host range, effect of coding changes in 3a cell- Ser237 as site of, 205, 93; erratum, 209, 284
to-cell movement gene, 214, 464 Catalysis
Bronchoalveolar lavage cells covalent, essential residues in vaccinia DNA ligase, mutational anal-
from HIV-1-infected patients, in analysis of viral promoter insertion ysis, 211, 73
in vivo, 208, 359 Cauliflower mosaic virus
Bunyavirus movement protein RNA-binding domain, identification, 206, 1145
recombinant, RNA template, transcription by transiently expressed CCAAT element
bunyavirus proteins, 211, 133 key role in regulation of hepatitis B virus surface protein expression,
tropism: evidence for G1 glycoprotein-mediated entry pathway com- 206, 1155
mon to California serogroup, 214, 339 Cell adhesion molecules
ICAM-1, interferon-independent virus-specific, early expression in-
C duced by flavivirus in quiescent nonproliferating fibroblasts, im-
plications for virus–host interaction, 208, 437
Calcium Cell binding
effect on double-stranded RNA bacteriophage f6 in vitro transcrip- HIV-1, enhancement by V3 loop-derived synthetic peptides, minimal
tion, 207, 400 sequence requirements, 206, 807
California encephalitis virus Cell culture
infection in vitro and in vivo, role of G1 protein, 206, 945 long-term
California serogroup Epstein–Barr virus in Burkitt’s lymphoma 1 B-lymphoblastoid cell
G1 glycoprotein-mediated pathway: bunyavirus tropism, 214, 339 hybrids, subsequent selective loss of integrated EBV genomes,
Canine parvovirus 212, 179
capsid, dimple and canyon regions, cell- and erythrocyte-binding fibroblasts, transformation by chimeric jun oncogene (quail em-
activities, 211, 123 bryo), 207, 321
Capping enzyme Cell cycle
avian reovirus S1133, identification, 206, 1017 G1, arrest after X-irradiation, effects of expression of adenovirus 21-
Caprine arthritis–encephalitis virus kDa and 54-kDa E1B proteins, 212, 543
complete provirus, erratic GrA hypermutation in, sequence, 209, HPV p53-mediated arrest in RKO cells, abrogation of, correlation with
297 p53 binding and degradation by E6 protein in vitro, 208, 111
Capripoxvirus role in West Nile virus expression of interferon-independent virus-
strain KS-1, HindIII Q2 fragment encoding G protein-coupled chemo- specific ICAM-1 in quiescent nonproliferating fibroblasts, 208,
kine receptor homolog, sequence analysis, 209, 207 437
Capsids S phase, dependence of DNA synthesis of bovine herpesvirus 4 on,
effect on replication in vitro, 213, 328B19 parvovirus, localization of VP1 minor capsid protein on surface,
211, 359 Cell fusion, see also Membrane fusion; Syncytia formation
canine parvovirus, dimple and canyon regions, cell- and erythrocyte- cell–cell
binding activities, 211, 123 mediated by HIV-1 T-cell line tropic strains in macrophages, and
HSV-1, association with UL6 gene product, 206, 465 viral entry, restriction by V3 loop, 209, 696
T  4 Nudaurelia capensis v virus, protein assembly, post-transla- role of murine coronavirus spike protein, mutational analysis, 214,
tional cleavage, and specific encapsidation of mRNA in baculo- 453
virus expression system, 207, 89 role of varicella–zoster virus gH:gL glycoprotein complex, analysis
Capsomeres by laser scanning confocal microscopy, 210, 429
pentameric, SV40, associated structural protein Vp1, assembly into HIV-1, subtype D Zairian isolate NDK, determinants, 209, 649
disulfide-linked postpentameric complexes in cell-free lysates, human parainfluenza virus type 2 hemagglutinin–neuraminidase
207, 251 protein regions promoting, identification, 213, 190
Carbohydrates induction by avian reovirus sC protein after expression in COS-7
addition site, on hemagglutinin protein of highly pathogenic H7 sub- cells, 208, 678
type avian influenza virus, identification, 213, 276 monoclonal antibody inhibiting, binding to presumed stalk domain
N-linked, role in Newcastle disease virus hemagglutinin–neuramini- of human parainfluenza type 2 virus hemagglutinin–neuramini-
dase activities, 212, 398 dase protein, 206, 1117
Carboxylate groups parainfluenzavirus type 1, hemagglutinin–neuraminidase-mediated,
enhancement by single amino acid change, 209, 654role in tobacco mosaic virus disassembly, confirmation by site-di-
rected mutagenesis, 206, 724 Cell lines
Carboxy terminus 2G10 (B-cell hybridoma), reovirus serotype 3 persistent infection in,
HIV-1 Vpr, role in Vpr stability and virion incorporation into viral eradication by passage in medium with anti-reovirus antibodies,
212, 272particles, 214, 647
Carmovirus 3CI8 (Friend leukemia), interferon-b-resistant, response to interferon-
g, mechanism, 211, 113related RNA-directed RNA polymerase, genes encoding, specific de-
tection with highly conserved motifs in plant virus RdRp as tags, 3T6 (murine fibroblasts), mouse adenovirus type 3-infected, viral pro-
duction of early region 3-encoded 11K protein, 208, 457207, 312
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293 (human embryonic kidney) BmN (Bombyx mori), beet western yellows luteovirus capsid proteins
produced by recombinant baculoviruses, assembly into virion-accumulation of adenovirus early and late RNAs, associated muta-
like particles, 213, 204tions in Ad-encoded single-strand DNA-binding proteins, identi-
BS-C-1 (African green monkey kidney)fication, 212, 91
hepatitis A virus rapid replication and cytopathic effect in, associ-and derived clones, herpes simplex virus type 2 ribonucleotide
ated genomic regions: construction of infectious chimeric virusreductase large subunit ICP10 internalization and associated
cDNAs, 212, 686signaling pathways, 210, 345
for radioimmunofocus assays of hepatitis A virus RNA transcriptDNA replication, inhibition by adeno-associated virus rep gene,
infectivity, 213, 213207, 246
Burkitt’s lymphoma, Epstein–Barr virus efficient superinfection andhepatitis B virus L protein retention, role of C-terminal PreS1 se-
productive cycle, role of Cp viral promoter expression, 206, 866quence, 213, 57
Burkitt’s lymphoma 1 B-lymphoblastoid cell hybrids, Epstein–Barrliving, Rev and transdominant Rev protein trafficking, analysis with
virus-immortalized, selective loss of integrated EBV genomesgreen fluorescent protein fusions, 213, 439
after long-term cultivation, 212, 179A9 (murine fibroblasts), minute virus of mice transcription, inhibition
C6 (rat glioma), measles virus persistent infection, cure with MVby constitutive expression of NS-1 transactivator protein-tar-
antisense sequences, 207, 168geted antisense RNA, 206, 57
C6/36 (Aedes albopictus)A72 (canine fibroma), binding activities of dimple and canyon regions
of canine parvovirus capsid, 211, 123 in analysis of Kunjin virus antigenic variation, 206, 49
California encephalitis virus infection in vitro, role of G1 protein,A549 (human lung carcinoma)
206, 945adenovirus early region 1-transformed, high p53 levels in, effect
on MDM2 expression, 210, 323 C127 (murine fibroblasts), infection with papillomavirus virions, early
phase, 214, 167interferon-inducible gene expression, induction by mutated murine
intracellular IFN-g cDNA, 212, 438 Caco-2 (human intestinal epithelial), polarized, measles virus prefer-
ential entry and release through apical plasma membrane, 210,ACH-2 (T lymphoma), HIV RNA expression in transition from latent
91to productive transition, in situ hybridization-based single cell
transcript analysis, 206, 16 CEF (chicken embryo fibroblasts)
avian influenza virus replication in, effect of 4-guanidino-2,4-di-AGMK (African green monkey kidney), microevolution of poliovirus
type 3 Sabin strain in, implications for vaccine quality control, deoxy-2,3-dehyro-N-acetyl neuraminic acid, 212, 323
211, 377 intracellular maturation of Newcastle disease virus fusion protein,
effect of strain differences in predicted amphipathic a-helix adja-Akata (Burkitt’s lymphoma), anti-immunoglobulin induced Epstein–
Barr virus lytic cycle, blockage by cyclosporin A and FK506, cent to fusion domain, 208, 827
209, 225 Rous sarcoma virus replication, necessary role of suboptimal src
3* splice site, 206, 1099B95–8 (marmoset), producing Epstein–Barr virus, transmissible ret-
rovirus in, identification and characterization, 209, 374 Shc protein binding to avian erythroblastosis virus v-erbB protein,
identification of binding site, 206, 269BGM (baby green monkey kidney), expression of Melolontha melo-
lontha entomopoxvirus fusolin, 208, 427 Sindbis virus release, inhibition in low-ionic-strength medium, mu-
tant resistant to, isolation, 210, 237BHK (baby hamster kidney)
135-kDa protein, herpes simplex virus type 1 Vmw110 multimeriza- CEM13 (human T-cell leukemia), HIV-1 infection, inhibition by gp120
V3 loop-derived multibranched constructs via interaction withtion and interaction with, identification of required viral se-
quences, 209, 174 CD4, 206, 457
CET (chicken embryo tendon), avian reovirus growth, comparisonCalifornia encephalitis virus infection in vitro, role of G1 protein,
206, 945 with primary fibroblasts, 207, 117
chicken spleen, Rev-T-retrovirus-transformed, complexation of viralfoot-and-mouth disease virus infection and gene expression, effect
of protease 3C expression, 212, 111 v-Rel oncoprotein with Rel-related proteins, 207, 362
CHO (Chinese hamster ovary)HPV type 16 E7 gene transformation potential, correlation with
expression levels, 207, 260 and CHO-12, HIV-1 Tat activation, role of TAR sequences, 206,
690HSV-1-infected association of ICP4 and ICP0, effect of cell type,
211, 209 vaccinia virus restricted replication in, occurrence at stage of viral
intermediate protein synthesis, 206, 984infection with HSV-1, intracellular localization of viral ribonucleo-
tide reductase subunits during, 213, 615 CIN-612 (cervical intraepithelial neoplasia), HPV type 31b episome-
bearing, differentiation-dependent expression of viral E1 P E4infectivity of foot-and-mouth disease virus acid-resistant mutant,
206, 69 proteins, 206, 679
CMMT, mammary, CD4-expressing, detecting SIV after single repli-rabies virus-infected, cellular ezrin–radixin–moesin family pro-
teins, association with viral envelope proteins and incorporation cation cycle and infectable by diverse SIV isolates, characteriza-
tion (macaque), 213, 386into rabies virion, 206, 485
rubella virus infected, identification of viral nonstructural proteins, COS (African green monkey kidney)
206, 843 CD4 degradation by HIV-1 Vpu protein: role of alpha-helix structure
in CD4 proximal cytoplasmic region in antigen sensitivity, 209,Semliki Forest virus-infected and nsP1-transfected, nonstructural
615protein distribution, 208, 610
expression of avian reovirus sC protein and associated syncytiaSendai virus-infected, cytoskeletal and lipid components, interac-
formation, 208, 678tion with viral fusion, matrix, and hemagglutinin–neuraminidase
proteins, 209, 701 HIV-1 tropism, effect of amino acid change in V2 domain envelope
gp120, 206, 878transfection with human foam virus-derived retroviral vectors di-
recting high-level foreign gene expression, 210, 167 Newcastle disease virus
hemagglutinin–neuraminidase activities, role of N-linked carbo-BK-LF (bovine kidney), infectivity of foot-and-mouth disease virus
acid-resistant mutant, 206, 69 hydrates, 212, 398
/ m4655fcsin 12-12-95 10:59:24 vira AP-Virology
719CUMULATIVE SUBJECT INDEX
syncytia formation, depression by mutations in fusion glycopro- microtubule-associated protein 4 cleavage, mediation by poliovi-
rus 3C protease, 211, 451tein cytoplasmic domain, 210, 264
transmembrane proteins, stable complex formation with HPV type parainfluenzavirus type 1 HN, fusogenicity, enhancement by single
amino acid change, 209, 65416 E5 protein, 211, 227
CRFK (Crandell–Reese feline kidney) paramyxovirus SV5 F glycosylation mutants expressed in, subse-
quent SV5 assembly, transport, and fusion activity, 209, 250feline herpesvirus type 1 short segment transcripts from, transcrip-
tional analysis and insertional mutagenesis of ORF US8.5, 208, poliovirus-infected, cellular protein binding to viral RNA 5* noncod-
ing region, role of stem–loop synergy, 206, 923704
feline immunodeficiency virus infectivity, correlation with envelope poliovirus replication, role of membrane binding mediated by viral
2C protein amino-terminal regions, 208, 540fusogenic properties, 206, 796
feline immunodeficiency virus replication, role of LTR C/EBP site, replication of Tat0 HIV-1 with wild-type LTRs in, 211, 157
208, 492 Semliki Forest virus-infected and nsP1-transfected, nonstructural
protein distribution, 208, 610infectivity of feline calcivirus RNA transcripts derived from cloned
full-length copy, role of VpG protein, 210, 383 subgroup C adenovirus productive infection, metabolism of small
cellular RNA species during, 206, 100CV-1 (African green monkey kidney)
fowl plague virus hemagglutinin expression, role of neuramini- varicella–zoster virus gH:gL glycoprotein complex, intracellular
transport and fusogenic role, analysis by laser scanning confo-dase, 212, 77
cal microscopy, 210, 429hepatitis C virus core gene products, differential subcellular local-
ization, 213, 455 HEp-2 (human epidermoid carcinoma)
clones cured of persistence poliovirus infection, subsequent se-infection with papillomavirus virions, early phase (mouse), 214,
167 lective permissivity to wild-type Mahoney strain and partial re-
sistance to attenuated Sabin 1 strain, 212, 309paramyxovirus SV5 mutant fusion protein expression, associated
syncytia formation, 209, 242 HSV-1-infected association of ICP4 and ICP0, effect of cell type,
211, 209Rous sarcoma virus lysosomally targeted envelope glycoprotein
transport, role of transient cell surface expression, 206, 353 hepatocellular carcinoma, B3N locus, woodchuck hepatitis virus inte-
gration in, recurrence (woodchuck), 214, 229Sendai virus P protein intracellular phosphorylation, 208, 408
HepG2.1 and Huh7 (human hepatoma), transcription of hepatitis BD17 (canine osteosarcoma)
virus nucleocapsid promoter, modulation by hepatocyte nuclearconstruction of improved retroviral packaging lines from spleen
factor 3 (human), 208, 147necrosis virus, 208, 234
HFS, hepatitis A virus-infected, observed VP1 protein, comparisononcoretroviral-infected, SU protein maturation and translocation,
with protein encoded by proposed VP1 gene, 213, 671effects of mutations in conserved cysteine residues in CWLC
motif, 206, 885 HL-60 (human promyelocytic leukemia)
HIV-1 T-lymphotropic isolate NL4–3 in, replication, comparisonDEF (duck embryo fibroblasts), infected with Marek’s disease virus
oncogenic strains and attenuated derivitives, expression of 14- with H9 T-cell line, 206, 641
kDa immediate-early phosphoprotein, 206, 695 human cytomegalovirus immediate early enhancer/promoter, stim-
ulation by TNF-a, mediation via NF-kB induction, 208, 197F111 (Fisher rat), polyomavirus-mediated oncogenic transformation,
role of middle-T antigen domains, 208, 26 HLtat (human cervical carcinoma)
FR3T3 (rat embryo fibroblasts), intrachromosomal recombination, HIV-1-infected, viral protease overexpression, effects on intracellu-
mediation by polyomavirus large T antigen, 206, 227 lar cleavage of Gag and viral infectivity, 206, 854
gro2C (murine L cell mutant), HSV-1 attachment in absence of hep- living Rev and transdominant Rev protein trafficking, analysis with
aran sulfate, viral interaction with chondroitin sulfate, 208, 531 green fluorescent protein fusions, 213, 439
H9 (human T cells) HT-29 (human colon adenocarcinoma), HIV-1 replication, restriction,
genetic control by gag–pol region of HIV-1 genome, 207, 160HIV-1 clone HX10-infected, monoclonal antibody binding of gp41
epitopes in extracellular domain, 206, 713 human choriocarcinoma, HIV-1 infection, role of membrane CD4 and
Fc receptors in viral entry, 208, 784HIV-1 T-lymphotropic isolate NL4–3 in, replication, comparison
with promyelocytic leukemia cells, 206, 641 human fetal, adenovirus early region 1-transformed, high p53 levels
in, effect on MDM2 expression, 210, 323HEK (human embryonic kidney), transformation function of HPV type
16 E6 mutants and viral interaction with p53, 212, 535 human lymphoid, primary and long-term, replication of Tat0 HIV-1
with wild-type LTRs in, 211, 157HeLa (human cervical carcinoma)
accumulation of adenovirus early and late RNAs, associated muta- human teratocarcinoma, expression of human endogenous retrovi-
rus clones HERV(K)27 and (K)67, 208, 733tions in Ad-encoded single-strand DNA-binding proteins, identi-
fication, 212, 91 HUT 78 (human T lymphoma)
adenovirus entry into, role of protease, 213, 494 acyclovir-treated, HIV-1 spread, protection by Tat-inducible HSV-
1 thymidine kinase gene expression, 206, 495CD4/, nonproducer HIV-1-transfected, HIV susceptibility, effect of
full expression of proviral DNA, 206, 76 HIV-1 macrophage-tropic variant adaptation to growth in, role of
amino acid substitutions in V3 loop, 210, 490expression of minute virus of mice NS1 mutant, 209, 122
HIV-1 Vpr nuclear localization, domains involved in, analysis, 212, HIV-1 tropism, effects of amino acid changes in gp120 V2 domain,
206, 878331
HTLV-I-infected, 2*,5*-oligoadenylate synthetase and p68 kinase HUT 102 and MT 2.6 (human T lymphoid), HTLV-I expression, role
of cellular stress response, 208, 816activation by viral Rex response element, 206, 913
human adenovirus type 5-based vector transfected with, firefly IC-21 (murine macrophages), immortalized, measles virus persis-
tence in, 207, 12luciferase and b-galactosidase gene expression, 210, 226
influenza A nucleoprotein interaction with nucleoprotein interactor ID13, transformed, maintenance of bovine papillomavirus at high
copy number (mouse), 213, 5261, 206, 116
intracellular membrane trafficking pathway, effects of HIV-1 Vpu interferon-a-producing, responding to DNA and RNA viruses, fre-
quency, 204, 1; erratum, 206, 1159; 207, 342protein expression, 213, 639
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J-Jhan (human T cell) simian virus 5-infected, association of viral V protein with nucleo-
capsid and identification as structural component of SV5 virion,HIV-1– human herpesvirus type 6 interactions, 211, 544
208, 121HIV NF-kB-independent promoter domain activity and Sp1 phos-
MDV OU2.1 and MDV OU2.2 (chicken embryo fibroblasts), sustain-phorylation, induction by okadaic acid, 208, 753
able, infected with Marek’s disease virus, development, 214,Jurkat (human T lymphoma)
541CD4 surface expression, downregulation by HIV-1 Nef protein, role
MeWo (human melanoma), varicella–zoster virus growth in vitro, roleof CD4 lck-binding protein, 207, 338
of ORF 1-encoded membrane protein, 206, 835HIV-1 pol ribozyme-transduced, viral production, 206, 381
MKT-1 (chicken lymphoblastoid), Marek’s disease virus-transformedwith stably integrated HIV-1 LTR and HTLV-I LTR/lacZ vectors, LTR
and -infected, viral cDNAs mapping to BamHI-I2, -Q2, and -Lresponse to T-cell activation, 209, 633
fragments of MDV genome from, isolation and characterization,K562 (erythroleukemia), response to poliovirus infection, strain com-
213, 590parison (human), 213, 7
MOLT-3 (human T lymphoma), HIV-1 cell-binding and infection en-KB (human nasopharyngeal carcinoma), human adenovirus type 3
hancement by V3 loop-derived synthetic peptides, minimal se-subgroup B replication in, role of 20.5-K protein, 208, 226
quence requirements, 206, 807L929 (murine fibrosarcoma)
MOLT-4 (human T lymphoma), HIV-1 pol ribozyme-transduced, viralinfected with vaccinia virus K3L0 and E3L0 mutants, interferon
production, 206, 381sensitivity patterns, 210, 254
MT-4 (human T cells), HIV-1 acutely infected, in vivo processing ofrotavirus infection in, enhancement by dansylcadaverine and cyto-
Pr160gag-pol, 214, 624chalasin D, 212, 429
mTAL (murine epithelial kidney), polarized, mouse hepatitis virus A59LCL (CD4/ B lymphoblastoid), Epstein–Barr virus- and HIV-1-in-
entry and release, 210, 54fected, lack of pseudotype formation, 209, 643; erratum, 212,
murine mammary epithelial cells, hyperplastic, tumorigenic potential,757
promotion by expression of mouse mammary tumor virus longLd-652Y (Lymantria dispar), Orgyia pseudotsugata multinucleocapsid
terminal repeat open reading frame, 211, 84nuclear polyhedrosis virus DNA replication in
MYA-1 (T-lymphoblastoid), feline immunodeficiency virus replication,second putative origin of, identification and characterization, 207,
role of LTR C/EBP site, 208, 492417
NFLK (feline kidney), binding activities of dimple and canyon regions
trans-acting regions and replication gene lef-1, identification, 207,
of canine parvovirus capsid, 211, 123
417
NGP (neuronal), poliovirus-infected, cellular protein binding to viral
LD-C11.3 (Lymantria dispar), growth of Amsacta moorei entomopox-
RNA 5* noncoding region, role of stem–loop synergy, 206, 923
virus, effects of viral inhibitors, 211, 462
NIH 3T3 (murine fibroblasts)
leukemic T cell, establishment from mice inoculated with MAIDS human PKR transfected into, stimulation of expression of genes
defective virus, 206, 555 under control of HIV-1 or HTLV-I LTR, 214, 653
L-M, equine herpesvirus type 1 gene expression, regulatory role of polyomavirus-mediated oncogenic transformation, role of middle-
ICP22 protein, 210, 273 T antigen domains, 208, 26
LMH (chicken hepatoma), avian retroviral vector-packaging, trans- transfection with Harvey murine sarcoma virus/MDR1 retroviral
mission of defective retroviral endogenous RNA by infectious vector: virus production and gene transduction efficiency, 208,
particles, 207, 271 621
LTBMC, long-term primary bone marrow culture-derived adherent P388 (murine monocytic leukemia), mdr3 gene conferring multidrug
cells, in vitro infection by HIV-1, effect on ability to support hema- resistance, transcription activation, role of mouse mammary tu-
topoiesis, 213, 245 mor virus LTR and mdr3 sequences, 210, 244
mammalian, transient expression of bacteriophage T7 RNA polymer- packaging, avian leukosis virus-based, for contaminant defective vi-
ase after transfection with recombinant vaccinia virus vector, rus production, analysis, 209, 671
210, 202 PLC/PRF/5 (human hepatoma), hepatitis B virus–mevalonate kinase
mammalian and mosquito, infected Sindbis virus–Japanese enceph- fusion proteins and Mk overexpressed in, enzymatic properties,
alitis virus recombinants, secretion of JEV subviral particles, sup- 208, 696
pression by SIN nonstructural protein, 209, 155 QT6 (quail fibroblasts), avian myeloblastosis virus v-myb-mediated
MDBK (Madin–Darby bovine kidney) transformation, association with weak transcriptional activation,
bovine herpesvirus type 1 entry, modulatory function of glycopro- 208, 467
tein D, 207, 429 Raji (human lymphoma), HIV RNA expression in transition from latent
bovine herpesvirus type 1 glycoprotein C-minus infectivity, inhibi- to productive infection, in situ hybridization-based single cell
tion by heparin, 209, 230 transcript analysis, 206, 16
bovine herpesvirus type 1-infected, viral glycoprotein H synthesis RKO, abrogation of HPV p53-mediated cell cycle arrest, correlation
and processing, 206, 651 with p53 binding and degradation by E6 protein in vitro, 208,
bovine herpesvirus type 1 infection, role of major tegument protein 111
VP8, 206, 413 Sf (Spodoptera frugiperda)
bovine viral diarrhea virus-resistant mutant CRIB, viral entry- AcNPV homologous region 1a-containing fragment in, replication
blocking, isolation, 208, 565 and enhancer functions, 208, 742
influenza A nucleoprotein interaction with nucleoprotein interactor AcNPV-infected
1, 206, 116 cytochalasin D-induced proteolysis of p6.9, 207, 1
MDCK (Madin–Darby canine kidney) detection of fuctional chitinase, 212, 673
avian influenza virus replication in, inhibitory effect of 4-guanidino- effect of shift to nonpermissive temperature during early infec-
2,4-dideoxy-2,3-dehyro-N-acetylneuraminic acid, 212, 323 tion on late gene and polyhedrin expression, 209, 90
infection by influenza A virus, prevention by monoclonal antibody localization and biosynthesis of viral 25K protein, 208, 279
recognizing conserved epitope of viral hemagglutinin, 212, 526 baculovirus expression of T  4 Nudaurelia capensis v virus cap-
sid protein and capsid protein assembly and mRNA processing,influenza A virus assembly and M2 cell surface expression, effects
of M2 antibody, 212, 411 207, 89
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expressed orbivirus nonstructural NS2 protein, structure and pseudorabies virus EPO deletion mutant replication, effect of ho-
mologous protein expression, 209, 281ssRNA-binding ability, 209, 624
expression of rubella virus-infected
defective-interfering RNAs generated during serial undilutedglutathione S-transferase-tagged HIV-1 gp120, 208, 142
influenza virus A RNA polymerase subunit PB2, 208, 38 passage, characterization, 206, 216
identification of viral nonstructural proteins, 206, 843Melolontha melolontha entomopoxvirus fusolin, 208, 427
rubella virus E2 glycoprotein secreted forms, 206, 736 Cell surface receptors
human T-cell lymphotropic virus, localization to human chromosometobacco ringspot virus capsid protein and satellite RNA, 213,
472 17q23.2–17q25.3, 212, 196
Cell-to-cell transportHPV type 16 E2 protein and subdomains expressed in, character-
ization, 211, 418 cucumber mosaic virus RNA in tobacco plants, potentiation by viral
3a protein, 207, 345lepidopteran transposon IFP2 movement in, assay with baculovi-
rus genome as target DNA, 211, 397 Cell tropism
serotype differences of HSV-1 and HSV-2 glycoprotein C in, effect ofMarburg virus glycoprotein acylation, 208, 289
transient origin-dependent DNA replication assay, substitution of differential role of gC-1 and gC-2 in viral binding, 214, 29
Cellular factorsvaricella–zoster virus origin-binding protein for herpes simplex
virus OBP, 206, 655 AP1, synergistic interaction with other factors, in regulation of tran-
scriptional activity of HPV type 31b enhancer, 211, 184tubular structures, induction by nonstructural Nsm protein of to-
mato spotted wilt virus, 214, 485 Cellular stress response
role in expression of HTLV-I in lymphocytes, 208, 816SH-SY5Y (human neuroblastoma), induction of double-stranded RNA-
specific adenosine deaminase by interferon-a and INF-g, 210, Cellular tropism
feline immunodeficiency virus, role of envelope glycoprotein, 206,508
SL2 (Spodoptera littoralis), wild-type AcNPV-induced apoptosis, 209, 796
HIV-1 in T cells, effects of amino acid changes in gp120 V2 domain,519
SRS (ascites tumor), derived virus from TSZ complex from mainland 206, 878
HTLV-II, in peripheral blood mononuclear cells from patients withChina, biological characterization and molecular cloning, 212,
367 high viral load, 206, 1126
Central nervous systemTrichoplusia ni
rice tungro bacilliform virus-infected, reverse transcriptase proteo- B10 mouse, H-2D-restricted cytotoxic lymphocytes in, targeting of
Theiler’s virus capsid proteins VP1 and VP2, 214, 91lytic processing and activation, 208, 207
tomato spotted wilt virus-infected, tubular structures, induction by HIV-1-directed gene expression, role of neurodevelopmental
changes, analysis in transgenic mouse, 210, 361viral nonstructural Nsm protein, 214, 485
U937 (human promonocytic leukemia) Venezuelan equine encephalitis virus neuroinvasion via olfactory
system and trigeminal nerve (mouse), 208, 662acyclovir-treated, HIV-1 spread, protection by Tat-inducible HSV-
1 thymidine kinase gene expression, 206, 495 vesicular stomatitis virus entry after infection of olfactory neuroepi-
thelium, early events (mouse), 209, 257CD4 surface expression, downregulation by HIV-1 Nef protein, role
of CD4 lck-binding domain, 207, 338 CFA virus
and SRE and RYU viruses: different evolutionary rates in genus Flavi-human cytomegalovirus IE2 protein-mediated transcriptional acti-
vation, negative regulation by retinoblastoma gene product, 208, virus, 206, 1133
Channel catfish virus450
UB31-B3 (human glioblastoma), human cytomegalovirus-induced attenuation by thymidine kinase gene deletion, effect on infectivity,
209, 658syncytia formation, effect of viral glycoprotein B mutation, 209,
580 structural proteins, identification by mass spectrometry, 206, 1035
Chemokine receptorsU (human amnion), induction of double-stranded RNA-specific aden-
osine deaminase by interferon-a and INF-g, 210, 508 G protein-coupled, capripoxvirus HindIII Q2 fragment encoding ho-
molog of, sequence analysis, 209, 207Vero (African green monkey kidney)
African swine fever virus-infected, replication of transfected plas- Cherry leafroll virus
accumulation in tobacco protoplasts, reduction by transient expres-mid DNA in, 207, 392
avian infectious bronchitis virus-infected, expression of ORF 1a- sion of viral antisense RNA and coat protein-encoding se-
quences, 208, 132encoded 87-kDa polypeptide, 208, 48
hamster neurotropic strain measles virus persistent infection: infections, associated subgenomic RNA, description, 211, 33
Chicken anemia virusphosphoprotein hypermutation and altered mRNA editing, 207,
555 genomic organization, 209, 480
Chimpanzee lentivirushantavirus cultivation: viral isolates from California, 206, 963
HSV-1-infected, association of ICP4 and ICP0, effect of cell type, natural infection, virologic and serologic characterization, 211, 312
Chitinase211, 209
HSV UL41-transfected, CAT reporter gene inhibition by virion host encoding gene in Autographa californica nuclear polyhedrosis virus
genome, identification and characterization, 212, 673shutoff protein in absence of other viral gene products, 211, 491
influenza A virus abortive infection, 212, 225 Chloramphenicol acetyltransferase
reporter gene, expression in Vero cells, inhibition by HSV virion hostKunjin virus antigenic variation, 206, 49
measles virus infection shutoff protein in absence of other viral gene products, 211, 491
Chlorella viruscure with MV antisense sequences, 207, 168
effect of membrane cofactor protein lacking N-glycans, 210, 479 CVK1, genome, induction of large deletions in, 214, 405
PBCV-1polarized, measles virus preferential entry and release through
apical plasma membrane, 210, 91 330-kb genome, 43 kb of DNA located at left end, analysis, 212,
134poliovirus type 3 Sabin strain microevolution in, implications for
vaccine quality control, 211, 377 antigenic variants, large deletions in, properties, 214, 413
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genome, 45 kb of DNA located at left end, analysis, 206, 339 neurotrophic, chronically infected mouse, astrocyte activation in spi-
nal cord, 213, 482Chlorosis
severe, tobacco mosaic virus coat protein inducing, role of single Cotia virus
nucleotide change, 207, 234 DNA characterization and physical mapping, and localization of thy-
Chondroitin sulfate midine kinase gene, 210, 67
and herpes simplex virus type 1, interaction during infection in ab- Cottontail rabbit papillomavirus
sence of heparan sulfate, 208, 531 E2 protein, immune response to, association with tumor regression,
Choristoneura fumiferana nuclear polyhedrosis virus 208, 298
DNA polymerase gene, identification, localization, transcription, and postattachment neutralization by monoclonal and polyclonal antibod-
sequence analysis, 209, 538 ies, 207, 136
genome, origin of DNA replication, identification and analysis, 209, Cowpea chlorotic mottle virus
409 3a gene, role in infection spread and host specificity, 206, 276
Chromosomes in vitro assembly from coat protein expressed in Escherichia coli
17q23.2– 17q25.3, human T-cell lymphotropic virus putative cell sur- and in vitro-transcribed viral cDNA, 207, 486
face receptor localization, 212, 196 Coxsackie A virus
Cis-acting elements
serotype comparison by sequencing of 3* and 5* untranslated re-
in barley yellows dwarf virus RNA replication, identification, 212, 186
gions, VP4–VP2 capsid protein, and polymerase 3D region, 212,
in bovine immunodeficiency virus LTR, identification, 209, 604
30
encephalomyocarditis virus internal ribosomal entry site, 214, 660
Coxsackievirus B4measles virus genomic termini, role in efficient expression and prop-
proteinase 2A, role in picornavirus 2A proteinase-mediated stimula-agation of reporter gene: rescue of synthetic MV minireplicons,
tion of internal initiation of translation, 213, 549208, 800
Crystallizationin vesicular stomatitis virus RNA encapsidation, replication, and bud-
bluetongue virus type 1 core particle, 210, 217ding into infectious defective interfering particles, 206, 760
CTL, see Cytotoxic T cellsCitrus tristeza virus
Cucumber mosaic virusIsraeli VT strain, associated defective RNA molecules, identification,
3a gene, transgenic tobacco expressing, complementation of virus208, 383
movement, 209, 188plants infected with, multiple species of defective RNA in, identifica-
antibodies, production from synthetic phage display library, 214, 235tion, 214, 264
helper virus strains Fny and Sny, RNAs and associated proteins,RNA genome, sequence analysis, 208, 511
accumulation in tobacco and zucchini squash, differential ef-subgenomic RNAs, characterization in infected tissues, 208, 576
fects of satellite RNA, 208, 58Cleavage
primary site, 2A/2B, hepatitis A virus polyprotein, identification and and related cucumoviruses, phylogenetic analysis, 207, 334
site-directed mutagenesis, effect on infectivity of HAV RNA tran- RNA, cell-to-cell trafficking in tobacco plants, potentiation by viral 3a
scripts, 213, 213 protein, 207, 345
self-cleavage site, NIa C-terminal 27-kDa protease of, turnip mosaic satellite RNA, hypervariable region variation, role of helper virus and
potyvirus C5, expression, purification, and identification, 213, initial sequence context, 206, 765
517 Cucumber necrosis virus
virulent avian influenza virus hemagglutinin by subtilisin-like endo- 0.9-kb subgenomic RNA, promoter for, deletion analysis, 214, 100
proteases, role of amino acid immediately downstream from coat protein gene, mutational analysis, 206, 38
cleavage site, 210, 466 defective interfering RNAs, accumulation in infected host plant, host
Cocksfoot mottle virus effects and essential sequences, 210, 41
putative replicase, translation as part of polyprotein by 01 ribosomal and defective interfering RNAs, coinfections of synthetic transcripts
frameshift, 207, 566 from cDNA clones, DI RNA dimers formed during, characteriza-
Coconut foliar decay virus tion and biological activity, 207, 282
replication-related gene, poly(A) addition site mapping and polyade-
Cucurbit aphid-borne yellows virus
nylation signal analysis in, 211, 345
full-length infectious cDNA clone, synthesis and use in gene ex-Complementation
change experiments with structural proteins from other luteovi-intragenomic, dicistronic poliovirus 3AB mutant, 209, 315
ruses, 214, 150in trans, defective point mutants of encephalomyocarditis virus inter-
and other luteoviruses, amino acid sequence alignment: evidence fornal ribosome entry site, 214, 82
recombination due to base-pairing between genomes of distinctturnip crinkle virus p28 and p88 replication components, 211, 525
viruses, 206, 1129Complexation
Culture mediaRev-T retrovirus v-Rel oncoprotein with Rel-related proteins in trans-
low-ionic-strength, Sindbis virus mutant resistant to inhibited releaseformed cells, 207, 362
in, isolation and identification of amino acids conferring resis-Computer modeling
tance, 210, 237prototypic and aberrant nucleocapsids of varicella–zoster virus, 214,
Cyclic AMP-response element321
and TATA box, role in herpes simplex virus type 1 latency-associatedConserved domains
transcript expression in murine trigeminal ganglia, 210, 141I, Sendai virus L polymerase protein, mutations in, effect on transcrip-
Cyclosporin Ation and replication, 213, 352
blockage of Epstein–Barr virus lytic cycle induction by anti-immuno-Copy number
globulin in lymphoma cells, 209, 225high, bovine papilloma virus, maintenance in transformed mouse cell
Cydia pomonella granulosis viruslines, 213, 526
Coronavirus, see also specific coronavirus identification of transposon TCl4.7 after coinfection with Cyp-
tophlebia leucotreta granulosis virus in C. leucotreta larvae, 207,feline, molecular genetics: comparative sequence analysis of ORF7a/
7b transcription unit of different biotypes, 212, 622 369
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Cymbidium ringspot virus lymphocytic choriomeningitis escape variants, biologic activity in
vivo, 211, 443defective interfering RNA dimers, generation, 207, 510
MHC class I H-2KB-restricted clone, simian virus 40 large T antigenresistance in transgenic tobacco plants expressing full-length viral
minimal recognition epitopes, identification, 208, 159replicase gene, characterization, 212, 240
MHC class I-restrictedRNA, accumulation, role of 3* terminal putative stem–loop structure,
measles virus nucleoprotein presentation, role of CD46 and effects214, 269
of viral inactivation, 212, 255satellite RNA mutants, replication, 206, 1092
response to measles virus nucleocapsid protein, induction by rep-Cyptophlebia leucotreta granulosis virus
lication-deficient adenovirus vector in murine model, 210, 456coinfection with C. pomonella granulosis virus in Cyptophlebia leuco-
MHC class I susceptibility to, adenovirus E1A regions affecting, iden-treta larvae, subsequent identification of transposon TCl4.7 in
tification, 211, 268CpGV genome, 207, 369
recognition of Epstein–Barr virus nuclear antigen 1, effect of se-Cysteine
quence variation in C-terminal unique domain (human), 208, 521conserved residues in simian immunodeficiency virus matrix protein,
response tomutational analysis, 210, 501
HIV-1 envelope glycoprotein, development in HIV-1–SIV-infectedCys76, and Gly75, conserved residues, role in HIV-1 Vpr function,
rhesus monkey, 208, 770210, 495
partially attenuated simian immunodeficiency virus nef deletionmajor antigenic region of hepatitis B virus small envelope proteins,
mutant (rhesus monkey), 212, 392role in assembly, secretion, and antigenicity, 211, 535
mutations, on transmembrane protein of Moloney murine leukemia
virus, analysis, 211, 285 D
Cysteine proteinase inhibitors
DansylcadaverineE64d, effect on mouse hepatitis virus strain A59 replication and pro-
tein processing, 208, 1 enhancement of rotavirus infection in murine L cells, 212, 429
DeacylationCytarabine
effect on Amsacta moorei entomopoxvirus growth in Lymantria dispar influenza A virus hemagglutinin by site-directed mutagenesis and
hydroxylamine treatment, effect on fusogenic properties, 210,cells, 211, 462
20Cytochalasin D
Dengue-2 virusenhancement of rotavirus infection in murine L cells, 212, 429
binding to human platelets, enhancement by antibodies, 213, 254induced p6.9 proteolysis in Autographa californica M nuclear polyhe-
drosis virus-infected cells, 207, 1 Dengue virus type 4
growth-restricted mutants containing deletions in 5* noncoding re-Cytolysis
gion of RNA genome, construction, 207, 68adenovirus-infected and -immortalized human cells by NK cells, sus-
ceptibility, effects of E1A gene expression, 210, 421 Dexamethasone
mediated suppression of HIV gene expression, role of glucocorticoidCytomegalovirus
receptor binding sites in HIV-1 long terminal repeat, 214, 512human
Dhori virusglycoprotein B proteolytic processing, mediation by furin, 206, 746
tick-borne, inborn resistance in mouse, role of Mx1 and MxA, 211,IE2 protein, mediated transcriptional activation, negative regula-
296tion by retinoblastoma gene product, 208, 450
Diadromus pulchellus reovirusimmediate early enhancer/promoter, stimulation by TNF-a in HL-
60 cells, mediation via NF-kB induction, 208, 197 double-stranded RNA genome segments, sequence analysis, 210,
109syncytia formation, effect of glycoprotein B mutation, 209, 580
Differentiationmurine
dependent transcription, epidermodysplasia verruciformis-associ-IE2 protein, role in viral growth and latency in infected mouse,
ated human papillomavirus type 5 in benign lesions, 214, 245209, 236
epithelial cells bearing HPV type 31b episomes, role in expressionimmediate-early gene expression, inhibition by interferon-a by
of HPV type 31b E1 P E4 protein, 206, 679down-regulation of NF-kB activity, 211, 251
monocytes/macrophages, effect on Puumala virus infection (human),and SV40, promoters, rabies virus DNA vaccine with, effect on im-
206, 8mune response in mouse, 209, 569
state, effect on Theiler’s virus growth in murine macrophage cellCytopathicity
lines, 209, 437hepatitis A virus cytopathic variants, associated genomic regions:
Dimerizationinfectious cDNA clone, 212, 686
human papillomavirus E7 oncoprotein in vivo, 214, 289Cytoskeleton
Rous sarcoma virus RNA in vitro and in vivo, 212, 47Sendai virus-infected BHK cells, components, interaction with fusion,
matrix, and hemagglutinin–neuraminidase proteins, 209, 701 Dinucleotides
altered content in latently transcribed regions of alphaherpesvirusCytotoxic T cells
DNA, implications for latent RNA expression and DNA structure,cross-reactive, induction by HIV-1 V3 loop synthetic peptides from
209, 358different viral strains, 211, 261
Diseaseescape variants of lymphocytic choriomeningitis virus and vaccinia
virus, generation and molecular characterization, 210, 29 attenuation, implications of effect of defective interfering RNA on
accumulation of tomato bushy stunt virus proteins, 211, 324feline immunodeficiency virus-specific, from chronically infected
cats, induction in vitro by retroviral vector-transduced feline T mucosal, bovine viral diarrhea virus onset after vaccination, effects
of genetic recombination between viral genotypes 1 and 2, 212,cells expressing FIV capsid protein, 209, 390
259influenza A virus-specific H-2d restricted cross-reactive epitope, de-
tection in hemagglutinin HA2 subunit of A/Udorn/72, 214, 445 DNA
adeno-associated virus, covalent linkage to viral Rep78 protein inisolation from healthy seropositive individuals specific for peptide
epitopes from Epstein– Barr virus nuclear antigen 1, 214, 633 preformed virion, 214, 360
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African cassava mosaic virus, strand nicking within conserved no- genomic, chicken anemia virus, cloning and sequencing, 209, 480
herpes simplex virus type I in trigeminal ganglia of latently infectednanucleotide motif during initiation of rolling circle replication,
206, 707 mouse, detection by in situ PCR, 206, 633
HIV-1 nef and LTR, sequence variation in sequentially derived iso-alphaherpesvirus, latently transcribed regions, altered dinucleotide
content, implications for latent RNA expression and DNA struc- lates, 208, 388
human genomic, endogenous HERV-H retroviral elements in, evi-ture, 209, 358
amplification in host cell genome by herpes simplex virus, suppres- dence for amplification via retrotransposition, 206, 164
human herpesvirus type 6 strain U1102, sequence structure, codingsion by adeno-associated virus type 2 rep gene, required se-
quence elements for, 206, 254 content, and genome evolution, 209, 29
human papillomavirus type 1A, replication, stimulation by mulimer-bacteriophage Cp-1 of Streptococcus pneumoniae, left early region
coding for terminal protein and DNA polymerase, nucleotide ized AT-rich palindromic sequence, 214, 301
infectious proviral clones of chimpanzee foamy virus generated bysequence and transcription, 211, 21
bacteriophage l, in vitro DNA packaging, defined system for, 211, long PCR, based evidence for close functional relatedness to
human foamy virus, 214, 685367
bacteriophage T7 inoculation in vivo, in induction of humoral and cellular immune re-
sponses to HIV-1 in nonhuman primates, 211, 102mature, single-stranded breaks in, 211, 329
packaged, specific nonproductive cleavage in vivo, 210, 409 linear duplex, adeno-associated virus, replication in vitro, minimum
origin requirements, 209, 692bending in wheat dwarf geminivirus large intergenic region, 208, 303
binding properties of immediate–early gene product of equine her- major binding protein, ICP-130, equine herpesvirus type 1, character-
ization and localization, 207, 380pesvirus type 1, characterization, 213, 46
bovine papillomavirus type 1, origin-specific binding and interaction open reading frames, see Open reading frames
Orgyia pseudotsugata baculovirus, replicationwith E2 transactivator, mapping of required E1 replication pro-
tein domains for, 211, 385 genes influencing, 212, 650
lef-3 gene essential for, identification and sequence and transcrip-capripoxvirus HindIII Q2 fragment encoding G protein-coupled chem-
okine receptor homolog, sequence analysis, 209, 207 tional analysis, 210, 372
packaging, see DNA packagingChlorella virus
CVK1 genome, induction of large deletions in, 214, 405 plasmid, African swine fever virus, replication in infected Vero cells
transfected with, 207, 392PBCV-1, 330-kb genome
43 kb, analysis, 212, 134 porcine adenovirus serotypes 1 to 5, inverted terminal repetition
sequences, comparison, 212, 23745 kb, analysis, 206, 339
antigenic variants, large deletions in, properties, 214, 413 primate genome: evolutionary origin and age of HERV-H family of
human endogenous retrovirus-like sequences, 213, 395complementary
cowpea chlorotic mottle virus, in vitro-transcribed, and coat protein proviral, nonproducer-interfering HIV-1, effect of full expression on
transfected HeLa CD4/ cell HIV susceptibility, 206, 76expressed in Escherichia coli, viral assembly in vitro from, 207,
486 rearrangements, effect on BK virus productive infection in urinary
tract tumors, 214, 273cytopathic hepatitis A virus, infectious clone, 212, 686
full-length infectious, clone of cucurbit aphid-borne yellows virus, repetitive element in Feldmannia sp. virus, characterization, 212, 474
simian parvovirus, cloning and sequencing, and homology with hu-synthesis and use in gene exchange experiments with structural
proteins from other luteoviruses, 214, 150 man parvovirus B19, 210, 314
simian virus 40 sequences, detection in human choroid plexus andLeishmania RNA virus, nucleotide sequence, 212, 84
Marek’s disease virus, mapping to BamHI-I2, -Q2, and -L fragments ependymoma tumors, 212, 710
subterranean clover stunt virus, nucleotide sequencing, 207, 354of MDV genome from transformed and persistently infected
cells, isolation and characterization (chicken), 213, 590 vaccinia virus, homologous recombination fidelity, 209, 688
woodchuck hepatitis virus, integration in B3N locus in woodchuckMtv-6 endogenous provirus, sequence analysis, 206, 395
mutated murine intracellular interferon-g, induction of IFN-induc- hepatocellular carcinoma, recurrence, 214, 229
DNA-binding proteinsible gene expression in human cells expressing: abrogation of
species specificity barrier, 212, 438 Epstein–Barr virus, major, interaction with viral DNase, 208, 712
RBP-Jk, interaction with Epstein–Barr virus nuclear antigen 2–estro-peste des petits ruminants virus nucleoprotein, cloning and ex-
pression in baculovirus for use in serological diagnosis, 208, gen receptor fusion proteins, 214, 675
sequence-specific, squirrel monkey retrovirus, interacting with direct776
rice yellow mottle virus, full-length infectious, synthesis, 206, 108 repeats in long terminal repeat, identification (human), 211, 316
single-stranded, adenovirus-encoded, mutations altering accumula-sigma rhabdovirus of Drosophila genes 2 and 3, nucleotide se-
quence, 213, 300 tion of early and late viral RNAs, identification, 212, 91
DNA-directed DNA polymerasesquirrel monkey retrovirus-B95–8, nucleotide sequence, 209, 374
Trichomonas vaginalis virus T1 isolate double-stranded RNA, se- adenovirus, temperature-sensitive, biochemical characterization,
205, 364; erratum, 207, 342quence analysis, 206, 773
Cotia virus, characterization and physical mapping, and localization African swine fever virus, encoding gene, nucleotide sequence, 214,
72of thymidine kinase gene, 210, 67
double-stranded, phage fiber genes, sequencing and evidence for Bombyx mori nuclear polyhedrosis virus, gene encoding, nucleotide
sequence and transcriptional analysis, 206, 435common ancestor, 212, 128
Epstein–Barr virus, selective loss after long-term cultivation of Bur- Choristoneura fumiferana nuclear polyhedrosis virus, gene encoding,
identification, localization, transcription, and sequence analysis,kitt’s lymphoma1 B-lymphoblastoid cell hybrids, role of chroma-
tin instability at integration site, 212, 179 209, 538
Epstein–Barr virus, stimulation by EBV EA-D, effects of EA-D muta-equine infectious anemia virus, incorporation of uracil into, correla-
tion with reduced viral replication in macrophages, 210, 302 tions, 211, 593
left early region of Streptococcus pneumoniae bacteriophage Cp-1expressing HIV-1 Env and noninfectious HIV-1 particles, induced
antibody response in mouse, 209, 147 coding for, nucleotide sequence and transcription, 211, 21
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and thymidine kinase, herpes simplex virus type 2, drugs or muta- preC region sequences, role in pregenomic RNA accumulation, 207,
549tions inhibiting, synergistic effects on ganglionic infections, 206,
263 in primary duck hepatocytes, potent inhibition by recombinant duck
interferon, 212, 641DNA-directed RNA polymerase
DUTPase, see dUTP pyrophosphatasecapsid, VP4–VP2, coxsackie A virus serotypes, sequence compari-
DUTP pyrophosphataseson, 212, 30
equine infectious anemia virus, mutation, effect on viral replicationmolluscum contagiosum virus, 22-kDa and 147-kDa subunits, gene
in macrophages, 210, 302encoding, identification and properties, 210, 471
vaccinia virus and T7, editing of Ebola virus glycoprotein mRNA, 214,
421 E
DNA ligase
Ebola virusvaccinia virus, residues essential for covalent catalysis, mutational
glycoprotein mRNA, editing by EBO polymerase and T7 and vacciniaanalysis, 211, 73
virus polymerases, 214, 421DNA packaging
Ectocarpus siliculosus virusbacteriophage l DNA in vitro, defined system for, 211, 367
coat protein, properties and improved virus isolation procedure, 206,bacteriophage f29 pRNA essential for, antisense oligonucleotides
520targeting, inhibition of viral assembly, 211, 568
Ectromelia virusbacteriophage T3, inhibitory effect of hexapeptide analog of packag-
and vaccinia virus, interferon-g-binding proteins, species specificity,ing protein prohead-binding domain, 211, 516
208, 762DNA polymerase, see DNA-directed DNA polymerase
EggsDNA replication
embryonated, fluids and chorioallantoic membrane cells, selectionAcNPV in infected Sf9 cells, role of homologous region 1a, 208, 742
of different variants of influenza A viruses (chicken), 211, 302adenovirus, DNA polymerase role, analysis with temperature-sensi-
Electron cryomicrographytive Pol, 205, 364; erratum, 207, 342
in determination of tobacco ringspot virus-like particle 3D structure,beet curly top geminivirus, strain-specific determinants, 206, 904
213, 472
bovine herpesvirus 4, dependence on S phase of cell cycle, effect
El Moro Canyon hantavirus
on viral replication in vitro, 213, 328
M genomic segment, nucleotide sequence analysis, 211, 336
cellular and simian virus 40, inhibition by adeno-associated virus rep
Encapsidation
gene, 207, 246
adenovirus type 2 proteinase, effect of proline 137 mutation, 209,
HIV-1
167
in infected CD4/ T cells and monocytes, comparison, 206, 731 HIV-1, nonsufficiency of viral RNA 5* regions: implications for HIV-1
Nef-mediated optimization, relationship to Nef-mediated CD4 packaging signal, 212, 718
downregulation, 212, 451 T 4 Nudaurelia capensis v virus capsid protein mRNA, in baculovi-
negative-strand, GrA hypermutation in HIV-1VAU provirus, role of lo- rus expression system, 207, 89
cal sequence determinants, 208, 601 vesicular stomatitis virus RNA, required cis-acting sequences in ter-
Orgyia pseudotsugata nuclear polyhedrosis virus mini of VSV defective interfering particle RNAs, 206, 760
identification of essential trans-acting regions and replication gene Encephalomyocarditis virus
lef-1, 207, 417 internal ribosomal entry site
second putative origin of, identification and characterization, 207, cis-acting elements, 214, 660
572 defective point mutants, complementation in trans, 214, 82
rolling circle, African cassava mosaic virus recombinants, initiation- Endogenous retroviruses
associated strand nicking within conserved nonanucleotide mo- defective RNA, efficient transmission by infectious particles pro-
tif, 206, 707 duced on avian retroviral vector packaging cell line, 207, 271
varicella–zoster virus origin-binding protein substitution for herpes ERV-3, envelope protein expression: abundance in placental tropho-
simplex OBP in transient origin-dependent assay in Sf9 cells, blasts (human), 211, 589
206, 655 HERV-H, evolutionary origin and age (human), 213, 395
DNase Endonucleases
Epstein–Barr virus, characterization and interaction with major DNA- RNA polymerase subunit PB2, influenza A virus, cleavage of host cell
binding protein, 208, 712 mRNA and trimeric enzyme function, 208, 38
DNA topoisomerase type I Endoproteinases
orf virus, identification and characterization, 206, 203 subtilisin-like, virulent avian influenza virus hemagglutinin cleavabil-
DNA viruses ity by, role of amino acid immediately downstream from cleav-
interferon-a-producing cells responding to, frequency, 204, 1; erra- age site, 210, 466
tum, 206, 1159, 207, 342 Endothelial cells
Dose–mortality relationships in bone marrow stromal layer, susceptibility to HIV-1 infection (hu-
Autographa californica nuclear polyhedrosis virus in Trichoplusia ni man), 208, 779
and Heliothis virescens larvae, comparison, 209, 561 Enhancer–promoters
Drug resistance, see also Multidrug resistance immediate early, human cytomegalovirus, stimulation in HL-60 cells
HIV-1 to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine and deriv- by TNF-a, mediation via NF-kB induction, 208, 197
atives, generation by mutations at multiple sites of reverse tran- tyrosinase, hybrid LTRs containing, Moloney murine leukemia virus-
scriptase, 210, 186 derived retroviral vectors with, tissue-specific gene expression
influenza viruses to 4-guanidino-Neu5Ac2en, molecular basis, 214, in mouse from, 214, 307
642 Enhancers
Duck hepatitis B virus duck hepatitis B virus, HNF3 and HNF1 transcriptional factors, rela-
tionship, 213, 231enhancer, HNF3 and HNF1 transcriptional factors, relationship, 213,
231 ENII, hepatitis B virus, binding and activation by HNF3, 214, 371
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epithelial-specific, HPV type 16, activation by Oct-1 via synergistic linear B-cell
interaction with NFI at conserved composite regulatory element, hepatitis C virus NS3–NS4–NS5 proteins, synthetic peptide mod-
207, 77 eling, 206, 666
hepatitis B virus, binding and activation by hepatocyte nuclear factor and immunodominant regions, gE envelope protein of varicella–
3, 207, 98 zoster virus, identification, 214, 531
HPV type 31b, transcriptional activity, regulation via synergistic inter- MHC class I-binding, Epstein–Barr virus, associated nuclear antigen
action of AP1 with cellular factors, 211, 184 1 C-terminal unique domain, sequence variation, 208, 521
Enteroviruses neutralizing
68, 69, and 71, serotype comparison by sequencing of 3* and 5* bluetongue virus, homotypic and heterotypic, identification, 209,
untranslated regions, VP4–VP2 capsid protein, and polymerase 263
3D region, 212, 30 bovine herpesvirus type 1 glycoprotein D, fine mapping with type-
Entomopoxvirus specific mAb and sequence comparison with BHV-5 gD, 206,
242from Amsacta moorei, growth in Lymantria dispar cells, effects of
viral inhibitors, 211, 462 human rotavirus ST3, independent, identification on VP4 trypsin
cleavage products, 206, 148Envelope
caprine arthritis–encephalitis virus provirus/ visna virus, sequence mengo virus, characterization, 214, 118
variation, 209, 297 porcine group C rotavirus gene 3-encoded 82-kDa protein, identifi-
herpes simplex virions, glycoconjugate intermediate forms in, detec- cation, 208, 354
tion during transport along exocytic pathway, 214, 619 peptide, from Epstein–Barr virus nuclear antigen 1, healthy seroposi-
vaccinia virus tive individuals specific for, CTL isolation, 214, 633
organization and relationship to structure of intracellular mature poliovirus canyon rim residue, modulation of serotype-specific bind-
virions, 214, 503 ing of viruses to poliovirus receptor mutants, 214, 559
role of spicules in formation, analysis with conditional lethal mu- serotype-specific, infectious pancreatic necrosis virus VP2, mapping,
tant, 214, 494 209, 684
Epidermodysplasia verruciformis simian virus 40 large T antigen, recognizing MHC-I H-2Kb antigen-
associated human papillomavirus type 5 in benign lesions, differenti- restricted CTL clones, identification, 208, 159
ation-dependent transcription, 214, 245 T cell
Epithelial cells to bovine papillomavirus type 4, mapping, 206, 504
Epstein–Barr virus receptor CR2-transfected, in detection of MHC HLA class II-restricted, in human hepatomas, hepatitis B virus core
class II on virion, 213, 147 antigen mutation accumulation, 212, 151
Epithelium tobacco mosaic virus, kinetic and functional mapping using biosen-
midgut, Spodoptera exigua larva, Autographa californica nuclear sor technology, 213, 462
polyhedrosis virus passage, 208, 328 transmissible gastroenteritis virus nucleoprotein, elicitation of T
Epitope dilution assay helper cells collaborating in in vitro antibody synthesis to three
via predicted coiled coils, in determination of paramyxovirus phos- major structural viral proteins, 212, 746
phoprotein formation of homotrimers, 214, 139 Epizootic hemorrhagic disease virus
Epitope mapping and other orbiviruses, nonstructural NS2 proteins, structure and
antigenic epitopes, putative RNA-directed RNA polymerase of blue- ssRNA-binding ability, comparison, 209, 624
tongue virus U.S. serotypes, 214, 280 Epstein–Barr virus
Ty1 virus-like particle, 207, 59 anti-immunoglobulin induction of lytic cycle in lymphoma cells,
Epitopes blockage by cyclosporin A and FK506, 209, 225
antigenic, Murray Valley encephalitis virus envelope protein, struc- B95–8 cells producing, transmissible retrovirus in, identification and
tural and functional analysis, 211, 10 characterization, 209, 374
B-and T-cell, 10-amino-acid linear sequence of foot-and-mouth dis- diffused-form early antigen EA-D, functional analysis, 211, 593
ease virus VP1 containing, conferral of protection in mouse, 212, DNase, characterization and interaction with major DNA-binding pro-
614 tein, 208, 712
CD4/ T cells, identification in mouse hepatitis virus M protein, 208, efficient superinfection of group I Burkitt’s lymphoma cells, role of
173 Cp viral promoter expression and relationship to EBV productive
cytotoxic T cell cycle, 206, 866
cross-reactive, influenza A virus-specific H-2d restricted, detection Fp promoter, positive cis-regulatory elements, fine mapping, 206,
in hemagglutinin HA2 subunit of A/Udorn/72, 214, 445 183
mutations, role in production of CTL escape viral variants in vivo, genomic region BamHI-A, complementary-strand transcripts, expres-
210, 29 sion in EBV-carrying B cell lines, 208, 180
foot-and-mouth disease virus gp150 expressed from BDLF3 open reading frame, 209, 108
direct evaluation of immunodominance in natural host, 206, 298 and HIV-1, lack of pseudotype formation in productively coinfected
VP1 G-H loop, recognition by murine monoclonal antibodies, 210, B lymphoblastoid cells, 209, 643; erratum, 212, 757
120 infection of CR2-transfected epithelial cells, in detection of MHC
HIV-1 class II on virion, 213, 147
gp41 extracellular domain, monoclonal antibody binding, 206, 713 integrated genomes, selective loss after long-term cultivation of Bur-
kitt’s lymphoma1 B-lymphoblastoid cell hybrids, role of chroma-gp120, gp120–CD4 complex-dependent, identification by mono-
clonal antibodies, 211, 583 tin instability at integration site, 212, 179
latency, disruption by ZEBRA protein, restoration by addition of heter-infectious pancreatic necrosis virus major structural protein, localiza-
tion and strain variability, 214, 40 ologous activation regions, 211, 64
nuclear antigen 1, peptide epitopes from, healthy seropositive indi-influenza A virus hemagglutinin, conserved, recognition by neutraliz-
ing monoclonal antibody, 212, 526 viduals specific for, CTL isolation, 214, 633
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nuclear antigen 2, –estrogen receptor fusion proteins, transactiva- primates, mobilization of ERV9 human endogenous retroviral element
during, 213, 271tion of viral and cellular genes and interaction with RBP-Jk, 214,
675 RNA phages: relationship of PP7 phage from Pseudomonas aerugi-
nosa to coliphages, 206, 611nuclear antigen 2A and 2B, rat monoclonal antibodies differentiating,
Ross River virus, and geographic distribution, in Australia and Pacificproduction, 208, 336
Islands, 212, 20nuclear antigen EBNA-1, C-terminal unique domain, antigenic and
simian immunodeficiency virus quasispecies in vivo, requirement ofsequence variation, 208, 521
massive viral replication and clearance, 208, 644replicative gene transcription during de novo infection in human thy-
tick-borne encephalitis virus strains, hypothesis based on sequencemocytes, simultaneous early expression of BZLF-1 and repres-
analysis of 3*-noncoding region, 213, 169sor RAZ, 208, 685
Exocytic pathwayEquine arteritis virus
herpes simplex virion transport, detection of virion envelope glyco-field isolates, ORF 5 phylogenetic analysis, and identification of con-
conjugate intermediate forms during, 214, 619served and nonconserved regions in GL envelope glycoprotein,
Exo-a-sialidase214, 690
cooperative activity in paramyxovirus, 213, 241major envelope glycoprotein, neutralization site, identification, 207,
–hemagglutinin, see Hemagglutinin–neuraminidase518
influenza virus, variant with decreased sensitivity to 4-guanidino-subgenomic RNA, transcription, UV inactivation and translation inhi-
Neu5Ac2en, generation and characterization, 214, 475bition studies, 213, 364
inhibitor 4-guanidino-2,4-dideoxy-2,3-dehyro-N-acetylneuraminic acid,Equine encephalitis virus
inhibition of avian influenza A virus replication, 212, 323Venezuelan, see Venezuelan equine encephalitis virus
N9 subtype, influenza virus, red cells bound to, release by enzymeEquine herpesvirus type 1
activity, 211, 278challenge infection in murine model, effects of vaccination with for-
resistant N-thioacetylneuraminic acid acrylamide copolymer, sup-mulations of recombinant glycoprotein gp14, 208, 500
pression of influenza A virus infection, 212, 340gene 12, transactivation via octamer sequences in EHV IE gene
role in fowl plague virus hemagglutinin activity, 212, 77promoter, 213, 258
role in human parainfluenza virus type 3 life cycle, 214, 294ICP22 protein, regulatory function, characterization, 210, 273
IE gene promoter, octamer sequences, in transactivation of EHV-1
Fgene 12, 213, 258
immediate–early gene product, DNA binding properties, character-
Fab fragmentsization, 213, 46
chimeric macaque/human, neutralization of simian immunodefi-
Kentucky A strain, glycoprotein D, synthesis and processing, 208, 9
ciency virus, 207, 495
major DNA-binding protein, characterization and localization, 207,
Fc receptors
380
mediated adsorption of foot-and-mouth disease virus by macro-
Equine infectious anemia virus
phages, subsequent restriction of viral replication, 207, 503
DNA, incorporation of uracil into, correlation with reduced viral repli- membrane, role in HIV-1 entry in choriocarcinoma cells, 208, 784
cation in macrophages, 210, 302 Feldmannia sp. virus
Erythrocytes repetitive DNA element, characterization, 212, 474
binding activities of dimple and canyon regions of canine parvovirus Feline calicivirus
capsid, 211, 123 Urbana strain, RNA transcripts derived from cloned full-length ge-
bound to influenza virus N9 neuraminidase, release by enzyme activ- nome copy, infectivity, role of VpG, 210, 383
ity, 211, 278 Feline herpesvirus type 1
Escherichia coli recombinant, with deletion in genes for glycoproteins gI and gE, as
expressed cowpea chlorotic mottle virus coat protein, and in vitro vaccine for feline rhinotracheitis, 214, 12
transcribed viral DNA, viral assembly in vitro from, 207, 486 short segment of viral genome, transcriptional analysis and inser-
expression of tional mutagenesis of ORF US8.5, 208, 704
Gag–Pol-encoded avian retroviral proteinase, associated produc- Feline immunodeficiency virus
tion of proteinase PR(/IleGly), 207, 185 host cell range, correlation with envelope fusogenic properties, 206,
HSV-1 uracil–DNA glycosylase, 211, 307 796
human respiratory syncytial virus phosphoprotein P, 205, 93; erra- LTR C/EBP binding site, role in efficient viral replication and in inhibi-
tum, 209, 284 tion of FIV LTR-directed gene expression by pseudorabies virus
tobacco etch virus recombinant NIa proteinase, 210, 194 ICP4, 208, 492
Estrogen receptor specific cytotoxic T lymphocytes from chronically infected cats, in-
–Epstein–Barr virus nuclear antigen 2 fusion proteins, transactiva- duction in vitro by retroviral vector-transduced feline T cells
tion of viral and cellular genes and interaction with RBP-Jk, 214, expressing FIV capsid protein, 209, 390
675 Feline leukemia virus
Evolution, see also Phylogeny induced multicentric lymphomas, genetic determinants, 214, 431
Bacillus subtilis bacteriophage f29 holin gene, conservation of dual induced thymic lymphomas, long terminal repeat alterations, in vivo
translational start motif, 206, 479 selection, 206, 661
coliphage 186 tail fiber genes, DNA sequence and evidence for variants, occurrence in experimentally induced thymic lymphosarco-
common ancestor of dsDNA phage fiber genes, 212, 128 mas (cat), 214, 584
cytopathic simian immunodeficiency virus variants, 207, 528 Feline rhinotracheitis
HERV-H endogenous retroviruses, 213, 395 immunization against, with recombinant feline herpesvirus-1 with
human herpesvirus type 6 strain U1102 genome, 209, 29 deletion in genes for glycoprotein gI and gE as, 214, 12
modular, phage genomes: genetic relationship between lytic and Fiber
temperate phages, 212, 632 encoding gene, and hexon gene, in immunological adenovirus sub-
genus D variant strains, sequence comparison, 213, 313mouse hepatitis virus during chronic infection, 209, 337
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Fibers Fusolins
Melolontha melolontha entomopoxvirus, relationship to lepidopteranhuman adenovirus type 2, receptor-binding domain, localization of
antigenic sites, 214, 110 EPV fusolin and to baculovirus 37K glycoprotein, 208, 427
Fibroblasts
avian reovirus growth, comparison with primary tendon cells (chicken G
embryo), 207, 117
in bone marrow stromal layer, susceptibility to HIV-1 infection (hu- b-Galactosidase
man), 208, 779 expression by human adenovirus type 5-based vectors in HeLa cells,
human cytomegalovirus-infected, proteolytic processing of viral gly- 210, 226
coprotein B, mediation by furin, 206, 746 gene encoding, under control of HIV-1 or HTLV-I LTR, expression by
in long-term culture, transformation by chimeric jun oncogene (quail murine cells, stimulation by transfected human PKR, 214, 653
embryo), 207, 321 HIV-1 LTR-directed expression in developing central nervous system
quiescent nonproliferating, West Nile virus early expression of inter- of transgenic mouse, 210, 361
feron-independent virus-specific ICAM-1, implications for virus – Galactosylceramide
host interactions, 208, 437 oligodendrocytes expressing, putative binding by HIV-1 gp120 and
Firefly luciferase, see Photinus-luciferin 4-monooxygenase (ATP-hy- associated increased intracellular Ca2/, analysis (rat), 206, 1084
drolyzing) Ganglia
FK506 trigeminal, see Trigeminal ganglia
blockage of Epstein–Barr virus lytic cycle induction by anti-immuno- Geminiviruses
globulin in lymphoma cells, 209, 225 subterranean clover stunt virus affinities with: nucleotide sequenc-
Flaviviruses ing, 207, 354
different evolutionary rate: phylogeny of TYU, SRE, and CFA viruses, Gene exchange
206, 1133 experiments with structural proteins from luteoviruses, use of full-
Foot-and-mouth disease virus length infectious cDNA clone of cucurbit aphid-borne yellows
3C proteinase, active-site residues, identification, 213, 581 virus, 214, 150
acid-resistant mutant, characterization, 206, 69 Genes
leader protein, critical amino acids, identification, 213, 140 1
major antigenic site, direct evaluation of immunodominance in natu- mouse hepatitis virus A59, 65-kDa proteins processed from, identi-
ral host, 206, 298 fication and characterization, 207, 316
protease 3C expression, effect on viral infection and gene expres- polyprotein-encoding, transmissible gastroenteritis virus, nucleo-
sion, 212, 111 tide sequence, 206, 817
replication in macrophage cell cultures, restriction after Fc receptor- 2 and 3, sigma rhabdovirus of Drosophila, nucleotide sequence, 213,
mediated adsorption, 207, 503 300
serotype C, swine polyclonal antibodies and murine monoclonal anti- 3, porcine group C rotavirus, encoding 82-kDa protein, associated
bodies to, reactivity with synthetic peptides of VP1 G-H loop, neutralizing epitope, identification, 208, 354
210, 120 3a
VP1 10-amino-acid linear sequence containing B- and T-cell epi- cowpea chlorotic mottle bromovirus, relationship to infection
topes, induction of protection in mouse, 212, 614 spread and host specificity, 206, 276
Formaldehyde cucumber mosaic virus, transgenic tobacco expressing, comple-
measles virus inactivation by, effects on CD46-dependent presenta- mentation of virus movement, 209, 188
tion to murine MHC class I-restricted CTLs and MHC class II- 12, equine herpesvirus 1, transactivation via octamer sequences in
restricted helper T cells, 212, 255 EHV IE gene promoter, 213, 258
Foscarnet 33K, ovine adenovirus homologue, sequence, 209, 400
HIV-1 strain resistant to, characterization, 212, 58 63, varicella-zoster virus, transcript mapping and regulatory activity,
Fowl plague virus 209, 218
abortive infection of Vero cells, 212, 225 100K hexon assembly, ovine adenovirus homologue, sequence, 209,
hemagglutinin activity, role of neuraminidase, 212, 77 400
Fowlpox virus A224L, African swine fever virus, encoded IAP homologue, identifica-
Marek’s disease virus ORFs homologous to, nucleotide sequences, tion as late structural polypeptide, 214, 670
206, 324 apoptotic, Fas antigen, activation upon influenza virus infection, role
Frameshifting of spontaneously produced b-interferon, 209, 288
ribosomal, see Ribosomal frameshifting 2–5A synthetase, induction by interferon-g, mechanism, 211, 113
Friend murine leukemia virus attachment glycoproteins of pneumonia virus of mice, from mouse
FB29, induced neurodegeneration of rat: correlation of neuropatho- and tissue culture-passaged strains, nucleotide sequencing,
genicity with cellular tropism, 214, 239 207, 240
infection, resistance in transgenic and bone marrow chimeric mice B3N locus, in hepatocellular carcinoma, woodchuck hepatitis virus
with Fv4 env-expressing hematopoietic cells, 208, 75 integration in, recurrence (woodchuck), 214, 229
inoculation with, preventative effects against perinatal neurotropic barley yellow dwarf virus PAV serotype, products involved in RNA
retrovirus CasBrE infection in mouse, 206, 372 replication, identification, 212, 186
Furin bel 1, human foamy virus, expression, effect of promoter II TATA box
mutation, 206, 601mediation of human cytomegalovirus glycoprotein B proteolytic pro-
cessing, 206, 746 BL1 and BR1, bipartite geminiviruses, virus and host-specific adapta-
tions, 214, 330Furoviruses
genomic organization, heterogeneity: potato mop-top virus RNA3 se- bovine herpesvirus-1 3*-coterminal cluster containing UL1–UL3.5
ORFs, identification and transcriptional analysis, 213, 28quence analysis and gene content, 206, 701
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BZLF-1, Epstein–Barr virus, and repressor RAZ, simultaneous ex- gag
HIV-1, host cell-dependent mutant, generation and characteriza-pression during de novo infection in human thymocytes, 208,
685 tion, 212, 251
HIV-1, matrix-deficient mutant, inhibition of wild-type virus produc-capsid protein, human papillomavirus type 16 and type 31, sequence
variation, 214, 664 tion, 208, 808
human T-cell leukemia virus type 2, translation efficiency, modula-CAT, efficient expression and propagation from synthetic measles
virus minireplicons, role of cis-acting elements in genomic ter- tion of ribosomal frameshifting frequency, 208, 312
gag–pol, avian retroviral proteinase encoded by, expression in Esch-mini, 208, 800
CAT reporter, expression in Vero cells, inhibition by HSV virion host erichia coli and production of proteinase PR(/IleGly), 207, 185
b-galactosidaseshutoff protein in absence of other viral gene products, 211, 491
cell-to-cell movement 3a, brome mosaic virus, coding changes, ef- under control of HIV-1 or HTLV-I LTR, expression by murine cells,
stimulation by transfected human PKR, 214, 653fects on host range of viral systemic infection, 214, 464
c-erB, insertionally activated, transformation resistance, phenotype expression by human adenovirus type 5-based vectors in HeLa
cells, 210, 226dominance in avian and murine fibroblasts, 212, 277
chitinase, in Autographa californica nuclear polyhedrosis virus ge- HIV-1 LTR-driven expression in developing central nervous system
of transgenic mouse, 210, 361nome, identification and characterization, 212, 673
coat protein, tobacco mosaic virus, role of single nucleotide change glycoprotein, rabies virus, long 3* noncoding region lacking pseu-
dogene properties, 206, 718in induction of severe chlorosis, 207, 234
core protein, hepatitis C virus, differential subcellular localization, glycoproteins gI and gE, deletion in, recombinant feline herpesvirus-
1 with, as vaccine for feline rhinotracheitis, 214, 12213, 455
cucumber necrosis virus coat protein, mutational analysis, 206, 38 hemagglutinin, avian influenza virus highly pathogenic and non-
pathogenic strains, phylogenetic analysis, 209, 664DNA-dependent RNA polymerase, molluscum contagiosum virus, 22-
kDa and 147-kDa subunits, identification and properties, 210, hemagglutinin H, measles virus, complementary antisense mRNA
sequences, cure of persistently MV-infected cells, 207, 168471
E1A, adenovirus, hexon, human adenovirus subgenus B and E, sequence comparison,
212, 232autoregulation, phenotypic determinants: variable region between
conserved coding domains 2 and 3, 213, 666 hexon and fiber, immunological adenovirus subgenus D variant
strains, sequence comparison, 213, 313expression, induced susceptibility to NK cell killing in human cells,
effects of Ad infection versus immortalization, 210, 421 HIV-1, steroid-mediated suppression of expression, role of glucocor-
ticoid receptor binding sites in HIV-1 long terminal repeat, 214,E2 and E3, Ross River virus, nucleotide sequence analysis, 212, 20
E5, HPV type 16, expression and detection in COS cells, 211, 227 512
holin, Bacillus subtilis bacteriophage f29, evolutionary conservationE7, HPV type 16, expression levels, correlation with transforming
potential, 207, 260 of dual translational start motif, 206, 479
human polyoma JC virus, transcriptional regulation of expression,env
bovine leukemia virus proviral sequences, in vivo mutations during review, 213, 283
ICP4 and ICP0, herpes simplex virus, TAATGARAT motifs, positivevirus-induced leukemogenesis, 206, 769
hepatitis B virus, deletion and site-specific mutants expressed in and negative regulation, 207, 107
ie1, AcNPV temperature-sensitive mutant, associated amino acid293 cells, analysis, 213, 57
HIV-1 substitutions, effect on protein interaction with viral enhancer
elements, 209, 90derived antisense RNA, 19-kDa protein encoded by, recognition
in sera of HIV-infected individuals, 206, 196 immediate-early
murine cytomegalovirus, expression, inhibition by interferon-a byfrom individuals infected from same source, sequence distances
between, implications for study of transmission events, 211, down-regulation of NF-kB activity, 211, 251
pseudorabies virus, chimeric trans-gene product repressing tran-198
microglial-associated SIV, enrichment of env quasispecies in brain scription of, inhibition of viral replication, 210, 128
immediate–early product, equine herpesvirus type 1, DNA bindingafter serial passages, 212, 458
simian immunodeficiency virus, constant regions 3 and 4, effects properties, characterization, 213, 46
jun, chimeric, transformation of long-term quail fibroblast culture,of mutations, 210, 448
expression by foot-and-mouth disease virus, effects of protease 3C 207, 321
L, measles virus, nucleotide sequences from wild-type virus andexpression, 212, 111
F and L, human respiratory syncytial virus cold-passaged attenuated SSPE brain tissue, comparison, 208, 795
L2 and L3, beet curly top virus, role in viral pathogenesis, 206, 1044strain, mutations, identification, 208, 478
feline immunodeficiency virus LTR-directed expression by pseudora- L3, mediated resistance against tobamoviruses, role of coat protein
(Capsicum chinese), 209, 498bies virus ICP4, inhibition by FIV LTR C/EBP site, 208, 492
fiber lef-1, Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis
virus, role in viral DNA replication, 207, 417adenovirus subgenus D, characterization, 206, 564
adenovirus types Ad35p and Ad34a, organization and hemaggluti- lef-3, Orgyia pseudotsugata baculovirus, identification and sequence
and transcriptional analysis, 210, 372nating capacity, comparison, 206, 686
ovine adenovirus homologue, sequence, 209, 400 M2 and L2, temperature-sensitive lesion-containing, reovirus mutant
tsA279 with, characterization as defective in transmembranefirefly luciferase, expression by human adenovirus type 5-based vec-
tors in HeLa cells, 210, 226 transport and deficient in viral protein production, 207, 46
MDR1, as selectable marker in Harvey murine sarcoma virus retrovi-foreign, human foamy virus-constructed replication-competent ret-
roviral vectors directing high-level expression in BHK-21 cells, ral vector, virus production and gene transduction efficiency,
208, 621210, 167
Fv4, envelope, Friend murine leukemia, expression by hematopoietic mdr3–mouse mammary tumor virus, fusion transcript activation from
cryptic viral promoter, stimulation by mdr-derived sequence incells in transgenic and bone marrow chimeric mice, correlation
with resistance to retroviral infection, 208, 75 intron I, 210, 244
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nef pepper mild mottle tobamovirus, 54-kDa region, Nicotiana ben-
thamiana transformed with, resistance responses against viralHIV-1, sequence variation in sequentially derived isolates, 208,
388 infection, 211, 170
HIV-1 and HIV-2 phenotypes with mutations in, manifestation, role RNA-directed RNA polymerase, carmovirus-related, specific detec-
of virus and host components, 213, 158 tion with highly conserved motifs in plant virus RdRp as tags,
nested, p19 and p22, functioning in cell-to-cell movement and host- 207, 312
dependent systemic invasion, regulation of tomato bushy stunt rotavirus group A, virulence- and host range restriction-associated,
virus spread, 213, 425 identification in gnobiotic piglet model, 209, 274
non-H-2-linked, effects on anti-virus immune responses and long- serpins B13R and B22R, vaccinia virus, characterization, 206, 136
term survival in mouse with persistent E-55/ murine leukemia surface envelope, bovine lentivirus, identification of hypervariable
virus infection, 211, 507 and conserved regions, 212, 728
nonstructural protein NSP3, rotavirus serotype G, comparative nucle- tail fiber, coliphage 186, DNA sequence and evidence for common
otide and amino acid sequence analysis, 207, 327 ancestor of dsDNA phage fiber genes, 212, 128
nonvirion protein, of unknown function, viral hemorrhagic septicemia tail sheath and tail tube, coliphage 186, nucleotide sequencing, 212,
virus region containing, genomic organization, 212, 741 218
nucleoprotein, rabies virus and lyssavirus genotypes, phylogenetic tat, HIV-1, enhancement of human herpesvirus type 6 replication,
analysis, 209, 526 211, 544
nucleoprotein N, measles virus, complementary antisense mRNA thymidine kinase
sequences, cure of persistently MV-infected cells, 207, 168 Cotia virus, nucleotide sequence and amino acid sequence homol-
nucleoprotein and phosphoprotein, measles virus hamster neuro- ogy with other poxvirus TK genes, 210, 67
tropic and Philadelphia 26 strains, comparison, 207, 555 HSV-1, Tat-inducible, expression, protection of acyclovir-treated
in Orgyia pseudotsugata baculovirus DNA replication, analysis: lef- CD4 cells from HIV-1 spread by conditional suicide and reverse
2 and ie-1 as essential and ie-2, ie-3, and Op-iap as stimulatory transcription inhibition, 206, 495
genes, 212, 650 tissue-specific expression from Moloney murine leukemia virus-de-
p2, replicase, alfalfa mosaic virus, mediated resistance in trans- rived retroviral vectors with hybrid LTRs containing murine ty-
formed tobacco plants, 207, 467 rosinase enhancer/promoter, 214, 307
p17 structural protein, African swine fever virus, mapping and se- UL6 and UL7, HSV-1, transcript analysis, and association of UL6
quencing, 206, 1140 protein with viral capsids, 206, 465
p39, peanut clump virus RNA 2, in vitro translation by leaky scanning UL21, pseudorabiesvirus, mutations affecting, role in avirulence of
mechanism, 208, 215 live attenuated Bartha vaccine strain, 212, 466
p53, tumor suppressor, mutations, association with bovine leukemia UL21 to UL4, herpes simplex virus, 30-kb region of bovine herpesvi-
virus-induced leukemogenesis (bovine, sheep), 209, 676 rus 1 genome exhibiting colinear gene arrangement with, nucle-
pk2, AcNPV, encoding truncated protein kinase homolog, expression otide sequence, 210, 100
and functional analysis, 206, 314
UL39, UL38, and UL37, bovine herpesvirus type 1, sequence analysis,
plant circovirus replication-related, poly(A) addition site mapping and
and expression studies of ribonucleotide reductase subunits
polyadenylation signal analysis in, 211, 345
UL40 and UL39, 212, 734
pol
V, J, W, and I, bacteriophage P2, involved in baseplate assembly,
Bombyx mori nuclear polyhedrosis virus, nucleotide sequence and
sequences, 213, 109
transcriptional analysis, 206, 435
vaccinia virus A38L, product identification as 33-kDa integral mem-full-length, S71-related human endogenous retroviral sequences
brane glycoprotein, 214, 177with, identification, 209, 550
VA RNA, human and simian adenoviruses, phylogenetic inferencesHIV-1
from, 207, 32hairpin ribozyme targeted to, in vitro and in vivo characterization,
viral and cellular, transactivation by Epstein–Barr virus nuclear anti-206, 381
gen 2–estrogen receptor fusion proteins, 214, 675inhibitor-escape mutant, single point mutation-induced impair-
v-myb, avian myeloblastosis virus, weak transcriptional activation-ment of infectivity, 210, 212
induced transformation of QT6 fibroblasts, 208, 467human foamy virus, reverse transcriptase and ribonuclease H do-
for VP1 of hepatitis A virus, proposed, encoding of protein largermains, molecular biological characterization, 213, 97
than protein observed in HAV-infected cells and virions, 213,in phylogenetic analysis of primate foamy viruses, 207, 577
671poly(A) polymerase, molluscum contagiosum virus, identification and
vpr, HIV-1, role in efficient viral replication in mononuclear phago-properties, 210, 471
cytes, 206, 935preS and core, hepatitis B virus, mutation frequency in isolates from
Gene therapychronic HBV-infected patients and correlation with disease se-
with Harvey murine sarcoma virus retroviral vector using MDR1 asverity, 208, 672
selectable marker, virus production and foreign gene transduc-promoters, see Promoters
tion efficiency, 208, 621pVIII, ovine adenovirus homologue, sequence, 209, 400
Genetic analysisQ2/3L, capripoxvirus, encoding G protein-coupled chemokine recep-
lytic and temperate phages: genetic relationship between temperatetor homolog, sequence analysis, 209, 207
Streptococcus thermophilus bacteriophage and lytic phages,RAZ, Epstein–Barr virus, and BZLF-1, simultaneous expression dur-
212, 632ing de novo infection in human thymocytes, 208, 685
Genetic determinantsrep, adeno-associated virus
feline leukemia virus-induced multicentric lymphomas, 214, 431AAV type 2, sequence elements required for suppression of herpes
HIV-1 growth in monocyte macrophages, 206, 646simplex virus-induced DNA amplification, 206, 254
Genetic mapinhibition of cellular and simian virus 40 DNA replication, 207, 246
orf virus, establishment, 212, 698replicase
Genetic reassortmentcymbidium ringspot virus, full-length, transgenic tobacco plants
expressing, characterization of resistance in, 212, 240 Sin Nombre virus by natural occurrence, 214, 602
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Genome amplification E2
rubella virus, secreted forms, expression and characterization intobacco etch potyvirus, role of helper component–proteinase-medi-
Sf9 cells, 206, 736ated proteolysis, 209, 268
Sindbis virus, ectodomain mutations, mapping in 6K protein mutantGenome typing
pseudorevertant correcting for aberrant particle formation, 206,rice dwarf Phytoreovirus, 212, 724
1027Genomic organization
Ebola virus, mRNA, editing by EBO polymerase and T7 and vacciniaAfrican swine fever virus strain BA71V, 208, 249
virus polymerases, 214, 421Borna disease virus, minireview, 210, 1
envelopechicken anemia virus, 209, 480
feline immunodeficiency virus, role in cell tropism, 206, 796furovirus, heterogeneity: potato mop-top virus RNA3 sequence analy-
GL, equine arteritis virus, conserved and nonconserved regions,sis and gene content, 206, 701
identification, 214, 690herpesvirus of turkeys: identification of ORF in long unique region
gp140, SIV isolate 251, monoclonal antibodies against, specificityand truncated pp38 homolog in internal repeat, 207, 205
and neutralizing capacity, 211, 339
human herpesvirus type 6 strain U1102, 209, 29
gp150, expression by Epstein–Barr virus BDLF3 open reading
lettuce infectious yellows virus, 208, 99 frame, 209, 108
orf virus, high degree of conservation among divergent poxviruses: hepatitis B virus, N-linked glycosylation, role in viral secretion,
genetic map establishment, 212, 698 213, 660
viral hemorrhagic septicemia virus region containing gene coding HIV-1 cytotoxic T-cell responses specific to, development in SIV–
for nonstructural protein of unknown function, 212, 741 HIV-1-infected monkey, 208, 770
Genomic variability Rous sarcoma virus, lysosomally targeted, transport, role of tran-
hepatitis B virus preS and core regions, frequency in isolates from sient cell surface expression, 206, 353
chronic HBV-infected patients and correlation with disease se- fusion, Newcastle disease virus, depression of syncytia formation
verity, 208, 672 by mutations in cytoplasmic domain, 210, 264
G-H loop G1
foot-and-mouth disease virus, VP1, epitope recognition by murine California encephalitis virus, role in in vitro and in vivo infection,
monoclonal antibodies, 210, 120 206, 945
Glucocorticoid receptor mediated entry pathway common to California serogroup: bunyvi-
binding sites, in HIV-1 long terminal repeat, role in steroid-mediated rus tropism, 214, 339
suppression of HIV gene expression, 214, 512 G1 and G2, Uukuniemi virus, homodimeric association, 211, 241
gH:gL complex, varicella–zoster virus, cell surface expression andGlutathione S-transferase
fusion, analysis by laser scanning confocal microscopy, 210,tagged HIV-1 gp120, expression, purification, and interaction with
429CD26, 208, 142
gI and gE, encoding genes, deletion in, recombinant feline herpesvi-N-Glycans
rus-1 with, as vaccine for feline rhinotracheitis, 214, 12role in membrane cofactor protein function as measles virus recep-
gp1tor, 210, 479
Ectocarpus siliculosus virus, amino acid sequence, 206, 520Glycine
lymphocytic choriomeningitis virus, acid-induced structuralGly75, and Cys76, conserved residues, role in HIV-1 Vpr function,
changes, pH dependence and kinetics, 209, 3210, 495
gp14, equine herpesvirus type 1, vaccination with recombinant for-Glycoconjugates
mulations, protective effects against EHV-1 challenge infectionintermediate forms, detection in herpes simplex virion envelope dur-
in murine model, 208, 500ing transport along exocytic pathway, 214, 619
gp41, HIV-1, extracellular domain, epitope binding by monoclonalGlycoproteins
antibodies, 206, 71311-kDa, mouse adenovirus type 1 early region 3-encoded, character-
gp64, envelope fusion, Orgyia pseudotsugata nuclear polyhedrosisization, 208, 457
virus, synthesis, oligomerization, and processing in infected Ly-
33-kDa integral membrane, vaccinia virus A38L gene product identifi-
mantria dispar cells, 209, 592
cation as, 214, 177
gp120, HIV-1
attachment, pneumonia virus of mice, encoding genes, nucleotide
–CD4 covalently crosslinked complexes, monoclonal antibodies
sequence for mouse and tissue culture-passaged strains, 207,
raised against, identification of complex-dependent gp120 epi-
240
tope, 211, 583
B, human cytomegalovirus, proteolytic processing, mediation by furin, glutathione S-transferase-tagged, expression, purification, and in-
206, 746
teraction with CD26, 208, 142
baculovirus-related, thogoto virus, immune protection abilities, 213, putative binding to galactosylceramide-expressing oligodendro-
249 cytes and associated increased intracellular Ca2/, analysis, 206,
B and C, bovine herpesvirus type 1, heparin binding, 209, 230 1084
C T-cell line-tropic, effect of amino acid changes in V2 domain, 206,
HSV-1 and HSV-2, differential role in viral binding, effect on sero- 878
type differences in cell tropism, 214, 29 V3 loop
respiratory bovine herpesvirus 1 and neurovirulent BHV-5, anti- amino acid substitutions in, role in adaptation to growth of mac-
genic variation between, molecular basis, 213, 558 rophage-tropic clone in transformed T cell lines, 210, 490
D multibranched peptide constructs derived from, inhibition of viral
bovine herpesvirus type 1 infection via CD4 interaction, 206, 457
modulatory function in viral entry, 207, 429 role in restriction of viral entry of T-cell tropic strains in macro-
neutralizing epitopes, fine mapping with type-specific mAb and phages, 209, 696
sequence comparison with BHV-5 gD, 206, 242 synthetic peptides derived from, enhancement of cell binding
and infection, minimal sequence requirements, 206, 807equine herpesvirus type 1, synthesis and processing, 208, 9
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value in molecular transmission studies, 211, 198 causative agent Black Creek Canal virus, genetic and serologic anal-
ysis (human, rat), 210, 482gp160, simian immunodeficiency virus, processing, effects of muta-
Harvey murine sarcoma virustions in env constant regions 3 and 4, 210, 448
based retroviral vector with MDR1 as selectable marker, virus pro-gpFI, in defined system for in vitro bacteriophage l DNA packaging,
duction and foreign gene transduction efficiency, 208, 621211, 367
HB receptorH, bovine herpesvirus type 1, synthesis and processing, 206, 651
sensitivity to N9 influenza neuraminidase activity, 211, 278major envelope, equine arteritis virus, neutralization site, identifica-
Helicasetion, 207, 518
related protein, and polymerase-like protein, brome mosaic virus,Marburg virus, acylation, 208, 289
interaction, biochemical and genetic analysis, 214, 59rabies virus
Helicoverpa armigera stunt viruslong 3* noncoding region lacking pseudogene properties, 206, 718
larger genomic RNA encoding viral RNA polymerase, nucleotide se-monoclonal antibodies neutralizing, effect of acidic configuration,
quence, 208, 84210, 400
Helper component–proteinaseSU, oncoretroviral, maturation and translocation, effects of mutations
mediated proteolysis, role in tobacco etch potyvirus genome amplifi-in CWLC motif conserved cysteine residues, 206, 885
cation, 209, 268Venezuelan equine encephalitis virus, specific mutations, effects on
Helper T cellsdisease progression in mouse model, 206, 994
collaborating in in vitro antibody synthesis to three major structuralGlycosaminoglycan
transmissible gastroenteritis coronavirus proteins, elicitation byheparan sulfate, structural features required in inhibition of herpes
viral nucleoprotein epitope, 212, 746simplex virus type 1 binding, analysis with related chemically
MHC class II-restricted, measles virus nucleoprotein presentation,modified heparin compounds, 206, 1108
role of CD46 and effects of viral inactivation, 212, 255Glycosylation
Helper virusesKunjin virus E proteins, 206, 49
role in generation of cucumber mosaic virus satellite RNA hypervaria-N-Glycosylation
bility, 206, 765lactate dehydrogenase-elevating virus envelope proteins, 212, 512
Hemagglutinationrole in
adenoviruses Ad35p and Ad34a, fiber gene capacity for, comparison,hepatitis B virus secretion, 213, 660
206, 686
paramyxovirus SV5 fusion protein assembly, intracellular transport,
Murray Valley encephalitis virus envelope protein antigenic variants
and fusion activity, 209, 250
with altered properties, analysis, 211, 10
Goose parvovirus
Hemagglutinin
genome, cloning and partial nucleotide sequencing, and homology
avian influenza virus, genes from highly pathogenic and nonpatho-
to human adeno-associated virus type 2, 210, 283
genic strains, phylogenetic analysis, 209, 664
and muscovy duck parvovirus, nucleotide sequence analysis and cleavage site sequences and cleavability, in H5N2 influenza virus,
common ancestral origin with adeno-associated virus 2, 212, relationship to pathogenicity, 213, 223
562 fowl plague virus, hemagglutinating activity, role of neuraminidase,
G proteins 212, 77
chimeric and truncated, respiratory syncytial virus groups A and B, HA2 subunit, influenza A virus A/Udorn/72, detection of influenza
antigenic analysis, 209, 70 A virus-specific H-2d restricted cross-reactive cytotoxic T cell
secreted and membrane-bound, in rabies virus DNA vaccine, effect epitope, 214, 445
on immune response in mouse, 209, 569 highly pathogenic H7 subtype avian influenza virus, carbohydrate
4-Guanidino-2,4-dideoxy-2,3-dehyro-N-acetylneuraminic acid addition site, identification, 213, 276
inhibition of avian influenza A virus replication, 212, 323 influenza A virus, deacylated by site-directed mutagenesis and hy-
4-Guanidino-Neu5Ac2en droxylamine treatment, assessment of fusogenic properties,
influenza virus neuraminidase variant with decreased sensitivity to, 210, 20
generation and characterization, 214, 475 influenza B virus, structural analysis with site-directed mutagenesis,
resistance of influenza viruses to, molecular basis, 214, 642 206, 787
Guanosine nucleotides virulent avian influenza virus, cleavability by subtilisin-like endopro-
synthesis, inhibition by mycophenolic acid, as strategy for inhibition teases, role of amino acid immediately downstream from cleav-
of human immunodeficiency virus replication, 211, 554 age site, 210, 466
Hemagglutinin–esterase
pseudorecombinant mouse hepatitis virus expressing, generationH
with viral defective-interfering RNA as expression vector, 208,
Hantavirus 319
in California, related to hantaviruses causing hantavirus pulmonary Hemagglutinin H
syndrome measles virus, encoding gene, complementary antisense mRNA se-
complete nucleotide sequences of M and S sequences (deer quences, cure of persistently MV-infected cells, 207, 168
mouse), 206, 973 Hemagglutinin–neuraminidase
isolation and initial characterization (deer mouse), 206, 963 arainfluenza virus type 2, stalk domain, binding by cell fusion-inhib-
distinct lineages, coexistence in rodents indigenous to North iting monoclonal antibody (human), 206, 1117
America, 213, 122 human parainfluenza virus
prevalence and geographic genetic variation in New World harvest type 2, regions important for promotion of cell fusion, identification,
mice: identification of divergent genotype in Costa Rican strain, 213, 190
207, 452 type 3 variant, in analysis of neuraminidase role in viral life cycle,
Hantavirus pulmonary syndrome 214, 294
Newcastle disease virus, role of individual oligosaccharide chains,associated Sin Nombre virus, naturally occurring genetic reassort-
ment, 214, 602 212, 398
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parainfluenzavirus type 1, fusogenicity enhancement by single amino viral attachment, blockage by antibodies in human sera specific to
envelope protein E2 hypervariable region 1, 208, 653acid change, 209, 654
paramyxovirus Hepatocyte nuclear factors
HNF1 and HNF3, relationship in duck hepatitis B virus enhancer,domain required for promotion of cellular fusion by fusion protein
spike, localization, 209, 457 213, 231
HNF3membrane-spanning domain, structural requirements for forma-
tion of stable tetramer, 213, 263 binding and activation of hepatitis B virus enhancer, 207, 98
Sendai virus, interaction with host cytoskeletal and lipid components binding and activation of hepatitis B virus enhancer II, 214, 371
in infected BHK cells, 209, 701 functional binding site in hepatitis B virus nucleocapsid promoter,
Hematopoiesis characterization, 208, 147
support by bone marrow-adherent cells, effect of in vitro infection by Hepatocytes
HIV-1, 213, 245 cultured primary, duck hepatitis B virus in, potent inhibition by recom-
Hematopoietic cells binant duck interferon, 212, 641
Friend murine leukemia virus Fv4 env expression in transgenic and HEPT, see 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine
bone marrow chimeric mice, correlation with resistance to ret- Herpes simplex virus
roviral infections, 208, 75 ICP4 and ICP0 TAATGARAT motifs, positive and negative regulation,
Heparin 207, 107
binding by bovine herpesvirus type 1 glycoproteins B and C, and ICP27, acidic amino-terminal region, functional homology with vari-
effect on gC-minus virus infectivity, 209, 230 cella-zoster virus ORF4 amino-terminal region, 208, 376
structural features required for inhibition of herpes simplex virus type induced DNA amplification, suppression, sequence elements of ad-
1 binding, identification, 206, 1108 eno-associated virus rep gene required for, 206, 254
Hepatitis A virus induction by free and heteromeric forms of E2F transcription factor,
cytopathic, infectious cDNA clone: genomic regions associated with 213, 624
rapid replication and cytopathic effect, 212, 686 type 1
polyprotein, primary cleavage site, identification and site-directed association with ICP4 and ICP0, effect of host cell, 211, 209
mutagenesis, effect on infectivity of HAV RNA transcripts, 213, binding, heparin structural features required for inhibition, identifi-
213 cation, 206, 1108
VP1 protein, proposed gene, encoding of protein larger than protein ganglionic infections, synergistic effects of viral polymerase- and
observed in HAV-infected cells and virions, 213, 671 thymidine kinase-inhibiting drugs or mutations, 206, 263
Hepatitis B virus and HSV-2, glycoprotein C, differential role in viral binding, effect
core antigen mutations in hepatomas, accumulation in T-cell epi- on serotype differences in cell tropism, 214, 29
topes, 212, 151 ICPO, functional homology with pseudorabies virus early protein
core promoter, negative regulatory element, cell type-dependent reg- O, 209, 281
ulation of activity, 214, 198 immediate-early peptide Vmw110, multimerization and interaction
duck, see Duck hepatitis B virus with cellular 135-kDa protein, required sequences, identification,
enhancer, binding and activation by hepatocyte nuclear factor 3, 207, 209, 174
98 interaction with chondroitin sulfate proteoglycans during infection,
enhancer II, binding and activation by HNF3, 214, 371 208, 531
interferon action, mode, recombinant duck interferon as reagent for latency-associated transcripts, expression in murine trigeminal
studies, 212, 641 ganglia, role of cAMP-response element and TATA box, 210,
large surface antigen promoter, SP1-binding site, characterization, 141
208, 399 neuroattenuated mutant, in treatment of experimental intracranial
large surface protein, myristylation, role in viral infectivity, 213, 292 murine melanoma, 211, 94
L protein, retention in 293 cells, role of C-terminal PreS1 sequence, origin-binding protein, substitution by varicella–zoster virus OBP
213, 57 in transient origin-dependent DNA replication assay in Sf9 cells,
–mevalonate kinase fusion proteins and Mk overexpressed in hu- 206, 655
man hepatoma cell line PLC/PRF/5, enzymatic properties, 208, purified virions, tegument, association with UL37 protein, 206,
696 1055
nucleocapsid promoter, functional hepatocyte nuclear factor 3 bind- ribonucleotide reductase, subunits, intracellular localization of
ing site, characterization, 208, 147 subunits during infection of cultured cells, 213, 615
preS and core regions of viral genome, heterogeneity in isolates Tat-inducible thymidine kinase gene, expression, protection of
from chronic HBV-infected patients, 208, 672 acyclovir-treated CD4 cells from HIV-1 spread by conditional
secretion, role of N-linked glycosylation, 213, 660 suicide and reverse transcription inhibition, 206, 495
small envelope proteins lacking cysteines in major antigenic region, transactivator VP16, DNA-binding derivitives lacking carboxy-ter-
secretion and antigenicity, 211, 535 minal acidic activation domain, transcriptional activity, 209, 19
surface protein expression regulation, key role of CCAAT element, in trigeminal ganglia of latently infected mouse, detection by in
206, 1155 situ DNA PCR and RNA hybridization, 206, 633
two closely linked precore predominant mutations, mechanism of UL6 gene product, transcript analysis and association of encoded
natural occurrence, 211, 144 product with viral capsid, 206, 465
Hepatitis C virus UL21 to UL4 genes, 30-kb region of bovine herpesvirus 1 genome
core gene products, differential subcellular localization, 213, 455 exhibiting colinear gene arrangement with, nucleotide se-
quence, 210, 100NS3–NS4–NS5 proteins, linear B-cell epitopes, synthetic peptide
modeling, 206, 666 UL37 protein, association with tegument of purified virions, 206,
1055NS3 serine proteinase, in vitro assay, 209, 52
RNA, 5*-noncoding region, cellular protein-binding, role in viral repli- uracil–DNA glycosylase, expression, characterization, and inhibi-
tion by 6-(p-n-octylanilino)uracil, 211, 307cation and pathogenesis, 208, 723
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type 1 and 2 tobacco ringspot virus satellite RNA replication, initiation effective-
ness of linear and circular RNA (Phaseolus vulgaris), 208, 832associated 140-kDa RR1 protein, kinase autophosphorylation ac-
tivity and defective transphosphorylation, 207, 409 beet, beet curly top virus pathogenesis, role of L2 and L3 genes
(Beta vulgaris), 206, 1044DNA, latently transcribed regions, altered dinucleotide content,
implications for latent RNA expression and DNA structure, 209, beet armyworm, Autographa californica nuclear polyhedrosis virus
358 passage through larval midgut epithelium (Spodoptera exigua),
208, 328type 2
genital infection, subsequent HSV-specific T cells in murine female bovine
genital tract, analysis, 212, 481 bovine leukemia virus-induced leukemogenesis, relationship to
and HSV-1, glycoprotein C, differential role in viral binding, effect p53 tumor-suppressor gene mutations, 209, 676
on serotype differences in cell tropism, 214, 29 bovine papillomavirus type 4 infection, associated T-cell re-
humoral immune responses against, generation in murine female sponses to E7 protein and epitope mapping, 206, 504
genital tract, 206, 234 postvaccinal onset of bovine viral diarrhea virus mucosal disease,
ribonucleotide reductase, large subunit ICP10, intracellular inter- effects of genetic recombination between viral genotypes 1 and
nalization and associated signaling pathways, 210, 345 2, 212, 259
virion envelope, glycoconjugate intermediate forms, detection during brown alga
transport along exocytic pathway, 214, 619 Ectocarpus siliculosus virus-infected, virus isolation procedure
virion host shutoff protein, inhibition of reporter gene expression in and properties of viral coat protein (E. siliculosus), 206, 520
absence of other viral gene products, 211, 491 Feldmannia sp. virus infecting, repetitive DNA element, character-
Herpesvirus ization (Feldmannia sp), 212, 474
bovine, see Bovine herpesvirus brown planthopper, Nilaparvata lugens reovirus transmission via rice
channel catfish, see Channel catfish virus plant (Nilaparvata lugens), 207, 303
Herpesvirus of turkeys cabbage looper
gene organization: identification of ORF in long unique region and AcNPV early pathogenesis and dose–mortality relationship in
truncated pp38 homolog in internal repeat, 207, 205 larva (Trichoplusia ni), 209, 561
recombinant, expressing infectious bursal disease virus VP2 immu- fourth instar, orally inoculated with Autographa californica M nu-
nogen, induction of protection against IBDV virulent challenge clear polyhedrosis virus, developmental resistance (Trichoplusia
in chicken, 211, 481 ni), 209, 384
Herpesvirus saimiri cat, experimentally induced thymic lymphosarcomas, occurrence of
transformed T lymphocytes, interleukin-2 and IL-4 expression, 208, feline leukemia virus variants, 214, 584
418 chicken, pseudorabiesvirus virulence, effects of UL21 gene muta-
Herpesvirus type 1, see Equine herpesvirus type 1; Feline herpesvirus tions, 212, 466
type 1 citrus species, citrus tristeza virus subgenomic RNAs from infected
Herpesvirus type 6 tissues, characterization (Citrus aurantifolia, C. medica, C. si-
replication, enhancement by HIV-1 tat gene (human), 211, 544 nensis), 208, 576
strain U1102, DNA sequence: structure, coding content, and genome cotton rat
evolution (human), 209, 29 Black Creek Canal virus infection (Sigmodon hispidus), 210, 482
Hexapeptides bovine adenovirus type 3, pathogenesis and immunogenicity, 213,
analog of prohead-binding site of bacteriophage T3 packaging pro- 131
tein, in fine structure analysis, 211, 516 cowpea
Hexon brome mosaic virus systemic infection, effects of coding changes
encoding gene, and fiber gene, in immunological adenovirus subge- in 3a cell-to-cell movement gene (Vigna sinensis unguiculata),
nus D variant strains, sequence comparison, 213, 313 214, 464
Hexon assembly cowpea chlorotic mottle bromovirus infection spread and host
100K protein, encoding gene, ovine adenovirus homolog for, se- specificity, role of 3a gene (Vigna sinensis), 206, 276
quence, 209, 400 cucumber, accumulation of cucumber necrosis virus defective in-
HIV, see Human immunodeficiency virus terfering RNAs, host effects and essential sequences (Cucumis
Holins sativus), 210, 41
Bacillus subtilis bacteriophage f29, encoding gene, evolutionary Cyptophlebia leucotreta, identification of transposon TCl4.7 in Cydia
conservation of dual translational start motif, 206, 479 pomonella granulosis virus after larval coinfection with CpGV
Host index and C. leucotreta granulosis virus, 207, 369
alemow, citrus tristeza virus Israeli VT strain-infected, identification gorilla, simian foamy virus isolated from, functional and phylogenetic
of defective RNA molecules (Citrus macrophylla), 208, 383 relationship to human and primate foamy viruses (Gorilla gorilla),
207, 217baboon, simian retrovirus type D isolated from, characterization
(Papio cynocephalus), 207, 292 gypsy moth, Orgyia pseudotsugata nuclear polyhedrosis virus-in-
fected, GP64 envelope fusion protein synthesis, oligomerization,barley, brome mosaic virus systemic infection, effects of coding
changes in 3a cell-to-cell movement gene (Hordeum vulgare), and processing (Lymantria dispar), 209, 592
214, 464 hamster
barley and Chenopodium, biological significance of amino-terminal immune protection abilities of baculovirus-related glycoprotein of
basic residues of brome mosaic virus coat protein, 211, 42 thogoto virus, 213, 249
bean measles virus hamster neurotropic strain persistent infection:
phosphoprotein hypermutation and altered mRNA editing, 207,bean golden mosaic virus complementable and noncomplement-
able host adaptation defects (Phaseolus vulgaris), 212, 263 555
horse, equine infectious anemia virus replication in macrophages,bean golden mosaic virus/tomato golden mosaic virus hybrids
in, virus- and host-specific adaptations in BL1 and BR1 genes reduction, correlation with uracil incorporation into viral DNA,
210, 302(Phaseolus vulgaris), 214, 330
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human E-55/ murine leukemia virus persistent infection, associated anti-
virus immune responses and long-term survival, effects of non-Black Creek Canal virus-infected, immunoprecipitation analysis,
210, 482 H-2-linked genes, 211, 507
experimental intracranial melanoma, treatment with neuroattenu-chronic hepatitis B virus infection, preS and core regions of viral
genome in isolates from, heterogeneity and correlation with dis- ated HSV-1 mutant, 211, 94
foot-and-mouth disease virus challenge, protection by VP1 10-ease severity, 208, 672
chronic hepatitis C virus infected, serum antibodies to hypervari- amino-acid linear sequence containing T- and B-cell epitopes,
212, 614able region 1, blockage of viral attachment to tissue culture
cells, 208, 653 hantavirus prevalence and geographic genetic variation in: identifi-
cation of divergent genotype in Costa Rican strain (Reithrodonto-HIV-1-infected
bronchoalveolar lavage cells, in analysis of promoter insertion mys sp.), 207, 452
herpes simplex virus type 2 genital infection in female, HSV-spe-in vivo, 208, 359
nef and LTR sequence variation, assessment during course of cific T-cell response, analysis, 212, 481
herpes simplex virus type 2-induced humoral immune response,disease progression, 208, 388
HIV-1 subtype D, G, and A/D recombinant transmissions in Swe- generation in female genital tract, 206, 234
hMT-c-fos-LTR transgenic, bone tumorigenesis, enhancement byden, 209, 136
HTLV-II cellular tropism in peripheral blood, analysis with mononu- Akv murine leukemia virus, 206, 85
inborn resistance to tick-borne Dhori virus, role of Mx1 and MxA,clear cells isolated from patients with high viral load, 206, 1126
respiratory tissues with HPV type 11 latent infection, identification 211, 296
influenza virus A/WSN inoculation, subsequent isolation and char-of low-abundance RNA transcripts for viral E1 and E2 proteins,
212, 285 acterization of viral defective interfering RNAs from lung provid-
ing protection from lethal infection, 210, 9simian virus 40 natural strains, presence in choroid plexus and
ependymoma tumors, 212, 710 Japanese encephalitis virus lethal infection, protection by innocu-
lation with double-subgenomic Sindbis virus recombinants ex-jimsonweed
peanut chlorotic streak caulimovirus-infected, viral ORFs VII, A, B, pressing JEV immunogenic proteins, 212, 587
lymphocytic choriomeningitis infection, prevention by response toand C, functional significance (Datura stramonium), 206, 823
tomato spotted wilt virus-infected, identification of RNA-dependent CTL escape variants, 211, 443
lymphocytic choriomeningitis virus persistent infection in, viralRNA polymerase activity (Datura stramonium), 207, 308
Leishmania major, Leishmania RNA virus, cDNA and amino acid clearance, role of interferon g, 212, 244
mengo virus infection, with attenuated virus: characterization ofsequences, 212, 84
monkey neutralization epitopes, 214, 118
mouse hepatitis virus chronic infection, virus evolution during, 209,HIV-1– SIV-infected, development of HIV-1 Env-specific cytotoxic
T-cell response (Macaca mulatta), 208, 770 337
mouse mammary tumor virus endogenous provirus Mtv-6 expres-infected with partially attenuated simian immunodeficiency virus
nef deletion mutant, cellular immune response, 212, 392 sion and biological activity, 206, 395
murine cytomegalovirus infection, role of viral IE2 protein, 209,inoculated with attenuated SIV, limited viral spread and rapid im-
mune response in lymph nodes, 213, 535 236
murine rotavirus antibody production and protection from reinfec-lymphocyte-tropic SIV persistent infection in brain, 213, 600
neurovirulence of Sabin type 3 poliovirus temperature-sensitive tion, induction after single oral immunization in neonate, 211,
474derivatives, testing methods, 210, 160
poliovirus neurovirulence, effect of mutations accumulating on cul- myc-k transgenic and wild-type, lymphomagenesis, enhancement
by Akv murine leukemia virus, 206, 93tivation of Sabin 2 strain oral vaccine, 209, 366
simian immunodeficiency virus-infected neurotropic retrovirus CasBrE perinatal infection, prevention by
inoculation with Friend murine leukemia virus, 206, 372progression to AIDS in, association with replication, tropism,
and cytopathic properties of variant virus population (Macaca poliovirus-sensitive
neurovirulence of Sabin type 3 poliovirus temperature-sensitivenemestrina), 207, 528
viral neutralization by chimeric macaque/human Fab molecules derivatives, testing methods, 210, 160
in neurovirulence test for oral live poliovaccines, 206, 1075(Macaca fascicularis), 207, 495
viral quasispecies development in vivo, requirement of massive polyomavirus A2-induced runting in Balb/c and NIH Swiss strains,
potentiation by coinfection with Moloney murine leukemia virus:viral replication and clearance (Macacca fascicularis), 208,
644 model for mixed virus disease, 212, 356
polyomavirus persistence and reactivation, effects of incompletemosquito
California encephalitis virus infection, role of G1 protein (Aedes immunocompetence, 212, 268
rabies virus infection, immune effector mechanisms for protection,dorsalis), 206, 945
Sindbis virus replication and tissue tropism (Aedes albopictus), 214, 398
SCID, antibodies to HTLV-II external envelope in, rapid generation212, 1
mouse by growth of mouse plasmacytomas, 214, 680
Sendai virus infectionathymic mouse, human foreskin grafts to skin, analysis of mol-
luscum contagiosum virus replication in, 213, 655 kinetics of antibody-forming cell response in different anatomi-
cal locations, 207, 287B-cell deficient, rotavirus infection and protection against reinfec-
tion, resolution, effector functions of antibody and CD8/ cells, protection by immunization with human parainfluenza virus type
1, 212, 13214, 387
central nervous system, H-2D-restricted cytotoxic lymphocytes in, tick-borne encephalitis virus infection, effects on requirements for
nitric oxide synthesis in macrophages, 212, 174targeting of Theiler’s virus capsid proteins VP1 and VP2, 214,
91 transgenic and bone marrow chimeras with Friend murine leuke-
mia virus Fv4-env-expressing hematopoietic cells: retroviral in-chronically infected with neurotrophic coronavirus, astrocyte acti-
vation in spinal cord, 213, 482 fection resistance, 208, 75
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Venezuelan equine encephalitis virus-infected tobacco
induced disease, progression, effects of specific glycoprotein alfalfa mosaic virus
mutations, 206, 994 infection, replicase-mediated resistance (Nicotiana tabacum),
neuroinvasion, mechanism, 208, 662 207, 467
vesicular stomatitis virus infection of olfactory neuroepithelium and RNA synthesis, regulatory role of viral coat protein (Nicotiana
entry into CNS, early events, 209, 257 sp.), 208, 583
xenograft system, human papillomavirus type 11 E1 P E4 and L1 bean golden mosaic virus/tomato golden mosaic virus hybrids
proteins, colocalization at multiple time points, 214, 259 in, virus- and host-specific adaptations in BL1 and BR1 genes
nonhuman primates, DNA inoculation in vivo, in induction of humoral (Nicotiana benthamiana), 214, 330
and cellular immune responses to HIV-1, 211, 102 beet curly top virus
peach, Prunus necrotic ringspot virus PE-5 isolate RNA 3, nucleotide DNA replication, strain-specific determinants (Nicotiana ben-
sequence (Prunus persica), 208, 349 thamiana), 206, 904
pepper, L3 gene-mediated resistance against tobamoviruses, role of pathogenesis, role of L2 and L3 genes (Nicotiana benthamiana),
coat protein (Capsicum chinese), 209, 498 206, 1044
plant families, tomato bushy stunt virus spread in, regulation by beet necrotic yellow virus RNA infection, effects of P14 mutations
nested genes functioning in cell-to-cell movement and host- on RNA 2 and coat protein accumulation (Nicotiana tabacum),
dependent systemic invasion, 213, 425 210, 73
plants, infected with citrus tristeza virus, multiple species of defective cherry leafroll virus infection, associated subgenomic RNA (Nicoti-
RNA in, identification, 214, 264 ana tabacum), 211, 33
quinoa cucumber mosaic virus-infected
cherry leafroll virus infection, associated subgenomic RNA (Cheno- accumulation of defective interfering RNAs, host effects and
podium quinoa), 211, 33 essential sequences (Nicotiana benthamiana, N. clevelandi),
infection with beet necrotic yellow virus RNA, effects of P14 muta- 210, 41
tions on RNA 2 and coat protein accumulation (Chenopodium
accumulation of helper virus RNA and associated proteins, ef-
quiona), 210, 73
fects of satellite RNA (Nicotiana tabacum), 208, 58
potexvirus-infected, coat protein, subcellular immunolocalization
viral RNA trafficking in, potentiation by viral 3a protein (Nicotiana
(Chenopodium quinoa), 214, 314
tabacum), 207, 345
recombinant brome mosaic virus infectivity, stability, and activity
cucumber necrosis virus and defective interfering RNA/cDNA coin-(Chenopodium quinoa), 208, 370
fections, DI RNA dimers formed during, characterization and
rabbit
biological activity (Nicotiana clevelandii), 207, 282
CD4 transgenic and normal, apoptosis of lymphocytes from, effect
cymbidium ringspot virus resistance, in transgenic plants express-of HIV-1, 213, 450
ing full-length viral replicase gene, characterization (Nicotianaimmune response to cottontail rabbit papillomavirus E2 protein,
benthamiana), 212, 240association with tumor regression, 208, 298
cymbidium ringspot virus satellite RNA mutants in, replication (Ni-rabbitpox virus pathogenesis, role of 35-kDa major secreted pro-
cotiana benthamiana), 206, 1092tein, 206, 591
inoculation with cymbidium ringspot tombusvirus genomic andrat
defective interfering RNA transcripts, subsequent generation ofBorna disease virus inoculation with high-dose attenuated virus,
DI RNA dimers (Nicotiana benthamiana, N. clevelandii), 207,induction of protection against Borna disease, 206, 426
510murine coronavirus JHMV neurovirulence for, localization of deter-
protoplasts, cherry leafroll virus accumulation, reduction by tran-minant on S1 subunit, 208, 67
sient expression of viral antisense RNA and coat protein-encod-murine leukemia virus infection, effects of adoptive immune trans-
ing sequences (Nicotiana tabacum), 208, 132fers, 211, 408
red clover necrotic mosaic virus movement protein-transformed,red deer, parapoxvirus isolated from, evidence for inclusion in genus
viral movement in, role of virion formation (Nicotiana benthami-parapoxvirus (Cervus elaphus), 208, 812
ana), 212, 607rice, protoplasts, infection with rice yellow mottle virus full-length
satellite tobacco mosaic virus RNA accumulation and systemiccDNA clone (Oryza sativa), 206, 108
movement, effects of mutations in 5* and coat protein ORFsrodents indigenous to North America, coexistence of distinct hantavi-
(Nicotiana tabacum), 212, 121ruses (Microtus spp., Peromyscus spp., Reithrodontomys mega-
tobacco etch virus cell-to-cell and long distance movement, effectslotis), 213, 122
of capsid protein mutations (Nicotiana tabacum), 206, 1007sheep
tobacco mosaic virus infectionbovine leukemia virus-induced leukemogenesis, relationship with
associated chlorosis, role of single nucleotide change in viralp53 tumor-suppressor gene mutations, 209, 676
coat protein gene, 207, 234infection with maedi-visna virus strain EV1, LTR variation in vivo,
conferral of coat protein-mediated resistance by PM2 assembly-208, 343
defective mutant, 208, 485soybean, peanut chlorotic streak caulimovirus-infected, viral ORFs
susceptibility, effects of defective movement protein and func-VII, A, B, and C, functional significance (Glycine max), 206, 823
tional analog (Nicotiana tabacum), 206, 307swine
tobacco mosaic virus-mediated programmed cell death, role offoot-and-mouth disease virus
serine/threonine protein phosphatase (Nicotiana tabacum), 207,immunodominance of major antigenic site, 206, 298
460polyclonal antibodies to, reactivity to synthetic peptides of VP1
tobamovirus and dianthovirus, movement proteins, functional ho-G-H loop, 210, 120
mology (Nicotiana benthamiana), 213, 38gnotobiotic model, in identification of rotavirus group A genes
associated with virulence and host range restriction, 209, 274 tomato bushy stunt virus-infected, replicase protein coordinate ex-
pression and membrane association (Nicotiana benthamiana),pseudorabiesvirus virulence, effects of UL21 gene mutations, 212,
466 208, 365
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tomato bushy stunt virus protein accumulation, effect of defective in construction of replication-competent retroviral vectors directing
high-level expression of foreign genes, 210, 167interfering RNA and implication for disease attentuation (Nicoti-
ana benthamiana), 211, 324 gene expression and infectivity, effect of promoter II TATA box muta-
tion, 206, 601tomato golden mosaic virus complementable and noncomplem-
reverse transcriptase and ribonuclease H domains, molecular bio-entable host adaptation defects (Nicotiana benthamiana), 212,
logical characterization, 213, 97263
Human immunodeficiency virustomato spotted wilt virus-infected, tubular structures, induction by
E-55/ murine leukemia virus as murine model for persistent infec-viral nonstructural Nsm protein (Nicotiana rustica), 214, 485
tion, antivirus immune responses and long-term survival, effectstransformed with 54-kDa region of pepper mild mottle virus repli-
of non-H-2-linked genes, 211, 507case gene, resistance responses against viral infection (Nicoti-
integrase, conserved central domain, activities and substrate speci-ana benthamiana), 211, 170
ficity, 206, 448transgenic
NF-kB-independent promoter domain activity, and Sp1 phosphoryla-expressing cucumber mosaic virus 3a gene, complementation
tion, in T lymphocytes, induction by okadaic acid, 208, 753of virus movement (Nicotiana tabacum), 209, 188
TAR RNA, binding activity of full-length and R-domain forms of inter-for tobacco vein mottling virus, potato virus X/potyviral syner-
feron-inducible RNA-dependent protein kinase R: determinationgism, mediation by 5* proximal potyviral sequences (Nicotiana
of dissociation constants, 206, 511tabacum), 206, 583
transition from latent to productive infection, viral RNA expression,tobacco budworm larva, AcNPV early pathogenesis and dose–mor-
single cell transcript analysis, 206, 16tality relationship (Heliothis virescens), 209, 561
type 1tomato
BaL and IIIB strains, infectivity in primary human neuroblasts, 210,potato spindle tuber viroid
221infection, symptom expression and viroid replication, suppres-
different strains, V3 loop synthetic peptides from, induction ofsion by pathogenicity domain-stabilizing mutations (Lycoper-
cross-reactive cytotoxic T lymphocytes, 211, 261sicon esculentum), 208, 554
DNA expressing HIV-1 Env and noninfectious HIV-1 particles, in-pathogenicity, interdependence with viroid replicability (Lyco-
duced antibody response in mouse, 209, 147persicon esculentum), 209, 60
DNA synthesis in infected CD4/ T cells and monocytes, compari-tomato black ring nepovirus RNA-1-encoded polyprotein, proteo-
son, 206, 731lytic activity, functional characterization (Lycopersicon esculen-
effect on apoptosis of lymphocytes from human CD4 transgenictum), 206, 362
and normal rabbits, 213, 450Trichomonas vaginalis, T. vaginalis virus T1-infected, double-
efficient replication in mononuclear phagocytes, role of vpr, 206,stranded satellite RNA in, identification, 208, 189
935
trout, leukocyte proliferation, stimulation by viral hemorrhagic septi-
envelope V1 and V2 regions, virus spread-related effect on replica-
cemia virus G and N cDNA-derived protein sequences with
tion efficiency in macrophages, 213, 70
individual fish variation (Onchorynchus mykiss), 212, 348
env gene
tuatara, highly divergent retroviral sequence from, isolation and char-
derived antisense RNA, 19-kDa protein encoded by, recognition
acterization (Sphenodon), 210, 206
in sera of HIV-infected individuals, 206, 196
woodchuck, hepatocellular carcinoma B3N locus, recurrence of from individuals infected from same source, sequence distances
woodchuck hepatitis virus integration, 214, 229 between, implications for study of transmission events, 211,
yeast strain GGY1:171, tobacco vein mottling virus coat protein and 198
genome-linked protein in, interaction with viral polymerase, 214, and Epstein–Barr virus, lack of pseudotype formation in produc-
159 tively coinfected B lymphoblastoid cells, 209, 643; erratum, 212,
zucchini squash, accumulation of cucumber mosaic virus helper vi- 757
rus RNA and associated proteins, effects of satellite RNA (Cucur- foscarnet-resistant strain, characterization, 212, 47
bita pepo), 208, 58 frequency of interferon-a cells responding to, 204, 1; erratum, 206,
Host range 1159; 207, 342
bean golden mosaic virus and tomato golden mosaic virus, analysis, gene expression in central nervous system, role of neurodevelop-
212, 263 mental changes, analysis in transgenic mouse, 210, 361
bipartite geminiviruses, and pathogenicity, role of BR1 and BL1 move- gp41, extracellular domain, epitope binding by monoclonal anti-
ment proteins, 207, 191 bodies, 206, 713
brome mosaic virus systemic infection, effects of coding changes in gp120
3a cell-to-cell movement gene, 214, 464 –CD4 covalently crosslinked complexes, monoclonal antibodies
human rotavirus, associated genes, identification in gnotobiotic pig- raised against, identification of complex-dependent gp120
let model, 209, 274 epitope, 211, 583
Host specificity glutathione S-transferase-tagged, expression, purification, and
cowpea chlorotic mottle bromovirus infection and cell-to-cell spread, interaction with CD26, 208, 142
role of 3a gene, 206, 276 putative binding to galactosylceramide-expressing oligodendro-
HPV, see Human papillomavirus cytes and associated increased intracellular Ca2/, analysis,
HSV, see Herpes simplex virus 206, 1084
HTLV, see Human T-cell lymphotropic virus V3 loop-derived
Human adenovirus type 2 multibranched peptide constructs, inhibition of viral infection
fiber, receptor-binding domain, localization of antigenic sites, 214, via CD4 interaction, 206, 457
110 synthetic peptides enhancing cell binding and infection, mini-
Human foamy virus mal sequence requirements, 206, 807
group O provirus HIV-1VAU, highly defective: role of local sequenceclose functional relatedness of chimpanzee foamy virus to, revealed
determinants in GrA hypermutation during negative-strand viralby infectious proviral clones of SFVcpz generated by long PCR,
214, 685 DNA synthesis, 208, 601
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growth in monocyte macrophages, genetic determinants, 206, 646 –SIV-infected rhesus monkey, development of HIV-1 Env-specific
cytotoxic T-cell responses, 208, 770HEPT derivative resistance, generation by mutations at multiple
sites in HIV-1 reverse transcriptase, 210, 186 spread in acyclovir-treated CD4 cells, protection by Tat-inducible
HSV-1 thymidine kinase gene expression, 206, 495and HIV-2, and SIV types, poly(A)signal, conservation of hairpin
structure, 207, 276 subtype D, G, and A/D recombinant, transmissions in Sweden,
biological and molecular characterization, 209, 136host cell-dependent gag gene mutant, generation and character-
ization, 212, 251 subtype D Zairian isolate NDK, fusogenic determinants, 209, 649
susceptibility of human bone marrow stromal cells, 208, 779and HTLV-I, LTRs, directed expression of genes in murine cells,
effect of transfected human PKR, 214, 653 tat
activation domain, zinc finger protein HT2A interacting with,humoral and cellular immune responses in nonhuman primates,
induction by in vivo DNA inoculation, 211, 102 identification, 209, 347
enhancement of human herpesvirus type 6 replication, 211, 544infected mononuclear phagocytes, arachidonic acid and prosta-
glandin E2 release from, relationship with viral replication and Tat protein
activation in rodent cells, role of TAR sequences, 206, 690TNF-a and IL-2 production, 208, 590
infection of choriocarcinoma cell lines, role of membrane CD4 and and DNA sequence-specific transcriptional activators, functional
similarities, 206, 1150Fc receptors in viral entry, 208, 784
inhibitor-escape mutant, infectivity, impairment after single point interaction with interferon-induced dsRNA-dependent kinase
PKR, 213, 413mutation in POL gene, 210, 212
integrase, high-affinity RNA ligands to, isolation from random pool, transactivation of HIV-2 LTR via TAR RNA element lacking dinu-
cleotide bulge binding sites, 206, 673209, 327
integrase-defective, self-limiting cell type-dependent replication in Tat0 protein, infection and replication: genetic analyses of LTR
and tat mutations in primary and long-term human lymphoidhuman primary macrophages, 208, 242
integrase mutants, analysis, 211, 332; erratum, 213, 680; 211, 332 cells, 211, 157
T-cell line-tropicintegrated LTR vectors, and HTLV-I LTR-lacZ integrated vectors,
in Jurkat T-cell clones, response to T-cell activation, 209, 633 gp120 function, effects of the amino acid changes in V2 domain,
206, 878long terminal repeat, glucocorticoid receptor binding sites, role in
steroid-mediated suppression of HIV gene expression, 214, 512 isolate NL4–3, restricted replication in HL-60 cells, 206, 641
mediated cell fusion and viral entry in macrophages, restrictionmacrophage-tropic clone HIV-1SF162, variant R3H, adaptation to
growth in transformed T-cell lines, role of V3 loop amino acid by V3 loop, 209, 696
virtually full-length provirus of diverse subtypes, recovery from pri-substitutions, 210, 490
mutant with decreased sensitivity to proteinase inhibitor Ro 31– mary virus cultures using PCR, 213, 80
in vitro infection of bone marrow-adherent cells, effect on ability8959, characterization, 206, 527
Nef0 phenotype manifestation, role of virus and host components, to support hematopoiesis, 213, 245
Vpr protein213, 158
Nef protein domains involved in subcellular localization, analysis, 212, 331
function, role of conserved dipeptide Gly75 and Cys76, 210, 495downregulation of CD4 surface expression, role of CD4 lck-
binding domain, 207, 338 incorporation into virion, N-terminal acidic domain residues es-
sential for, identification, 207, 297mediated downregulation of CD4, relationship to Nef-enhanced
viral propagation in vitro, 212, 451 stability and incorporation into viral particles, role of C-terminal
domain, 214, 647nonproducer variant, transfected HeLa CD4/ cells, HIV suscepti-
bility, effect of full expression of proviral DNA, 206, 76 Vpu protein
expression, effects on intracellular membrane trafficking path-pol gene, hairpin ribozyme targeted to, in vitro and in vivo charac-
terization, 206, 381 way in mammalian cells, 213, 639
induced CD4 degradation: role of alpha-helix structure in CD4Pr160gag-pol, in vivo processing in acutely infected cultured human
T cells, 214, 624 proximal cytoplasmic region in antigen sensitivity, 209, 615
wild-type, inhibition of viral production by matrix-deficient gag mu-promoter insertion in vivo, analysis in bronchoalveolar lavage cells,
208, 359 tant, 208, 808
type 1 and 2protease
enhancement by HIV-1 reverse transcriptase, 206, 387 replication in human lymphocytes and macrophages, inhibition by
polymerase substrate depletion, 211, 554overexpression, increased intracellular cleavage of Gag and re-
duction of viral infectivity, 206, 854 sensitivity to CD4-expressing macaque cell line sMAGI, 213, 386
and SIV types, poly(A)signal, conservation of hairpin structure, 207,protease flap, side chain at position 48, role in substrate specificity,
207, 475 276; erratum, 209, 284
type 2replication in intestinal cells, restriction, genetic control by gag–
pol region of HIV-1 genome, 207, 160 LTR, transactivation by HIV-1 Tat protein via TAR RNA element
lacking dinucleotide bulge binding sites, 206, 673Rev, activation domain, structural and functional analogy to SIV-
mac239 Rev protein activation domain, 211, 290 Nef0 phenotype manifestation, role of virus and host components,
213, 158Rev and transdominant Rev protein, trafficking in living cells, analy-
sis with green fluorescent protein fusions, 213, 439 Human JC polyomavirus
in analysis of transcriptional regulation, review, 213, 283RNA, alternative splicing, role of 5* splice sites and competing
suboptimal 3* splice sites, 213, 373 Human papillomavirus
E6 protein, directed mutations: abrogation of p53-mediated cell cycleRNA 5* regions, nonsufficiency for encapsidation, implications for
HIV-1 packaging signal, 212, 718 arrest correlated with p53 binding and degradation in vitro, 208,
111sequentially derived isolates, nef and LTR sequence variation, 208,
388 E7 oncoprotein, dimerization in vivo, 214, 289
and vaccinia virus, recombinants, induction of serum IgG, IgM, andand SIV, replication in CD4/ T cell lines, effect of interferon, 214,
379 mucosal IgA antibodies after immunization in mouse, 206, 174
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Human papillomavirus type 1A and HIV-1, LTRs, directed expresson of genes in murine cells,
effect of transfected human PKR, 214, 653DNA, replication, stimulation by mulimerized AT-rich palindromic se-
quence, 214, 301 integrated LTR-lacZ vectors, and HTLV-I LTR integrated vectors,
in Jurkat T-cell clones, response to T-cell activation, 209, 633Human papillomavirus type 5
epidermodysplasia verruciformis-associated, in benign lesions, dif- putative cell surface receptor, regional localization to human chro-
mosome 17q23.2–17q25.3, 212, 196ferentiation-dependent transcription, 214, 245
Human papillomavirus type 6 Rex response element, activation of 2*,5*-oligoadenylate synthe-
tase and p68 kinase, 206, 913virus-like particles, synthesis and assembly in Schizosaccharomyces
pombe, 206, 126 Tax protein, interactions with NF-kB2 and protein products p52
and p100, 206, 1066Human papillomavirus type 6A
sequence determination and assembly of virus-like particles in Sac- type II
cellular tropismcharomyces cerevisiae, 209, 506
Human papillomavirus type 6B in peripheral blood mononuclear cells from patients with high
viral load, 206, 1126L2 protein, nuclear targeting and accumulation, required sequences
for, 213, 321 susceptibility of human lymphocyte CD4/ and CD8/ subpopula-
tions in vitro and in vivo, 210, 441Human papillomavirus type 11
cottontail rabbit, and bovine type 1, neutralizing antibodies to, induc- external envelope proteins, antibodies against, rapid generation
by growth of mouse plasmacytomas in SCID mouse, 214, 680tion by anti-idiotypic antibodies, 210, 292
E1 P E4 and L1 proteins, colocalization in mouse xenograft system at gag gene translation efficiency, modulation of ribosomal frame-
shifting frequency, 208, 312multiple time points, 214, 259
latently infected respiratory tissues, low-abundance RNA transcripts X region, proteins produced by mRNAs spliced into, expression
and characterization, 209, 445for E1 and E2 proteins in, identification (human), 212, 285
postattachment neutralization by monoclonal and polyclonal antibod- Hybridization
RNA, see RNA hybridizationies, 207, 136
Human papillomavirus type 16 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine
and derivitives, HIV-1 resistance to, generation by reverse tran-capsid proteins, produced from recombinant Semliki Forest virus,
assembly into virus-like particles, 214, 349 scriptase mutations at multiple sites, 210, 186
HydroxylamineE2 protein and subdomains expressed in insect cells, characteriza-
tion, 211, 418 and site-directed mutagenesis, deacylation of influenza A virus hem-
agglutinin by, effect on fusogenic properties, 210, 20E5 protein, expression, detection, and stable complex formation with
transmembrane proteins in COS cells, 211, 227 Hydroxyl groups
vicinal, in template RNA, oxidation, effect on interaction betweenE6 protein, mutational analysis: transformation function for human
cells and degradation of p53 in vitro, 212, 535 RNA-dependent RNA polymerase of alfalfa mosaic virus and
template, 213, 650E7 gene expression levels, correlation with transforming potential,
207, 260 Hypermutations
GrAepithelial-specific enhancer, activation by Oct-1 via synergistic inter-
action with NFI at conserved composite regulatory element, 207, erratic, in complete caprine arthritis–encephalitis virus provirus,
sequence, 209, 29777
and HPV 31, capsid protein genes, sequence variation, 214, 664 in HIV-1VAU provirus, role of local sequence determinants during
negative-strand viral DNA synthesis, 208, 601virus-like particles, synthesis and assembly in Schizosaccharomyces
pombe, 206, 126 Hypervariability
cucumber mosaic virus satellite RNA, role of helper virus and initialHuman papillomavirus type 31
and HPV 16, capsid protein genes, sequence variation, 214, 664 sequence context, 206, 765
Human papillomavirus type 31B
E1 P E4 proteins, cell differentiation-dependent expression in epithe- I
lial cells bearing HPV type 31b episomes, 206, 679
enhancer, transcriptional activity, regulation via synergistic interac- ICAM, see Cell adhesion molecules, ICAM
Immortalizationtion of AP1 with cellular factors, 211, 184
Human parainfluenza virus adenovirus E1A in human cells, and Ad virus infection, subsequent
E1A gene expression, comparative effects on NK cell killing,type 2, hemagglutinin–neuraminidase protein, regions important for
promoting cell fusion, identification, 213, 190 210, 421
Immune cellstype 3
hemagglutinin–neuraminidase, domain required for promotion of murine leukemia virus-specific, effects of immune transfer on viral
infection in rat, 211, 408cellular fusion by fusion protein spike, localization, 209, 457
life cycle, role of neuraminidase, 214, 294 Immune memory
CD4/ T cells for Sendai virus: relationship between T-cell numbersHuman respiratory syncytial virus
P protein, transcriptional activity, effect of phosphorylation of Ser232, and activation phenotype, 210, 179
Immune responses213, 405
Human rhinovirus type 2 to cell-culture-attenuated Borna disease virus after inoculation in
weanling rat, 206, 426proteinase, role in picornavirus 2A proteinase-mediated stimulation
of internal initiation of translation, 213, 549 cellular
to cottontail rabbit papillomavirus E2 protein, association with tu-Human T-cell lymphotropic virus
Tax protein, and NF-kB/IkB transcription complex, molecular interac- mor regression, 208, 298
to herpes simplex virus type 2 genital infection in female mouse,tions, 214, 3
type I 212, 481
to partially attenuated simian immunodeficiency virus nef deletionexpression in lymphocytes, role of cellular stress response, 208,
816 mutant in rhesus monkey, 212, 392
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cytotoxic T cell, to HIV-1 envelope glycoprotein, development in HIV- acute and persistent, lymphocytic choriomeningitis, prevention by
host response to CTL escape variants, 211, 4431–SIV-infected rhesus monkey, 208, 770
to E-55/ murine leukemia virus in persistently infected mouse, ef- adenovirus in human cells, and E1A transfection, subsequent E1A
fects of non-H-2-linked genes, 211, 507 gene expression in, effects on susceptibility to NK cell killing,
humoral, HSV-specific, induction after murine female urogenital HSV- 210, 421
2 infection, 206, 234 alfalfa mosaic virus, initiation, role of coat protein N-terminal basic
humoral and cellular, to HIV-1 in nonhuman primates, induction by amino acids, 208, 405
in vivo DNA inoculation, 211, 102 Autographa californica nuclear polyhedrosis virus in Spodoptera exi-
MHC-I-restricted, to measles virus nucleocapsid protein, induction gua larva, viral passage through midgut epithelium, 208, 328
by replication-deficient adenovirus vector in murine model, 210, BK virus in urinary tract tumors, effect of DNA rearrangements, 214,
456 273
mucosal, in mouse immunized with vaccinia virus–HPV recombi- bovine herpesvirus type 1, role of major tegument protein VP8, 206,
nants, 206, 174 413
for protection against rabies virus, mechanism, 214, 398 bovine papillomavirus type 4 in cattle
protective, conferral by baculovirus-related glycoprotein of thogoto associated T-cell responses to E7 protein and epitope mapping,
virus, 213, 249 206, 504
to rabies virus DNA vaccine, role of promoter and antigen form and prevention by vaccination with N-terminus of L2, 211, 204
cellular location in vector construct (mouse), 209, 569 California encephalitis virus in vitro and in vivo, role of G1 protein,
to Sendai virus infection in mouse: kinetics of antibody-forming cell 206, 945
response in different anatomical locations, 207, 287 chronic, hepatitis B virus, maintenance, role of core antigen muta-
to SIV, induction in lymph nodes of macaques after inoculated with tions, 212, 151
attenuated virus, 213, 535 chronic demyelinating, with mouse hepatitis virus, virus evolution
Immunity during, 209, 337
bovine herpesvirus type 1, role of major tegument protein VP8, 206, citrus tristeza virus in Citrus spp., viral subgenomic RNA, character-
413 ization, 208, 576
Immunization, see also Inoculation; Vaccination cucumber mosaic virus and defective interfering RNA coinfection,
human parainfluenza virus type 1 in infant mouse, subsequent pro- with synthetic transcripts of cDNAs, DI RNA dimers formed dur-
tection from Sendai virus infection (human), 212, 13 ing, characterization and biological activity, 207, 282
recombinant herpesvirus of turkey expressing infectious bursal dis- Epstein–Barr virus
ease virus VP2 immunogen in chicken, induction of protection
in CR2-transfected epithelial cells, in detection of MHC class II on
against IBDV virulent challenge, 211, 481
virion, 213, 147
single oral, murine rotavirus, in neonatal mouse, subsequent long-
de novo, in human thymocytes, associated replicative viral gene
term production of rotavirus antibodies and protection against
transcription: simultaneous expression of BZLF-1 and repressor
reinfection, 211, 474
RAZ, 208, 685
Immunocompetence
foot-and-mouth disease virus, and viral gene expression, effect ofincomplete, effects on polyomavirus persistence and reactivation in
protease C3 expression, 212, 111mouse, 212, 268
herpes simplex virus in mouse, latent, detection of viral sequencesImmunodominance
in trigeminal ganglia by in situ DNA PCR and RNA hybridization,associated regions in gE envelope protein of varicella–zoster virus,
206, 633identification, 214, 531
herpes simplex virus type 1foot-and-mouth disease major antigenic site, direct evaluation in nat-
in BHK cells, intracellular localization of viral ribonucleotide reduc-ural host, 206, 298
tase subunits during, 213, 615Immunofluorescence
ganglionic, synergistic effects of viral polymerase- and thymidineindirect, in analysis of intracellular localization of HSV-1 ribonucleo-
kinase-inhibiting drugs or mutations, 206, 263tide reductase subunits during infection of cultured cells, 213,
interaction with chondroitin sulfate in absence of heparan sulfate,615
208, 531Immunogenicity
in murine trigeminal ganglia, latency-associated transcript expres-bovine adenovirus type 3 in cotton rat, 213, 131
sion, role of cAMP-response element and TATA box, 210, 141Immunogens
herpes simplex virus type 2VP2, infectious bursal disease virus, recombinant herpesvirus of tur-
in female urogenital mucosa, subsequent HSV-specific antibody-key expressing, induction of protection against IBDV virulent
secreting cell response, 206, 234challenge in chicken, 211, 481
genital, subsequent HSV-specific T cells in murine female genitalImmunoglobulins
tract, analysis, 212, 481anti-Ig, induction of Epstein– Barr virus lytic cycle in lymphoma cells,
HIV, transition from latent to productive infection, viral RNA expres-blockage by cyclosporin A and FK506, 209, 225
sion, in situ hybridization-based single cell transcript analysis,IgG, IgM, and mucosal IgA antibodies, generation in serum of mouse
206, 16immunized with HPV–vaccinia virus recombinants, 206, 174
HIV-1Immunolocalization
associated expression of 19-kDa protein encoded by antisensesubcellular, coat protein of potexviruses in infected Chenopodium
RNA derived from viral ENV gene, 206, 196quinoa, 214, 314
in CEM cells, inhibition by gp120 V3 loop-derived multibranchedImmunosuppression
peptide construct interaction with CD4, 206, 457placental, implications of abundant expression of endogenous ret-
in choriocarcinoma cell lines, role of membrane CD4 and Fc recep-roviral envelope protein in human placental trophoblasts, 211,
tors in viral entry, 208, 784589
human bone marrow stromal cell susceptibility, 208, 779Infection, see also Latency
abortive, influenza A virus in Vero cells, 212, 225 in MOLT-3 cells, enhancement by V3 loop-derived synthetic pep-
tides, minimal sequence requirements, 206, 807AcNPV in Sf9 cells, IE1 protein expression, 209, 99
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spread in acyclovir-treated CD4 cells, protection by Tat-inducible rotavirus in murine L cells, enhancement by dansylcadaverine and
cytochalasin D, 212, 429HSV-1 thymidine kinase gene expression, 206, 495
homologous rotavirus in mouse model, analysis, 207, 143 Sendai virus in mouse
antibody-forming cell response, kinetics in different anatomicalhost-dependent systemic, tomato bushy stunt virus, nested genes
functioning in, regulation of viral spread, 213, 425 locations, 207, 287
protection conferred by immunization with human parainfluenzainfluenza A virus
suppression by neuraminidase-resistant N-thioacetylneuraminic virus type 1, 212, 13
SIV in central nervous system: selection of homogeneous env quasi-acid acrylamide copolymer, 212, 340
WSN strain, lethal, defective interfering RNAs providing protection species in brain after serial passage, 212, 458
systemic, brome mosaic virus, host range, effect of coding changesfrom, isolation from murine lung and characterization: subset of
inoculum DI RNAs, 210, 9 in 3a cell-to-cell movement gene, 214, 464
tick-borne encephalitis virus, effects on requirements for nitric oxidelatent, HPV type 11 in respiratory tissues, low-abundance RNA tran-
scripts for E1 and E2 proteins in, identification (human), 212, synthesis in murine macrophages, 212, 174
vaccinia virus K3L0 and E3L0 mutants in L929 cells, interferon sensi-285
lethal, Japanese encephalitis virus in mouse, protection by innocula- tivity patterns, 210, 254
Venezuelan equine encephalitis virus in mouse model, associatedtion with double-subgenomic Sindbis virus recombinants ex-
pressing JEV immunogenic proteins, 212, 587 disease progression, effects of specific glycoprotein mutations,
206, 994measles virus, in C6 and Vero cells, persistent, cure with mRNAs
complementary to viral N or H genes, 207, 168 vesicular stomatitis virus in murine olfactory neuroepithelium, and
entry in central nervous system, early events, 209, 257mengo virus in mouse, with attenuated virus: characterization of
neutralization epitopes, 214, 118 Infectious bronchitis virus
1a/1b polyprotein, proteolytic processing, ORF 1a-encoding protein-mixed virus, model: polyomavirus A2-induced runting in Balb/c and
NIH Swiss mice potentiated by coinfection with Moloney murine ase domain responsible for, characterization and mutational
analysis, 209, 420leukemia virus, 212, 356
murine leukemia virus in rat, effects of adoptive immune transfers, IBV-Beaudette and IBV-M41, recombination in, evidence, 213, 569
Infectious bursal disease virus211, 408
murine rotavirus in mouse serotype I and II strains, genomic dsRNA segments, terminal se-
quences, 209, 10reinfection, protection after single oral immunization with murine
RV in neonate, 211, 474 VP2 immunogen, recombinant herpesvirus of turkey expressing, in-
duction of protection against IBDV virulent challenge in chicken,resolution, and protection against reinfection, effector functions of
antibody and CD8/ cells, 214, 387 211, 481
Infectious laryngotracheitis virusnatural, with chimpanzee lentivirus, virologic and serologic charac-
terization, 211, 312 thymidine kinase-deficient mutants, generation, 209, 304
Infectious pancreatic necrosis viruspapillomavirus virions in cultured cells, early phase, 214, 167
pepper mild mottle tobamovirus in Nicotiana benthamiana, effects major capsid protein VP2, serotype-specific epitope, mapping, 209,
684of transformation with 54-kDa region of viral replicase gene,
211, 170 major structural protein, epitopes, localization and strain variability,
214, 40perinatal, neurotropic retrovirus CasBrE in mouse, prevention by in-
oculation with Friend murine leukemia virus, 206, 372 virion-associated RNA polymerase, role in protein-primed RNA syn-
thesis in vitro, 208, 19persistent
E-55/ murine leukemia virus in mouse, associated anti-virus im- Infectivity
channel catfish herpesvirus, effect of attenuation by thymidine kinasemune responses and long-term survival, effects of non-H-2-
linked genes, 211, 507 gene deletion, 209, 658
feline calcivirus RNA transcripts derived from cloned full-length copylymphocyte-tropic SIV in rhesus monkey brain, 213, 600
lymphocytic choriomeningitis virus in mouse, viral clearance, role of viral genome, role of VpG protein, 210, 383
foot-and-mouth disease virus acid-resistant mutant, 206, 69of interferon g, 212, 244
poliovirus, subsequent selective permissivity to wild-type Mahoney glycoprotein C-minus bovine herpesvirus-1 in MDCK cells, inhibition
by heparin, 209, 230and partial resistance to attenuated Sabin 1 strains in cured
HEp-2c cell clones, 212, 309 with hepatitis A virus RNA transcripts, eukaryotic cells, effect of site-
directed mutagenesis of viral polyprotein primary cleavage site,polyomavirus in mouse, effects of incomplete immunocompetence,
212, 268 213, 213
hepatitis B virus, role of large surface protein myristylation, 213, 292reovirus serotype 3 in B-cell hybridoma, eradication by passage
in medium with anti-reovirus antibodies, 212, 272 HIV-1
BaL and IIIB strains in primary human neuroblasts, 210, 221phage f29 in Bacillus subtilis, associated expression of viral promot-
ers: transcription regulation, 207, 23 inhibitor-escape mutant, impairment after single point mutation in
POL gene, 210, 212poliovirus, K562 cell strain response, comparison, 213, 7
productive, subgroup C adenovirus, metabolism of small cellular RNA reduction by protease overexpression in infected cells, 206, 854
human foamy virus, and gene expression, effect of promoter II TATAspecies during, 206, 100
Puumala virus in human monocytes/macrophages, effects of inter- box mutation, 206, 601
Influenza A virusferon-a and cell differentiation, 206, 8
rabies virus in mouse, immune effector mechanisms for protection, abortive infection of Vero cells, 212, 225
avian, virulent214, 398
and replication, Tat0 HIV-1: genetic analyses of LTR and tat mutations hemagglutinin cleavability by subtilisin-like endoproteases, role of
amino acid immediately downstream from cleavage site, 210,in primary and long-term human lymphoid cells, 211, 157
retroviral, resistance to in transgenic and bone marrow chimeric 466
mutants arising during replication in embryonated chicken eggs,mice, correlation with Friend murine leukemia virus FV4 env
expression by hematopoietic cells, 208, 75 associated molecular changes, 206, 755
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avian strains, replication inhibition by 4-guanidino-2,4-dideoxy-2,3- loss of integrated EBV genomes after long-term cultivation, 212,
179dehyro-N-acetylneuraminic acid, 212, 323
Interferonconserved hemagglutinin epitope, recognition by neutralizing mono-
duck, recombinant, antiviral activity toward RNA viruses and inhibi-clonal antibody, 212, 526
tory effects against duck hepatitis B virus in primary hepato-European swine isolates, potential as source for pandemic, 212, 555
cytes, 212, 641hemagglutinin deacylated by site-directed mutagenesis and hydrox-
independent ICAM-1 early expression by West Nile virus in quiescentylamine treatment, assessment of fusogenic properties, 210, 20
nonproliferating fibroblasts, implications for virus–host interac-infection suppression by neuraminidase-resistant N-thioacetylneu-
tion, 208, 437raminic acid acrylamide copolymer, 212, 340
inducible RNA-dependent protein kinase R, full-length and R-domainM2 antibody, effects on M2 surface expression and virus assembly,
forms, RNA-binding activity: determination of dissociation con-212, 411
stants for VAi and TAR RNAs, 206, 511NS1 protein, multimer formation in vitro and in vivo, 212, 422
Interferon-anucleoprotein, interaction with nucleoprotein interactor 1, 206, 116
effect on Puumala virus infection in human monocytes/macrophages,RNA polymerase subunit PB2, cleavage of host cell mRNA and tri-
206, 8meric enzyme function, 208, 38
and IFN-g, induction of double-stranded RNA-specific adenosine de-specific H-2d restricted cross-reactive cytotoxic T cell epitope, detec-
aminase in human cells, 210, 508tion in hemagglutinin HA2 subunit of A/Udorn/72, 214, 445
inhibition of murine cytomegalovirus immediate-early gene expres-variants, selection by egg fluids and chorioallantoic membrane cells
sion by down-regulating NF-kB activity, 211, 251of embryonated chicken eggs, 211, 302
producing cells, responding to DNA and RNA viruses, frequency,WSN strain, defective interfering RNAs providing protection from le-
204, 1; erratum, 206, 1159; 207, 342thal infection, isolation from murine lung and characterization:
Interferon-a/bsubset of inoculum DI RNAs, 210, 9
effect on HIV-1 and SIV replication in CD4/ T cell lines, 214, 379Influenza B virus
sensitivity patterns in vaccinia virus K3L0 and E3L0 mutant-infectedHong Kong/8/73, hemagglutinin, structural analysis with site-directed
L929 cells, 210, 254mutagenesis, 206, 787
Interferon-bInfluenza virus
–double-stranded RNA system, role in activation of apoptotic Fasactivation of apoptotic Fas antigen-encoding gene upon infection,
antigen-encoding gene upon influenza virus infection, 209, 288role of spontaneously produced b-interferon, 209, 288
resistant cells, response to interferon-g, mechanism, 211, 113
avian
Interferon-g
highly pathogenic and nonpathogenic strains, hemagglutinin
and IFN-a, induction of double-stranded RNA-specific adenosine de-
genes, phylogenic analysis, 209, 664
aminase in human cells, 210, 508
pathogenic H7 subtype, hemagglutinin protein, carbohydrate addi-
intracellular, mutated murine cDNA, induction of IFN-inducible gene
tion site identification, 213, 276
expression in human cells expressing: abrogation of species
H5N2, pathogenicity, relationship to hemagglutinin cleavage site se- specificity barrier, 212, 438
quences and cleavability, 213, 223 response of interferon-b-resistant cells, mechanism, 211, 113
N9 neuraminidase, red cells bound to, release by enzyme activity, role in clearance of lymphocytic choriomeningitis virus in mouse with
211, 278 persistent infection, 212, 244
neuraminidase, variant with decreased sensitivity to 4-guanidino- Interferon-g-binding proteins
Neu5Ac2en, generation and characterization, 214, 475 ectromelia virus and vaccinia virus, species specificity, 208, 762
NS1 protein, binding to dsRNA, effect on activation of protein kinase Interleukin-2
phosphorylating eIF-2 translation initiation factor, 214, 222 and IL-4, expression in herpesvirus saimiri-transformed T lympho-
resistance to 4-guanidino-Neu5Ac2en, molecular basis, 214, 642 cytes, 208, 418
Inoculation, see also Immunization; Vaccination relationship with arachidonic acid and prostaglandin E2 production
DNA in vivo, in induction of humoral and cellular immune responses in HIV-infected mononuclear phagocytes, 208, 590
to HIV-1 in nonhuman primates, 211, 102 Interleukin-4
influenza virus A/WSN in mouse, subsequent isolation and character- and IL-2, expression in herpesvirus saimiri-transformed T lympho-
ization of protective viral defective interfering RNAs from lung, cytes, 208, 418
210, 9 Internalization
papillomavirus anti-idiotypic antibodies, induction of PV-neutralizing intracellular, herpes simplex virus type 2 ribonucleotide reductase
antibodies in BALB/c mouse, 210, 292 large subunit ICP10, 210, 345
with vaccinia virus–HPV recombinants, induction of serum IgG, IgM, Internal ribosomal entry sites
and mucosal IgA antibodies in mouse, 206, 174 bovine viral diarrhea virus 5* noncoding region, role in translation
Insertion initiation, 206, 750
HIV-1 promoter in vivo, analysis in bronchoalveolar lavage cells, 208, dicistronic mRNA containing, in analysis of molecular mechanism
359 of picornavirus 2A proteinase-mediated stimulation of internal
Integrase initiation of translation, 213, 549
HIV-1 encephalomyocarditis virus
defective mutant, self-limiting cell type-dependent replication in cis-acting elements, 214, 660
human primary macrophages, 208, 242 defective point mutants, complementation in trans, 214, 82
high-affinity RNA ligands to, isolation from random pool, 209, 327 Intracellular transport
mutants, analysis, 211, 332; erratum, 213, 680 paramyxovirus SV5 fusion protein, role of N-linked glycosylation, 209,
retroviral, evolutionarily conserved central domain, activities and sub- 250
strate specificity, 206, 448 Inverted terminal repeats
Integration site porcine adenovirus serotypes 1 to 5 DNA, sequence comparison,
212, 237Epstein–Barr virus-immortalized Burkitt’s lymphoma 1 B-lymph-
oblastoid cell hybrids, chromatin instability at, role in selective variola smallpox virus, topography, 211, 350
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Isatin-b-thiosemicarbazone Leukocytes
proliferation, stimulation by viral hemorrhagic septicemia virus G andeffect on Amsacta moorei entomopoxvirus growth in Lymantria dispar
N cDNA-derived protein sequences with individual fish variationcells, 211, 462
(Onchorynchus mykiss), 212, 348
LigationJ
self-, see Self-ligation
LipidsJapanese encephalitis virus
Sendai virus-infected BHK cells, interaction with fusion, matrix, andimmunogenic proteins, double-subgenomic Sindbis virus recombi-
hemagglutinin–neuraminidase proteins, 209, 701nants expressing, induction of protection against lethal JEV in-
Liver diseasefection in mouse, 212, 587
chronic, severity of, correlation with hepatitis B virus pre-S and coresubviral particles, secretion from mammalian cells infected by
region heterogeneity (human), 208, 672Sindbis virus–JEV recombinants, suppression by SIN vectors,
Long terminal repeats209, 155
avian retroviral, transcription regulatory elements, minireview, 206,JC polyomavirus
1in analysis of transcriptional regulation, review, 213, 283
bovine immunodeficiency virus, identification of cis-acting regulatorylarge T antigen phosphorylation domains, biochemical characteriza-
elements, 209, 604tion, 212, 295
bovine leukemia virus proviral sequences, in vivo mutations during
virus-induced leukemogenesis, 206, 769K
feline immunodeficiency virus, C/EBP binding site, role in efficient
viral replication and in inhibition of FIV LTR-directed gene ex-Kunjin virus
pression by pseudorabies virus ICP4, 208, 492isolates, antigenic variation and E protein glycosylation status, 206,
feline leukemia virus-induced thymic lymphomas, alterations, in vivo49
selection, 206, 661
HIV-1
L directed gene expression in developing central nervous system,
analysis in transgenic mouse, 210, 361La Crosse virus
DNA sequence variation in sequentially derived isolates, 208, 388L protein, amino acid sequencing and comparison with polymerases
glucocorticoid receptor binding sites, role in steroid-mediated sup-from other Bunyaviridae, 206, 742
pression of HIV gene expression, 214, 512
Lactate dehydrogenase-elevating virus
HIV-1 and HTLV-I
envelope proteins, membrane topography and N-glycosylation, 212,
directed expresson of genes in murine cells, effect of transfected
512
human PKR, 214, 653
strains P and C, genomic sequence heterogenicity, 209, 637
stably integrated in Jurkat clones, response to T-cell activation,
Larvae 209, 633
Bombyx mori, beet western yellows luteovirus capsid proteins pro- HIV-2, transactivation by HIV-1 Tat protein via TAR RNA element
duced by recombinant baculoviruses, assembly into virion-like lacking dinucleotide bulge binding sites, 206, 673
particles, 213, 204 hybrid, containing murine tyrosinase enhancer/promoter, Moloney
Latency murine leukemia virus-derived retroviral vectors with, tissue-
Epstein–Barr virus, disruption by ZEBRA protein, restoration by addi- specific gene expression from, 214, 307
tion of heterologous activation regions, 211, 64 lymphoproliferative disease virus, sequences required for efficient
murine cytomegalovirus in mouse, role of IE2 protein, 209, 236 transcription, identification, 208, 789
Latency-associated transcripts maedi-visna virus strain EV1, sequence and repeat structure variants
expression in herpes simplex virus type 1-infected murine trigeminal in vitro and in vivo, 208, 343
ganglia, role of cAMP-response element and TATA box, 210, mouse mammary tumor virus, role in activation of mdr3 gene tran-
141 scription in P388 cells, 210, 244
Leishmania RNA virus open reading frame, mouse mammary tumor virus, expression, pro-
LRV2–1, cDNA and amino acid sequences, 212, 84 motion of tumorigenic potential of hyperplastic mammary epithe-
Lelystad virus lial cells, 211, 84
ORFs 2 to 7, proteins encoded by, characterization, 206, 155 squirrel monkey retrovirus, human sequence-specific DNA-binding
Lesions proteins interacting with direct repeats in, identification, 211,
benign, epidermodysplasia verruciformis-associated human papillo- 316
mavirus type 5 in, differentiation-dependent transcription, 214, and tat mutations, in primary and long-term human lymphoid cells,
245 genetic analyses: infection and replication of Tat0 HIV-1, 211,
temperature-sensitive, in M2 and L2 genes, reovirus mutant tsA279 157
with, characterization as defective in transmembrane transport LTR, see Long terminal repeats
and deficient in viral protein production, 207, 46 Luteovirus
Lettuce infectious yellows virus recombinational event probably induced by base-pairing between
genome structure and phylogenetic analysis, 208, 99 genomes of distinct viruses, 206, 1129
Leukemia structural proteins, gene experiments, use of full-length infectious
TSZ complex, murine C-type retroviruses derived from, biological cDNA clone of cucurbit aphid-borne yellows virus, 214, 150
characterization and molecular cloning, 212, 367 Lymph nodes
Leukemogenesis macaques inoculated with attenuated SIV, limited viral spread and
bovine leukemia virus-induced rapid immune response, 213, 535
associated LTR and env proviral variation in vivo, 206, 769 Lymphocytes, see also specific type
CD4/, HIV-1 and HIV-2 replication, inhibition by polymerase sub-in cattle and sheep, relationship with p53 tumor-suppressor gene
mutations, 209, 676 strate depletion (human), 211, 554
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CD4/ and CD8/ subpopulations, susceptibility to HTLV-II cell tropism Maedi-visna virus
strain EV1, long terminal repeats, sequence and repeat structurein vitro and in vivo (human), 210, 441
variants in vitro and in vivo, 208, 343H-2D-restricted cytotoxic, in central nervous system of B10 mouse,
MAIDS, see Murine acquired immunodeficiency syndrometargeting of Theiler’s virus capsid proteins VP1 and VP2, 214,
Maize dwarf mosaic virus91
coat protein, N-terminus, inhibition of viral transmission by aphid,from human CD4 transgenic and normal rabbits, apoptosis, effect of
213, 676HIV-1, 213, 450
Marburg virusumbilical cord blood, HIV-1– human herpesvirus type 6 interactions
glycoprotein acylation, 208, 289(human), 211, 544
Marek’s disease virusLymphocytic choriomeningitis virus
cDNA, mapping to BamHI-I2, -Q2, and -L fragments of MDV genomeCTL escape variants
from transformed and persistently infected cells, isolation andbiologic activity in vivo, 211, 443
characterization, 213, 590generation and molecular characterization, 210, 29
oncogenic strains and attenuated derivitives, infected fibroblasts,glycoprotein complex, acid-induced structural changes, kinetics and
expression of 14-kDa immediate-early phosphoprotein, 206, 695pH dependence, 209, 3
pp38, truncated homolog, identification in herpesvirus of turkeys in-persistent infection in mouse, viral clearance, role of interferon g,
ternal repeat, 207, 205212, 244
sustainable chick cell line infected with, development, 214, 541Lymphomagenesis
unique short region, nucleotide sequence, 206, 324enhancement by Akv murine leukemia virus in myc-k transgenic and
Mass spectrometrywild-type mice, 206, 93
in identification of channel catfish virus structural proteins, 206, 1035Lymphoproliferative disease virus of turkeys
Maturationlong terminal repeat sequences required for efficient transcription,
intracellular, Newcastle disease virus fusion protein, effect of strainidentification, 208, 789
differences in predicted amphipathic a-helix adjacent to fusionLysates
domain, 208, 827cell-free, simian virus 40 Vp1 assembly into disulfide-linked postpen-
oncoretroviral SU protein, effects of mutations in conserved cysteinetameric complexes in, 207, 251
residues in CWLC motif, 206, 885
Lyssaviruses
Measles virus
nucleoprotein gene, genetic polymorphism, 209, 526
cellular receptor, membrane cofactor protein function as, role of N-
Lytic cycle
glycans, 210, 479
Epstein–Barr virus, induction by anti-immunoglobulin in lymphoma F protein, mRNA, preferential initiation at AUG2: role for long untrans-cells, blockage by cyclosporin A and FK506, 209, 225 lated region, 214, 628
hamster neurotropic strain, phosphoprotein hypermutation and al-
M tered mRNA editing, 207, 555
inactivation with formaldehyde, effects on CD46-dependent presen-
M28 virus tation to murine MHC class I-restricted CTLs and MHC class
dsRNA sequence (Saccharomyces cerevisiae K28), 213, 341 II-restricted helper T cells, 212, 255
MAb, see Monoclonal antibodies L gene, from wild-type virus and SSPE brain tissue, nucleotide se-
Macrophages quences, comparison, 208, 795
in bone marrow stromal layer, susceptibility to HIV-1 infection (hu- nucleocapsid protein
man), 208, 779 high-level expression with replication-deficient adenovirus vector:
cell fusion and viral entry of HIV-1 T-cell line tropic strains, restriction induction of MHC-I-restricted CTL response and protection in
by V3 loop, 209, 696 murine model, 210, 456
differential processing of proteins of lymphocyte- and macrophage- utilization in replication of Sendai virus defective interfering parti-
tropic strains, 206, 535 cle genome in vitro, 206, 777
equine infectious anemia virus replication in, reduction, correlation nucleoprotein N and hemagglutinin H genes, complementary mRNA
with uracil incorporation into viral DNA (horse), 210, 302 antisense sequences, cure of persistently MV-infected cells,
foot-and-mouth disease virus replication in, restriction after Fc recep- 207, 168
tor-mediated adsorption (mouse), 207, 503 persistence in immortalized murine macrophage cell line, 207, 12
HIV-1-infected, arachidonic acid and prostaglandin E2 release, rela- P protein, phosphorylation, role of cellular casein kinase II, 211, 218
tionship with viral replication and TNF-a and IL-2 production preferential entry into and release from polarized epithelial cells
(human), 208, 590 through apical plasma membrane, 210, 91
HIV-1 replication efficiency in, virus spread-related effect of envelope synthetic minireplicons, rescue: direction of efficient reporter gene
V1 and V2 regions, 213, 70 expression and propagation by genomic termini, 208, 800
M1, P388D1, and RAW264.7, Theiler’s virus growth in, effect of state Melolontha melolontha entomopoxvirus
of differentiation (mouse), 209, 437 and lepidopteran EPV, associated fusolins, and baculovirus 37K gly-
monocyte-stage, and T cells, HIV-1 tropism, genetic determinants, coprotein, relationship, 208, 427
206, 646 Membrane fusion, see also Cell fusion; Syncytia formation
murine leukemia virus tropism for, correlation with neuropathogeni- by influenza A virus hemagglutinin deacylated by site-directed muta-
city enhancement: virus-induced neurodegeneration of rat, 214, genesis and hydroxylamine treatment, analysis, 210, 20
239 lymphocytic choriomeningitis virus, pH dependence and kinetics,
nitric oxide synthesis, requirements for, effects of tick-borne enceph- 209, 3
alitis virus infection (mouse), 212, 174 paramyxovirus, promotion by viral attachment protein and fusion pro-
primary, integrase-defective HIV-1 replication, self-limiting cell type tein spike, localization of associated HN domain, 209, 457
dependence (human), 208, 242 Membranes
chorioallantoic, and embryonated egg fluids, selection of differentPuumala virus infection, effects of interferon-a and cell differentiation
(human), 206, 8 variants of influenza A viruses (chicken), 211, 302
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microsomal, poliovirus 2C protein binding, mediation by amino-termi- to covalently crosslinked complexes of HIV-1 gp120 and CD4 recep-
tor, identification of complex-dependent gp120 epitope, 211, 583nal regions, 208, 540
differentiating Epstein–Barr virus nuclear antigens 2A and 2B, pro-Semliki Forest virus nonstructural protein nsP1 association in virus-
duction (rat), 208, 336infected and nsP1-transfected cells, 208, 610
epitope binding of HIV-1 gp41 extracellular domain, 206, 713Mengo virus
FcgRII-specific, IV.3, enhancement of binding of dengue-2 virus toneutralization epitopes, characterization: infection of mouse with at-
human platelets, 213, 254tenuated virus, 214, 118
to foot-and-mouth disease virus major antigenic sites, reactivity toa-2-O-Methyl-5-N-thioacetylneuraminic acid
synthetic peptides of VP1 G-H loop (mouse), 210, 120inhibitory effects on influenza A virus receptor binding and plaque
G protein-specific, immunoreactivity with group A and B respiratoryformation, 212, 340
syncytial virus G proteins, 209, 70Mevalonate kinase
in identification of bluetongue virus homotypic and heterotypic neu-and hepatitis B virus–Mk fusion proteins overexpressed in human
tralization determinants, 209, 263hepatoma, enzymatic properties, 208, 696
in immunological characterization of Ty1 virus-like particle, 207, 59Microglia
in indirect immunofluorescence analysis of intracellular localizationassociated simian immunodeficiency virus, selection of homoge-
of HSV-1 ribonucleotide reductase subunits during infection ofneous env quasispecies in brain after serial passage, 212, 458
cultured cells, 213, 615murine leukemia virus tropism for, correlation with neuropathogeni-
to influenza A virus M2 protein, effects on M2 surface expressioncity enhancement: virus-induced neurodegeneration of rat, 214,
and virus assembly, 212, 411239
LMBH5, recognition of conserved epitope on influenza A virus hem-Minireplicons
agglutinin, 212, 526synthetic, measles virus, rescue: direction of efficient expression and
mengo virus neutrlization epitopes defined by, 214, 118propagation of reporter gene by genomic termini, 208, 800
neutralizingMinute virus of mice
7D11, targeting of myristylated membrane protein encoded by vac-replicator protein NS1, sequence motifs essential for nicking and
cinia virus L1R open reading frame, 211, 53covalent attachment to viral origin: identification of linking tyro-
to papillomaviruses, induction by anti-idiotypic antibodies (mouse),sine, 209, 122
210, 292transcriptional inhibition by constitutive expression of NS-1 transacti-
porcine group C rotavirus, production and characterization, 208,vator protein-targeted antisense RNA, 206, 57
354
Models
postattachment neutralization of papillomaviruses, 207, 136
murine, infant and adult, homologous rotavirus infection, analysis,
rotavirus VP7-specific, in selection of neutralization-resistant rotavi-
207, 143
rus variants, 209, 80
Molecular structure, see also Quaternary structure
Monocytes
CD4, alpha-helix in proximal cytoplasmic region, role in antigen sen- and CD4/ T cells, HIV-1-infected, viral DNA synthesis, comparison,
sitivity to HIV-1 Vpu protein-induced degradation, 209, 615 206, 731
heparin, features required in inhibition of herpes simplex virus type HIV-1-infected, arachidonic acid and prostaglandin E2 release, rela-
1 binding, analysis, 206, 1108 tionship with viral replication and TNF-a and IL-2 production
influenza B virus hemagglutinin, analysis with site-directed mutagen- (human), 208, 590
esis, 206, 787 HIV-1 tropism, effects of amino acid changes in gp120 V2 domain
plant satellite viruses, comparison, 214, 571 (human), 206, 878
secondary, RNA of single-stranded RNA phage PP7 from Pseudomo- Puumala virus infection, effects of interferon-a and cell differentiation
nas aeruginosa, 206, 611 (human), 206, 8
simian hemorrhagic fever virus subgenomic RNAs, junction se- Mononuclear cells
quences, and 5* leader, 207, 543 peripheral blood, from patients with high viral load of HTLV-II, cellular
Molluscum contagiosum virus tropism studies, 206, 1126
poly(A) polymerase and 22-kDa and 147-kDa subunits of DNA-depen- Mouse hepatitis virus
dent RNA polymerase, genes encoding, identification and prop- A59 strain
erties, 210, 471 entry and release in polarized murine epithelial kidney cells, 210,
replication, analysis in human foreskin grafts to skin of athymic 54
mouse, 213, 655 gene 1 polyprotein, 65-kDa proteins processed from, identification
Moloney murine leukemia virus and characterization, 207, 316
derived retroviral vectors, with hybrid LTRs containing murine tyrosi- leader papain-like proteinase, in vitro cleavage site identification,
nase enhancer/promoter, tissue-specific gene expression from, 209, 489
214, 307 replication and protein processing, inhibition by cysteine protein-
potentiation of polyomavirus-induced runting in Balb/c and NIH ase inhibitor E64d, 208, 1
Swiss mice: model for mixed virus disease, 212, 356 defective-interfering RNA, replication, role of cis-acting viral protein,
transmembrane protein, cysteine mutations on, analysis, 211, 285 209, 428
Monoclonal antibodies evolution during chronic infection, 209, 337
1B9, 6C11, and 3C8, against envelope glycoprotein of SIV isolate genomic RNA, 3* end, conserved motif, role in host protein binding
251, specificity and neutralizing capacity, 211, 339 and viral RNA replication, 214, 128
antiglycoprotein, rabies virus neutralization by, effect of acidic config- M protein, CD4/ T-cell epitope, identification, 208, 173
uration of glycoprotein, 210, 400 pseudorecombinant, expressing hemagglutinin–esterase, genera-
tion with viral defective-interfering RNA as expression vector,bovine herpesvirus type 1-specific, in fine mapping of glycoprotein
D neutralizing epitopes, 206, 242 208, 319
Mouse mammary tumor viruscell fusion-inhibiting, binding to presumed stalk domain of human
endogenous provirus Mtv-6, structure and biological activity, 206,parainfluenza type 2 virus hemagglutinin–neuraminidase pro-
tein, 206, 1117 395
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long terminal repeat open reading frame, expression, promotion of deletion, simian immunodeficiency virus nef, partially attenuated, cel-
lular immune response of infected rhesus monkeys, 212, 392tumorigenic potential of hyperplastic mammary epithelial cells,
211, 84 deletion and point, SV40 large T antigen, in identification of H-2Kb-
restricted determinant, 208, 159–mdr3 fusion transcript, activation from cryptic viral promoter, stimu-
lation by mdr-derived sequence in intron I, 210, 244 deletion and site-specific, hepatitis B virus env gene, expressed in
293 cells, analysis, 213, 57Multibranched peptide constructs
derived from HIV-1 gp120, inhibition of viral infection via CD4 interac- Dengue type 4 virus, growth-restricted, with deletions in 5* noncoding
region of RNA genome, construction, 207, 68tion, 206, 457
Multidrug resistance escape, human parainfluenza virus type 2, isolation with monoclonal
antibodies and identification of substituted amino acids in hem-mdr1 gene encoding, as selectable marker in Harvey murine sar-
agglutinin–neuraminidase protein (human), 206, 1117coma virus retroviral vector: virus production and foreign gene
transduction efficiency, 208, 621 hepatitis B virus small envelope proteins, lacking cysteines in major
antigenic region, secretion and antigenicity, 211, 535mdr3 gene conferring, transcription activation in P388 cells, role of
mouse mammary tumor virus LTR and mdr3 sequences, 210, HIV-1
244 with decreased sensitivity to proteinase inhibitor Ro 31–8959,
characterization, 206, 527Multimerization
influenza A virus NS1 protein in vitro and in vivo, 212, 422 gag
Murine acquired immunodeficiency syndrome host cell-dependent, generation and characterization, 212, 251
defective virus, establishment of leukemic T-cell lines from mice matrix-deficient, inhibition of wild-type virus production, 208, 808
inoculated with, 206, 555 inhibitor-escape, infectivity, impairment after single point mutation
Murine coronavirus in POL gene, 210, 212
JHMV, S1 subunit, localization of neurovirulence determinant for rat, integrase, analysis, 211, 332; erratum, 213, 680; 211, 332
208, 67 integrase-defective, self-limiting cell type-dependent replication in
spike protein, role in cell-to-cell fusion, mutational analysis, 214, 453 human primary macrophages, 208, 242
Murine leukemia virus HSV-1, neuroattenuated, in treatment of experimental intracranial
Akv, enhancement of murine melanoma, 211, 94
bone tumorigenesis in hMT-c-fos-LTR transgenic mouse, 206, 85 lethal, conditional, vaccinia virus, in analysis of spicule role in forma-
lymphomagenesis in myc-k transgenic and wild-type mice, 206, tion of viral envelopes, 214, 494
93 lymphocytic choriomeningitis CTL escape variants, biologic activity
C-type, derived from TSZ complex from mainland China, biological in vivo, 211, 443
characterization and molecular cloning, 212, 367 packaging-deficient, bovine leukemia virus, in identification of stem–
E-55/, persistent infection in mouse, associated anti-virus immune loop structure essential for viral genomic RNA packaging in
responses and long-term survival, effects of non-H-2-linked vivo, 211, 434
genes, 211, 507 point, defective, encephalomyocarditis virus internal ribosome entry
established infection in rat, effects of adoptively transferred virus- site, complementation in trans, 214, 82
specific immune cells, 211, 408 poliovirus receptor, serotype-specific binding of polioviruses, modu-
infection in rat, effects of adoptive immune transfers, 211, 408 lation by canyon rim residues, 214, 559
Murray Valley encephalitis virus polypeptide 3AB in dicistronic polioviruses, intragenomic comple-
envelope protein antigenic variants, structural and functional analy- mentation, 209, 315
sis, 211, 10 reovirus tsA279, with temperature-sensitive lesions in M2 and L2
Muscovy duck parvovirus genes, characterization as defective in transmembrane trans-
and goose parvovirus, nucleotide sequence analysis and common port and deficient in viral protein production, 207, 46
ancestral origin with adeno-associated virus 2, 212, 562 rotavirus, neutralization-resistant, selection with VP7-specific mono-
Mutagenesis clonal antibodies, 209, 80
Epstein–Barr virus diffused-form early antigen, functional effects, satellite tobacco ringspot virus RNA, nonaccumulating, stimulation
211, 593 of increase of trace amount of satellite RNA associated with
TRSV, 209, 470insertional, feline herpesvirus type 1 ORF US8.5, 208, 704
rice yellow mottle virus coat protein, 206, 108 Sindbis virus
site-directed 6K protein, pseudo-revertant correcting for aberrant particle forma-
tion, identification of mutations mapping to E2 glycoprotein ecto-hepatitis A virus polyprotein primary cleavage site, effect on infecti-
domain, 206, 1027vity of HAV RNA transcripts, 213, 213
and hydroxylamine treatment, deacylation of influenza A virus hem- resistant to release inhibition in low-ionic-strength medium, isola-
tion and identification of E2 protein amino acids conferring resis-agglutinin by, effect on fusogenic properties, 210, 20
tance, 210, 237Sendai virus L protein, effects on RNA synthesis in vitro, 211, 577
thymidine kinase-deficient, infectious laryngotracheitis virus, genera-in structural analysis of influenza B virus hemagglutinin, 206, 787
tion, 209, 304tobacco mosaic virus, in analysis of role of carboxylate groups in
vaccinia virus K3L0 and E3L0, infected L929 cells, interferon sensitiv-viral disassembly, 206, 724
ity patterns, 210, 254Mutants
Venezuelan equine encephalitis virus, attenuated, with lethal muta-acid-resistant, foot-and-mouth disease virus, characterization, 206,
tions in PE2 cleavage signal and second-site suppressor muta-69
tion in E1, pathogenicity in mouse and growth in mosquito cells,African swine fever virus, resistant to phosphonoacetic acid, func-
212, 102tional and molecular characterization, 214, 72
Mutational analysiscleavage, paramyxovirus SV5 fusion protein, induction of regulated
conserved cysteine residues in simian immunodeficiency virus ma-and extensive syncytium formation after expression in CV-1
trix protein, 210, 501cells, 209, 242
cymbidium ringspot virus satellite RNA, replication, 206, 1092 cucumber necrosis virus coat protein gene, 206, 38
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human papillomavirus type 16 E6 protein: transformation function for human cytomegalovirus glycoprotein B, effect on syncytia formation,
209, 580human cells and degradation of p53 in vitro, 212, 535
infectious bronchitis virus, ORF 1a encoding proteinase domain re- human foamy virus promoter II TATA box, effects on infectivity and
sponsible for proteolytic processing of viral 1a/1b polyprotein, gene expression, 206, 601
209, 420 large deletions
murine coronavirus spike protein role in cell-to-cell fusion, 214, 453 in Chlorella virus PBCV-1 antigenic variants, properties, 214, 413
NTP-binding domain in replication-associated protein AC1 of bean induction in Chlorella virus CVK1 genome, 214, 405
golden mosaic geminivirus, 211, 1 Newcastle disease virus fusion glycoprotein cytoplasmic domain,
retroviral integrase: activities and substrate specificity of evolution- induced depression of syncytia formation, 210, 264
arily conserved central domain, 206, 448 oncoretroviral SU protein in CWLC motif conserved cysteine resi-
vaccinia DNA ligase residues essential for covalent catalysis, 211, dues, effects on protein maturation and translocation, 206, 885
73 p53 tumor-suppressor gene, association with bovine leukemia virus-
Mutations, see also Hypermutations induced leukemogenesis (bovine, sheep), 209, 676
AcNPV, temperature sensitive, IE1 protein interaction with viral en- poliovirus
hancer elements, 209, 90 accumulating on cultivation of Sabin 2 strain oral vaccine, selec-
adenovirus-encoded single-stranded DNA-binding protein altering tion, 209, 366
accumulation of early and late viral RNAs, identification, 212, Sabin type 3 strain, microevolution in cell culture and implications
91 for vaccine quality control, 211, 377
bovine leukemia virus LTR and env proviral sequences, in vivo rate potato spindle tuber viroid pathogenicity domain-stabilizing, effect
during virus-induced leukemogenesis, 206, 769 on replication and symptom expression, 208, 554
brome mosaic virus coat protein N-terminal, biological significance, proline 137, adenovirus type 2 proteinase, effect on enzyme encapsi-
211, 42 dation and activity, 209, 167
cysteine, on transmembrane protein of Moloney murine leukemia pseudorabiesvirus UL21 gene, role in avirulence of live attenuated
virus, analysis, 211, 285 Bartha vaccine strain, 212, 466
cytotoxic T-cell epitopes, role in production of CTL escape viral vari- Sendai virus L polymerase protein conserved domain I, effect on
ants in vivo, 210, 29 transcription and replication, 213, 352
deletion simian immunodeficiency virus
cucumber necrosis virus 0.9-kb subgenomic RNA promoter, analy- env constant regions 3 and 4, effects on viral replication, gp160
sis, 214, 100 processing, and env binding to CD4 receptor, 210, 448
Dengue type 4 virus growth-restricted mutants containing, in 5* V3, compensating for inactivating mutations in constant region 4,
noncoding region of RNA genome, construction, 207, 68 identification, 213, 179
glycoprotein gI and gE genes, recombinant feline herpesvirus-1 Sindbis virus E2 glycoprotein ectodomain, in 6K protein mutant pseu-
with, as vaccine for feline rhinotracheitis, 214, 12 dorevertant correcting for aberrant particle formation, 206, 1027
deletion and frameshift, satellite tobacco mosaic virus coat protein spontaneous deletion, soil-born wheat mosaic virus RNA-2, analysis,
and 5* ORFs, effects on RNA accumulation and systemic move- 209, 213
ment, 212, 121
tat and LTR, in primary and long-term human lymphoid cells, genetic
directed, HPV E6 protein: abrogation of p53-mediated cell cycle ar-
analyses: infection and replication of Tat0 HIV-1, 211, 157
rest correlated with p53 binding and degradation in vitro, 208,
temperature-sensitive, adenovirus DNA polymerase, in analysis of
111
role in viral DNA replication, 205, 364; erratum, 207, 342
equine infectious anemia virus dUTP pyrophosphatase, effect on
thymidine kinase gene deletion, attenuation of channel catfish her-viral replication in macrophages, 210, 302
pesvirus and effect on infectivity, 209, 658
F and L genes, human respiratory syncytial virus cold-passaged
tobacco etch virus capsid protein, effects on viral cell-to-cell andattenuated strain, identification, 208, 478
long distance movement, 206, 1007hepatitis B virus
tobacco mosaic virus coat proteinclosely linked precore predominant, mechanism of natural occur-
assembly deficient, conferral of resistance, 208, 485rence, 211, 144
role in induction of severe chlorosis, 207, 234core antigen, in hepatomas, accumulation in T-cell epitopes, 212,
Venezuelan equine encephalitis virus glycoproteins, effects on dis-151
ease progression in mouse model, 206, 994preS and core genome regions, frequency in isolates from chronic
vesicular stomatitis virus matrix protein, at major phosphorylationHBV-infected patients and correlation with disease severity,
sites, effects on function, 206, 894208, 672
virulent avian influenza virusherpes simplex virus type 2, DNA polymerase- and thymidine kinase-
arising during replication in embryonated chicken eggs, associ-inhibiting, synergistic effects of ganglionic infections, 206, 263
ated molecular changes, 206, 755HIV-1
glycine residue immediately downstream from hemagglutininglycine substitution at protease position 48, effect on substrate
cleavage site, effect on HA cleavability by subtilisin-like endo-specificity, 207, 475
protease, 210, 466single point, in inhibitor-escape mutant POL gene, induced impair-
Mycophenolic acidment of infectivity, 210, 212
polymerase substrate inhibition by, as strategy for inhibition of hu-in V2 domain, effect on T-cell line-tropic envelope gp120 function,
man immunodeficiency virus replication, 211, 554206, 878
Myeloblastosis-associated virusV3 loop, role in adaptation to growth of variant of macrophage-
Gag–Pol-encoded proteinase, expression in Escherichia coli andtropic clone in transformed T-cell line, 210, 490
production of proteinase PR(/IleGly), 207, 185HIV-1 reverse transcriptase
Myristylationconferring foscarnet resistance, analysis, 212, 58
hepatitis B virus large surface protein, role in viral infectivity, 213,at multiple sites, generation of resistance to 1-[(2-hydroxyethoxy)-
methyl]-6-(phenylthio)thymine, 210, 186 292
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Myxoma virus Newcastle disease virus
cooperative neuraminidase activity in, 213, 241encoding of dual-specificity tyrosine/serine phosphatase essential
for viral viability, 206, 572 fusion protein, intracellular maturation, effect of strain differences in
predicted amphipathic a-helix adjacent to fusion domain, 208,
827N
hemagglutinin–neuraminidase
domain required for promotion of cellular fusion by membraneNatural killer cells
killing of adenovirus-infected and -immortalized human cells, suscep- protein spike, localization, 209, 457
function, role of individual oligosaccharide chains, 212, 398tibility, effects of E1A gene expression, 210, 421
Nerves syncytia formation, depression by mutations in fusion glycoprotein
cytoplasmic domain, 210, 264trigeminal, role in Venezuelan equine encephalitis virus neuroinva-
sion in mouse, 208, 662 Nilaparvata lugens reovirus
transmission to brown planthopper via rice plant, 207, 303Neuraminidase, see Exo-a-sialidase; Hemagglutinin–neuraminidase
Neuroblasts Nitric oxide
synthesis in murine macrophages, requirements for, effects of tick-primary, infectivity of HIV-1 BaL and IIIB strains (human), 210, 221
Neurodegeneration borne encephalitis virus infection, 212, 174
NK cells, see Natural killer cellsFriend murine leukemia virus-induced: correlation of neuropathogen-
icity with cell tropism (rat), 214, 239 NTP-binding domain
replication-associated protein AC1 of, bean golden mosaic geminivi-Neuroinvasion, see Neurotropism
Neurons rus, mutational analysis, 211, 1
Nuclear antigensolfactory receptor, infection by vesicular stomatitis virus, early events
(mouse), 209, 257 EBNA-1, Epstein–Barr virus
C-terminal unique domain, antigenic and sequence variation, 208,Neurotropism
measles virus hamster neurotropic and Philadelphia 26 strains, com- 521
peptide epitopes from, healthy seropositive individuals specificparison, 207, 555
reduced, in mouse, Murray Valley encephalitis virus envelope protein for, CTL isolation, 214, 633
EBNA-2, Epstein–Barr virus, –estrogen receptor fusion proteins,antigenic variants with, 211, 10
Venezuelan equine encephalitis virus in mouse, mechanism, 208, transactivation of viral and cellular genes and interaction with
RBP-Jk, 214, 675662
Neurovirulence EBNA-2A and -2B, Epstein–Barr virus, rat monoclonal antibodies
differentiating, production, 208, 336Friend murine leukemia virus, correlation with viral tropism for macro-
phages, microglia, and cerebral vascular cells, 214, 239 Nuclear factors, see Hepatocyte nuclear factors; Transcription fac-
torspoliovirus
oral live vaccines, test using poliovirus-sensitive transgenic mice, Nuclear targeting
human papillomavirus type 6B L2 protein, required sequences, iden-206, 1075
Sabin type 2 in monkey, effect of mutations accumulating on culti- tification, 213, 321
Nucleation sitesvation of oral vaccine, 209, 366
Sabin type 3 vesicular stomatitis virus, mediation of M protein aggregation, impli-
cations for viral assembly, 206, 28correlation with microevolution in cell culture and implications
for vaccine quality control, 211, 377 Nucleocapsids
hepatitis B virus, promoter, functional hepatocyte nuclear factor 3temperature-sensitive derivatives in poliovirus-sensitive trans-
genic mouse and cynomolgus monkey, testing methods, 210, binding site, characterization, 208, 147
prototypic and aberrant, varicella–zoster virus, computer modeling,160
Neutralization 214, 321
simian virus 5, association with viral V protein, 208, 121African horse sickness virus, associated site in capsid protein VP2,
identification, 210, 391 Nucleocytoplasmic transport
Rev and transdominant Rev protein in living cells, analysis with greenbluetongue virus, homotypic and heterotypic determinants, 209, 263
equine arteritis virus major envelope glycoprotein, associated site, fluorescent protein fusions, 213, 439
Nucleoprotein Nidentification, 207, 518
hepatitis C virus, human serum antibodies involved in, direction measles virus, encoding gene, complementary antisense mRNA se-
quences, cure of persistently MV-infected cells, 207, 168against hypervariable region 1, 208, 653
parvovirus B19, induction by minor capsid protein unique region- Nucleoproteins
influenza A virus, interaction with nucleoprotein interactor 1, 206,derived peptides, 206, 626
postattachment, papillomaviruses by monoclonal and polyclonal anti- 116
measles virus, presentation to MHC class I-restricted CTLs, role ofbodies, 207, 136
rabies virus by antiglycoprotein monoclonal antibodies, effect of CD46 and effects of viral inactivation, 212, 255
peste des petits ruminants virus, cloning and expression in baculovi-acidic configuration of glycoprotein, 210, 400
rotavirus rus for use in serological diagnosis, 208, 776
transmissible gastroenteritis coronavirus, epitope, elicitation of Tporcine group C, associated 82-kDa protein, functional and anti-
genic topography, 208, 354 helper cells collaborating in in vitro antibody synthesis to three
major structural viral proteins, 212, 746resistant mutants, selection with VP7-specific monoclonal antibod-
ies, 209, 80 Nucleotide sequence
adenovirus subgenus D fiber genes, 206, 564simian immunodeficiency virus
capacity of monoclonal antibodies against envelope glycoprotein adenovirus types Ad35p and Ad34a fiber genes, 206, 686
adenovirus VA RNA genes, human and simian Ad, 207, 32of SIV isolate 251, 211, 339
by chimeric macaque/human Fab molecules, 207, 495 African swine fever virus DNA polymerase gene, 214, 72
African swine fever virus p17 structural protein gene, 206, 1140isolates, assay using CD4-expressing macaque cell line, 213, 386
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African swine fever virus strain BA71V, 208, 249 immunological adenovirus subgenus D variant strain hexon and fiber
genes, 213, 313Aura virus RNA, 208, 621
bacteriophage Cp-1 left early region DNA, 211, 21 infectious bursal disease virus genomic dsRNA 5*- and 3*-noncoding
regions, 209, 10bacteriophage P2 genes involved in baseplate assembly, 213, 109
barley mild mosaic virus capsid protein and 3*-noncoding region influenza virus A/WSN putative defective interfering RNAs, 210, 9
from fungally and mechanically transmitted isolates, 212, 383 lactate dehydrogenase-elevating virus ORFs 2, 5, and 6, 212, 512
Black Creek Canal virus S genome segment 5*-nontranslated region, lactate dehydrogenase-elevating virus strains P and C, ORFs 1a and
210, 482 1b, 209, 637
bluetongue virus cognate L1 genes, 214, 280 Leishmania RNA virus cDNA, 212, 84
Bombyx mori nuclear polyhedrosis virus pol gene, 206, 435 lettuce infectious yellows virus RNAs 1 and 2, 208, 99
bovine herpesvirus 1 genomic 30-kb region exhibiting colinear gene lymphoproliferative disease virus direct repeats I and II, 208, 789
arrangement with HSV UL21-UL4 genes, 210, 100 Marek’s disease virus cDNAs mapping to BamHI-I2, -Q2, and -L frag-
bovine herpesvirus 1 UL1–UL3.5 gene cluster, 213, 28 ments of MDV genome (chicken MKT-1 cells), 213, 590
bovine herpesvirus 1 UL39, UL38, and UL37 genes, 212, 734 Marek’s disease virus unique short region, 206, 324
bovine leukemia virus provirus LTR and env gene, 206, 769 M28 dsRNA (Saccharomyces cerevisiae K28), 213, 341
broad bean mottle virus RNA2, 212, 574 measles virus L genes from wild-type virus and SSPE brain tissue,
capripoxvirus HindIII Q2 fragment encoding G protein-coupled chem- comparison, 208, 795
okine receptor homolog, 209, 207 Melolontha melolontha entomopoxvirus fusolin DNA, 208, 427
cherry leafroll virus RNA, 211, 33
mouse mammary tumor virus 5* LTR, 210, 244
Chlorella virus CVK1 genome large deletion regions, 214, 405
Mtv-6 endogenous provirus cDNA, 206, 395
Chlorella virus PBCV-1 330-kb genome, 43 kb of DNA, 212, 134
muscovy duck parvovirus, 212, 562
Chlorella virus PBCV-1 antigenic variant large deletion regions, 214,
myxoma virus and Shope fibroma virus tyrosine phosphatase ORFs,413
206, 572chlorella virus PBCV-1 genome, 45 kb of DNA, 206, 339
Newcastle disease virus wild-type and mutant fusion protein trans-Choristoneura fumiferana nuclear polyhedrosis virus
membrane and cytoplasmic domains, 210, 264DNA polymerase gene, 209, 538
nucleoprotein interactor-1 cDNA, 206, 116origin of DNA replication, 209, 409
orf virus: spot sequencing, 212, 698citrus tristeza virus
orf virus topoisomerase type I cDNA, 206, 203Israeli VT strain 2.4-kb defective RNA, 208, 383
Orgyia pseudotsugata baculovirus lef-3, 210, 372RNA genome, 208, 511
ovine adenovirus homologues for 100K hexon assembly, 33K, pVIII,coliphage 186 K and orf45 genes, 212, 128
and fiber genes, 209, 400coliphage 186 tail sheath and tube genes, 212, 218
ovine pestivirus 5* noncoding region, 209, 200Cotia virus thymidine kinase gene, 210, 67
pneumonia virus of mice attachment glycoprotein gene, 207, 240coxsackie A virus 3* and 5* untranslated regions, 212, 30
porcine adenovirus serotypes 1 to 5, inverted terminal repetitionCydia pomonella granulosis virus transposon TCl4.7/MCp5 DNA,
sequences, comparison, 212, 237207, 369
potato mop-top virus RNA3, 206, 701cymbidium ringspot tombusvirus defective interfering RNAs, 207, 510
primate foamy virus pol gene, 207, 577Diadromus pulchellus reovirus double-stranded RNA genome seg-
ments, 210, 109 Prunus necrotic ringspot virus PE-5 isolate RNA 3, 208, 349
duck DNA genomic fragment containing intronless interferon gene, rabies virus G–L noncoding region, 206, 718
212, 641 rotavirus NSP3 gene 3* end, 207, 327
El Moro Canyon hantavirus M genomic segment, 211, 336 S71-related endogenous retroviral reverse transcriptase and pol frag-
Epstein–Barr virus ments, 209, 550
BamHI-A region cDNA, 208, 180 sigma rhabdovirus of Drosophila genes 2 and 3, 213, 300
Cp viral promoter cDNA, 206, 866 simian foamy virus SFV-Gg proviral DNA, 207, 217
feline leukemia virus 3* LTR U3 region in thymic lymphomas, 206, simian parvovirus cDNA, 210, 314
661 simian varicella virus genome terminal sequences, 207, 154
feline leukemia virus LTRs, 214, 431 simian virus 40 DNA in human and monkey isolates, 212, 710
goose parvovirus, 212, 562
southern bean mosaic virus bean strain, 206, 287
goose parvovirus DNA, 210, 283
Sphenodon endogenous virus, 210, 206
hantavirus M and S segments from California isolates (deer mouse),
squirrel monkey retrovirus-B95–8 cDNA, 209, 374206, 973
subterranean clover stunt virus DNA, 207, 354Helicoverpa armigera stunt virus larger genomic RNA, 208, 84
tick-borne encephalitis virus 3*-noncoding region, 213, 169hepatitis B virus large surface antigen promoter region, 208, 399
transmissible gastroenteritis virus gene 1, 206, 817herpesvirus of turkeys 4.792 kb DNA, 207, 205
Trichomonas vaginalis virus T1HIV-1 env gene from individuals infected from same source, 211,
genomic cDNA, 206, 773198
plus-strand RNA, 208, 189HIV-1VAU hypermutated and nonhypermutated env and IN regions,
variola smallpox virus inverted terminal repeats, 211, 350208, 601
virulent bovine viral diarrhea virus type 2 genomic insertion fromHIV and SIV poly(A) site, 207, 276; erratum, 209, 284
virulent and noncytopathic isolates, 212, 39human endogenous retrovirus HERV-K clone pol regions, 208, 733
Nudaurelia capensis v virushuman papillomavirus type 16 and type 31 capsid protein genes,
214, 664 T  4 capsid protein assembly and mRNA post-translational cleav-
age and specific encapsidation in baculovirus expression sys-human respiratory syncytial virus phosphoprotein P, 205, 93; erratum,
209, 284 tem, 207, 89
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herpesvirus of turkeys, identification in long unique region, 207, 205
Lelystad virus, ORFs 2 to 7, proteins encoded by, characterization,O
206, 155
Obituaries long terminal repeat, mouse mammary tumor virus, expression, pro-
Bernard N. Fields, 208, 417 motion of tumorigenic potential of hyperplastic mammary epithe-
Andre´ Lwoff, 209, 1 lial cells, 211, 84
Richard Ellis Ford Matthews, 209, 287; erratum, 211, 598 L1R, vaccinia virus, myristylated membrane protein encoded by, as
Igor Tamm, 214, 1 target of neutralizing monoclonal antibody 7D11, 211, 53
6-(p-n-Octylanilino)uracil Marek’s disease virus, homologous to alphaherpes S component
selective inhibition of HSV-1 uracil–DNA glycosylase, 211, 307 genes and fowlpox virus, nucleotide sequence, 206, 324
Okadaic acid myxoma virus and Shope fibroma virus tyrosine phosphatase, se-
induction of Sp1 phosphorylation and NF-kB-independent HIV pro- quence alignment, 206, 572
moter domain activity in T lymphocytes, 208, 753
ORF-1 and -2, herpesvirus saimiri, role in interleukin-2 and IL-4 ex-
Olfactory system
pression in HVS-transformed T lymphocytes, 208, 418
role in Venezuelan equine encephalitis virus neuroinvasion in mouse,
ORF 5, equine arteritis virus field isolates, phylogenetic analysis,208, 662
and identification of conserved and nonconserved regions in GL2*,5*-Oligoadenylate synthetase
envelope glycoprotein, 214, 690activation by HTLV-I Rex response element, 206, 913
ORF7a/7b transcription unit of different biotypes of feline coronavi-Oligodendrocytes
ruses, comparative sequence analysis, 212, 622galactosylceramide-expressing, putative binding by HIV-1 gp120 and
p33 and p92, tomato bushy stunt virus, encoded replicase proteins,associated increased intracellular Ca2/, analysis (rat), 206, 1084
coordinate expression and membrane association, 208, 365Oligonucleotides
PreS1, hepatitis B virus, C-terminal sequence, role in viral L proteinantisense, targeting phage f29 pRNA essential for DNA packaging,
retention in 293 cells, 213, 57inhibition of viral assembly, 211, 568
Q2/3L, capripoxvirus, encoding G protein-coupled chemokine recep-Oligosaccharides
tor homolog, sequence analysis, 209, 207O-linked and complex N-linked, in human subgroup B adenovirus
E3–20.5K membrane protein, 210, 335 satelite tobacco mosaic virus coat protein and 5* ORFs, mutations
Oncoproteins in, effects on RNA accumulation and systemic movement, 212,
E7, human papillomavirus, dimerization in vivo, 214, 289 121
Oncoretroviruses subterranean clover stunt virus, amino acid sequence, 207, 354
SU protein maturation and translocation, effects of mutations in UL1–UL3.5, bovine herpesvirus-1, 3*-coterminal gene cluster, identi-
CWLC motif conserved cysteine residues, 206, 885 fication and transcriptional analysis, 213, 28
Open reading frames UL37, herpes simplex virus type 1, encoded protein, association with
1, encoded varicella–zoster membrane protein, role in viral growth, tegument of purified virions, 206, 1055
206, 835 US8.5, feline herpesvirus type 1, insertional mutagenesis, 208, 704
1a
VII, A, B, and C, peanut chlorotic streak caulimovirus, functional sig-
avian infectious bronchitis virus, 87-kDa polypeptide encoded by,
nificance, 206, 823
identification, expression, and processing, 208, 48
virulent bovine viral diarrhea virus type 2, amino acid sequence, 212,infectious bronchitis virus, encoding proteinase domain responsi-
39ble for proteolytic processing of 1a/1b polyprotein, characteriza-
ORF, see Open reading framestion and mutational analysis, 209, 420
Orf virus1a and 1b
genetic map: genomic organization pattern highly conserved amonglactate dehydrogenase-elevating virus strains P and C, sequence
divergent poxviruses, 212, 698analysis, 209, 637
Marek’s disease virus, immediate-early 14-kDa phosphoprotein topoisomerase type I, identification and characterization, 206, 203
encoded by, expression in fibroblasts infected with oncogenic Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus
viral strains and attenuated derivitives, 206, 695 DNA replication
1 and 2, tobacco necrosis virus, sufficiency for satellite RNA replica- genes influencing, 212, 650
tion, 212, 222 identification of essential trans-acting regions and replication gene
2, 5, and 6, lactate dehydrogenase-elevating virus, nucleotide se- lef-1, 207, 417
quence, 212, 512
second putative origin of, identification and characterization, 207,
3, rice tungro bacilliform virus, role in reverse transcriptase proteo- 572
lytic processing, 208, 207
GP64 envelope fusion protein, synthesis, oligomerization, and pro-
4, varicella-zoster virus, encoded protein, acidic amino-terminal re-
cessing in infected Lymantria dispar cells, 209, 592
gion, role in transactivation and functional homology with herpes
lef-3, identification and sequence and transcriptional analysis, 210,simplex virus ICP27 amino-terminal region, 208, 376
37261, varicella-zoster virus, encoded protein, functional homology with
Origin of replicationpseudorabies virus early protein O, 209, 281
adeno-associated virus linear duplex DNA in vitro, minimum origin206, turnip yellow mosaic virus, readthrough domain and overlapping
requirements, 209, 692coat protein ORF, functional studies, 206, 403
in Choristoneura fumiferana multinucleocapsid nuclear polyhedrosisAfrican swine fever virus strain BA71V, localization and characteriza-
virus genome, identification and analysis, 209, 409tion, 208, 249
minute virus of mouse replicator protein NS1 essential for nickingBDLF3, Epstein–Barr virus expression of gp150, 209, 108
and covalent attachment to, associated tyrosine linking motif,Chlorella virus PBCV-1 330-kb genome, analysis, 212, 134
identification, 209, 122chlorella virus PBCV-1 genome, analysis, 206, 339
encoded E2 protein, HPV type 16, and subdomains, characterization Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus,
second putative, identification and characterization, 207, 572and expression in insect cells, 211, 418
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P tobacco ringspot virus-like, 3D structure, 213, 472
virion-like, beet western yellows luteovirus, assembly of recombinant
Packaging, see also DNA packaging; RNA packaging baculovirus-produced capsid proteins into, in Bombyx mori cells
bacteriophage f29 DNA, role of circularly permuted viral pRNA, 207, and larvae, 213, 204
442 virus-like
retroviral, improved cell lines for, derivation from spleen necrosis bovine papillomavirus, fate after infection of cultured cells, 214, 167
virus, 208, 234 HPV type 6a, assembly in Saccharomyces cerevisiae, 209, 506
RNA, strategy in retroviruses and pararetroviruses, comparison, re- HPV types 6 and 16, synthesis and assembly in Schizosaccharo-
view, 213, 1 myces pombe, 206, 126
vesicular stomatitis virus RNA, required cis-acting sequences in ter-
human papillomavirus type 16, assembly by capsid proteins from
mini of VSV defective interfering particle RNAs, 206, 760
recombinant Semliki Forest virus, 214, 349
Palindromic sequence
from T  4 Nudaurelia capensis v virus capsid protein mRNAAT-rich, multimerized, stimulation of human papillomavirus type 1a
expression, post-translational cleavage and encapsidation inDNA replication, 214, 301
baculovirus system, 207, 89Pandemics
Ty1, immunological characterization, 207, 59influenza, European swine isolates as potential source, 212, 555
Parvoviruses, see also specific parvovirusPanencephalitis, see Subacute sclerosing panencephalitis
B19Papillomavirus, see specific type
minor capsid protein unique region-derived peptides, induction ofParainfluenzavirus type 1
neutralizing antibodies in rabbit, 206, 626hemagglutinin–neuraminidase glycoprotein, fusogenicity, enhance-
VP1 minor capsid protein, localization on capsid surface, 211, 359ment by single amino acid change (human), 209, 654
DNA replication, role of initiator protein and sequence homologyimmunization of infant mouse with, subsequent protection from Sen-
with prokaryotic rolling circle replication initiators, 209, 122dai virus infection (human), 212, 13
simian, DNA cloning and sequencing, and homology with humanParainfluenzavirus type 2
parvovirus B19, 210, 314hemagglutinin–neuraminidase protein, stalk domain, binding by cell
Pathogenesisfusion-inhibiting monoclonal antibody (human), 206, 1117
Parainfluenzavirus type 3 Autographa californica nuclear polyhedrosis virus in Trichoplusia ni
and Heliothis virescens larvae, comparison, 209, 561phosphoprotein, phosphorylation by protein kinase C z, identification
of serine 333 as major site (human), 211, 561 beet curly top virus, role of L2 and L3 genes, 206, 1044
Paramyxovirus bovine adenovirus type 3 in cotton rat, 213, 131
HN protein, membrane-spanning domain, structural requirements for hepatitis C virus, role of cellular proteins binding viral RNA 5*-non-
formation of stable tetramer, 213, 263 coding region, 208, 723
phosphoproteins, formation of homotrimers, determination by epi- rabbitpox virus, role of 35-kDa major secreted protein, 206, 591
tope dilution assay via predicted coiled coils, 214, 139 Venezuelan equine encephalitis virus in mouse model, effects of
SV5 fusion protein specific glycoprotein mutations, 206, 994
cleavage mutants, induction of regulated and extensive syncytium Pathogenicity
formation after expression in CV-1 cells, 209, 242 associated domain, potato spindle tuber viroid, mutations stabilizing,
intracellular transport, role of N-linked oligosaccharide chains, effect on viroid replication and symptom expression, 208, 554
209, 250 attenuated Venezuelan equine encephalitis virus with lethal muta-
Parapoxvirus of red deer tions in PE2 cleavage signal and second-site suppressor muta-
evidence for inclusion in genus parapoxvirus, 208, 812 tion in E1, in mouse, 212, 102
Pararetroviruses bipartite geminiviruses, and viral host range, role of BR1 and BL1
and retroviruses, packaging strategy, comparison, review, 213, 1 movement proteins, 207, 191
Particles Borna disease virus, cell-culture-attenuated, after inoculation in
core, bluetongue virus type 1, crystallization and preliminary x-ray weanling rat, 206, 426
analysis, 210, 217 H5N2 influenza virus, relationship to hemagglutinin cleavage site
core-like, bluetongue virus, assembly by interactions of BTV chimeric sequences and HA cleavability, 213, 223
VP3 molecules with VP7 protein, 214, 593 potato spindle tuber viroid in tomato, and replicability, interdepen-
defective interfering dence, 209, 60
Sendai virus, genome synthesis in vitro, utilization of measles virus
PCR, see Polymerase chain reaction
nucleocapsid protein, 206, 777
Peach latent mosaic viroid
vesicular stomatitis virus, RNA termini, cis-acting sequences nec-
derived transcripts, intra- and intermolecular nonenzymatic ligationsessary for RNA encapsidation, replication, and budding, 206,
within, 212, 705760
Peanut chlorotic streak caulimovirusGag, simian immunodeficiency virus, production, role of conserved
essential and nonessential genetic elements, molecular analysis,Cys57 and Cys83 in matrix protein domain, 210, 501
206, 823HIV-1, Vpr incorporation into, role of C-terminal domain, 214, 647
Peanut clump virusinfectious, produced on cell line packaging avian retroviral vectors,
RNA 2, P39 gene, in vitro translation by leaky scanning mechanism,efficient transmission of defective retroviral endogenous RNA,
208, 215207, 271
Peanut stunt virusJapanese encephalitis virus, subviral, secretion from mammalian
and related cucumoviruses, phylogenetic analysis, 207, 334cells infected with Sindbis virus–JEV recombinants, suppres-
Pepper mild mottle virussion by SIV vectors, 209, 155
in analysis of Capsicum L3 gene-mediated resistance to tobamovi-noninfectious, HIV-1, and Env, DNAs expressing, role in induction of
ruses: role of coat protein, 209, 498antibody response in mouse, 209, 147
SIV-related, containing envelope proteins, assembly using baculovi- replicase gene, 54-kDa region, Nicotiana benthamiana transformed
with, resistance responses against viral infection, 211, 170rus expression system, 214, 50
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Pepper mottle virus Phosphonoacetic acid
African swine fever virus mutants resistant to, functional and molecu-–potato virus X synergistic disease in transgenic tobacco, mediation
lar characterization, 214, 72by 5* proximal potyviral sequences, 206, 583
effect on Amsacta moorei entomopoxvirus growth in Lymantria disparPeptides
cells, 211, 462amino-terminal, vaccinia virus structural protein precursors, role in
Phosphoproteinsproteolytic processing, 207, 229; erratum, 209, 285; 207, 229
14-kDa, immediate-early, expression in fibroblasts infected withepitopes, from Epstein–Barr virus nuclear antigen 1, healthy sero-
Marek’s disease virus oncogenic strains and attenuated derivi-positive individuals specific for, CTL isolation, 214, 633
tives, 206, 695fusion, recognition in avian reovirus sC protein, 208, 678
human parainfluenza virus type 3, phosphorylation by protein kinaseimmediate-early, Vmw110, herpes simplex virus type 1, multimeriza-
C z, identification of serine 333 as major site, 211, 561tion and interaction with cellular 135-kDa protein, required se-
immediate–early, equine herpesvirus type 1, DNA binding proper-quences, identification, 209, 174
ties, characterization, 213, 46multibranched constructs, see Multibranched peptide constructs
measles virus hamster neurotropic strain, associated hypermutation,parvovirus B19 minor capsid protein unique region-derived, induction
207, 555of neutralizing antibodies in rabbit, 206, 626
P, human respiratory syncytial virussynthetic
bacterial expression and casein kinase II-mediated phosphoryla-foot-and-mouth disease virus VP1 G-H loop, reactivity with FMDV-
tion at Ser237, 205, 93; erratum, 209, 284specific swine polyclonal and murine monoclonal antibodies,
transcriptional activity, role of casein kinase II-mediated phosphor-210, 120
ylation, 205, 104; erratum, 209, 284HIV-1 V3 loop
paramyxovirus, formation of homotrimers, determination by epitopefrom different viral strains, induction of cross-reactive cytotoxic
dilution assay via predicted coiled coils, 214, 139T lymphocytes, 211, 261
pp38, Marek’s disease virus homolog, truncated, identification inminimal sequence requirements for enhancement of cell binding
herpesvirus of turkeys internal repeat, 207, 205and infection, 206, 807
vesicular stomatitis virus, interaction with L and N proteins, efficiencymodeling hepatitis C virus NS3–NS4–NS5 protein linear B-cell
in cells expressing recombinant proteins, 208, 821epitopes, 206, 666
PhosphorylationSV40 large T antigen, in identification of H-2Kb-restricted determi-
associated domains of JC virus large T antigen, biochemical charac-nant, 208, 159
terization, 212, 295viral hemorrhagic septicemia virus, G and N cDNA-derived se-
hierarchal constitutive, vesicular stomatitis virus P protein, effect onquences, stimulation of leukocyte proliferation with individual
P1 to P2 conversion, 214, 189fish variation (Onchorynchus mykiss), 212, 348
human parainfluenza virus type 3 phosphoprotein by protein kinaseVP1 of foot-and-mouth disease virus, T- and B-cell epitope mapping
C z, identification of serine 333 as major site, 211, 561and conferral of protection in mouse, 212, 614
human respiratory syncytial virus phosphoprotein P, casein kinasePermissivity
II-mediatedselective, to wild-type poliovirus Mahoney strain in HEp-2c cell
role in P protein transcription, 205, 104; erratum, 209, 284clones cured of persistent poliovirus infection, 212, 309
Ser237 as site of, 205, 93; erratum, 209, 284Peste des petits ruminants virus
major sites in matrix protein, effects on vesicular stomatitis virusNigeria 75/1 strain, nucleoprotein cloning and expression in baculo-
assembly, 206, 894
virus for use in serological diagnosis, 208, 776
measles virus P protein, role of cellular casein kinase II, 211, 218
Pestivirus
protein kinase, activity of herpes simplex virus type 1 and 2 140-kDa
evidence for more than three species within genus: characterization
RR1 protein, 207, 409
of border disease virus isolates, 209, 200
role in double-stranded RNA–interferon system activation of apop-
pH totic Fas antigen-encoding gene upon influenza virus infection,
low, configuration of rabies virus glycoprotein, effect on neutralization 209, 288
by antiglycoprotein monoclonal antibodies, 210, 400 Sendai virus P protein, intracellular and cell-free, comparison, 208,
role in lymphocytic choriomeningitis virus glycoprotein complex dis- 408
sociation from virion, 209, 3 Ser232 of human respiratory syncytial virus P protein, effect on pro-
Phagocytes tein transcriptional activity, 213, 405
mononuclear, HIV-1 replication, role of vpr, 206, 935 Sp1, and NF-kB-independent HIV promoter domain activity, in T lym-
Phenotype phocytes, induction by okadaic acid, 208, 753
activation, Sendai virus-specific CD4/ T cells, relationship to preva- tyrosine, phospholipase C-g1, by vaccinia virus growth factor, 214,
lence after intranasal inoculation in mouse, 210, 179 21
HIV-1 subtype D Zairian isolate NDK fusogenic determinants, charac- vesicular stomatitis virus P protein, role in viral transcription and
terization, 209, 649 replication, 208, 821
symptom, and long-distance movement, brome mosaic virus, effect Photinus-luciferin 4-monooxygenase (ATP-hydrolyzing)
of N-terminal mutations in coat proteins, 211, 42 encoding gene, expression by human adenovirus type 5-based vec-
transdominant negative, human respiratory syncytial virus phosphor- tors in HeLa cells, 210, 226
ylation-defective P mutant, 205, 104; erratum, 209, 284 Phylogenic analysis
Phenotypes equine arteritis virus ORF 5 from field isolates, and identification of
determinants, adenovirus E1A gene autoregulation: variable region conserved and nonconserved regions in GL envelope glycopro-
between conserved coding domains 2 and 3, 213, 666 tein, 214, 690
Nef0, HIV-1 and HIV-2, manifestations, role of virus and host compo- rabies virus noncoding region between G and L genes, 206, 718
nents, 213, 158 Phylogeny, see also Evolution
Phospholipase C-g1 adenoviruses, human and simian, inferences from analysis of VA
RNA genes, 207, 32tyrosine phosphorylation by vaccinia virus growth factor, 214, 21
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Aura virus, organizational and sequence similarity with Sindbis virus, RNA 5* noncoding region, cellular protein binding, role of stem–loop
structure synergy, 206, 923208, 621
avian influenza virus hemagglutinin genes from highly pathogenic Sabin type 3
and nonpathogenic strains, 209, 664 temperature-sensitive derivatives, neurovirulence in poliovirus-
Black Creek Canal virus, 210, 482 sensitive transgenic mouse and cynomolgus monkey, testing
border disease virus isolates, characterization: evidence for more methods, 210, 160
than three species within genus pestivirus, 209, 200 microevolution in cell culture and implications for oral poliovirus
Bunyaviridae L proteins, 206, 742 vaccine quality control, 211, 377
European swine influenza virus, 212, 555 serotype-specific binding to mutants of poliovirus receptor, modula-
goose parvovirus, 210, 283 tion by canyon rim residues, 214, 559
hantaviruses of New World harvest mice, 207, 452 wild-type Mahoney and attenuated Sabin 1 strain, selective permis-
HIV-1 and -2, and SIV types, poly(A) signal hairpin structure, 207, sivity and partial resistance of cell clones cured of persistent
276; erratum, 209, 284; 207, 276 infection, 212, 309
HIV-1 subtype D, G, and A/D recombinant transmitted in Sweden, Poliovirus receptor
209, 136 mutants, serotype-specific binding of polioviruses, modulation by
lettuce infectious yellows virus, 208, 99 canyon rim residues, 214, 559
parapoxvirus of red deer: evidence for inclusion in genus parapox- Polyadenylation signal
virus, 208, 812 analysis and poly(A) addition site mapping, in plant circovirus replica-
primate foamy viruses, analysis by pol sequence comparison, 207, tion-related gene, 211, 345
577 HIV-1 and -2 and SIV types, conservation of hairpin structure, 207,
rabies virus and lyssavirus nucleoprotein genes, 209, 526 276; erratum, 209, 284
rotavirus Poly(A) polymerase
nonstructural protein NSP3, 207, 327 molluscum contagiosum virus, gene encoding, identification and
VP8* protein, 210, 231 properties, 210, 471
simian foamy virus from gorilla, relationship to human and primate Polymerase, see also RNA-directed RNA polymerase
foamy viruses, 207, 217 Ebola virus, and T7 and vaccinia virus polymerases, editing of EBO
simian parvovirus, 210, 314 glycoprotein mRNA, 214, 421
tick-born encephalitis complex viruses in northern hemisphere, 210, related protein, and helicase-like protein, brome mosaic virus, inter-
152 action, biochemical and genetic analysis, 214, 59
TYU, SRE, and CFA viruses: different evolutionary rates in genus
Polymerase chain reaction
Flavivirus, 206, 1133
long, generated infectious proviral clones of chimpanzee foamy virus,
virus species, 207, 334
based evidence for close functional relatedness to human foamy
Physical mapping
virus, 214, 685
Cotia virus DNA, 210, 67
in recovery of virtually full-length HIV-1 provirus of diverse subtypes
Picornavirus
from primary virus cultures, 213, 80
proteinase 2A, mediated stimulation of internal initiation of transla-
reverse transcription, in rapid generation of tick-borne encephalitistion, molecular mechanism, 213, 549
virus infectious transcripts, 214, 611PKR, see Protein kinase, dsRNA-activated
in situ, in detection of herpes simplex virus DNA in trigeminal gangliaPlacenta
of latently infected mouse, 206, 633endogenous retroviral envelope protein expression, detection with
Polymerase substrate depletionaffinity-purified polyclonal antibodies: abundant expression in
as strategy for inhibition of HIV-1 and HIV-2 replication in humanplacental trophoblasts (human), 211, 589
lymphocytes and macrophages, 211, 554Plasma membrane
Polyomavirusesapical, measles virus preferential entry into and release from polar-
JC, see JC polyomavirusized epithelial cells, 210, 91
large T antigen, mediation of intrachromosomal recombination, 206,Plasmids
227African swine fever virus DNA-containing, replication in infected Vero
middle-T antigen domains, role in viral-mediated oncogenic transfor-cells transfected with, 207, 392
mation, 208, 26construction for one-step virofection, 211, 234
persistence and reactivation in mouse, effects of incomplete immu-Platelets
nocompetence, 212, 268binding to dengue-2 virus, enhancement by antibodies (human), 213,
strain A2, induced runting in Balb/c and NIH Swiss mice, potentiation254
by coinfection with Moloney murine leukemia virus: model forPneumonia virus of mice
mixed virus disease, 212, 356mouse and tissue culture-passaged strains, putative attachment gly-
Polypeptidescoproteins, genes encoding, nucleotide sequencing, 207, 240
3AB, mutant, in dicistronic polioviruses, intragenomic complementa-Poliovirus
tion, 209, 315dicistronic, polypeptide 3AB mutant, intragenomic complementation,
87-kDa, avian infectious bronchitis virus, ORF 1a-encoded, identifica-209, 315
tion, expression, and processing, 208, 48infection, K562 cell strain response, comparison, 213, 7
capsid, double-stranded RNA viruses, N-terminal fragment produc-live oral vaccines, neurovirulence test using poliovirus-sensitive
tion, interference with viral replication, 214, 215transgenic mice, 206, 1075
intracellular, Mr 38.5K and Mr 40K, vaccinia virus, effect on viralmembrane binding, mediation by 2C protein amino-terminal regions,
virulence in murine intranasal model, 206, 136role in viral RNA replication, 208, 540
late structural, African swine fever virus IAP homologue as, 214, 670oral vaccine, Sabin 2 strain, grown under different cell culture condi-
Polyproteinstions, genetic stability and mutant selection, 209, 366
protease 3C, mediation of microtubulle-associated protein 4 cleav- 250K, tomato black ring nepovirus RNA-1-encoded, proteolytic activ-
ity, functional characterization, 206, 362age, 211, 451
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encoding gene 1, transmissible gastroenteritis virus, nucleotide se- hepatitis B virus
large surface antigen, SP1-binding site, characterization, 208, 399quence, 206, 817
nucleocapsid, functional hepatocyte nuclear factor 3 binding site,Gag, avian sarcoma leukemia virus, viral protease linked adjacent
characterization, 208, 147to, enzymatic activity, 214, 439
HIV, NF-kB-independent, induction by okadaic acid in T lymphocytes,gene 1, mouse hepatitis virus A59, 65-kDa proteins processed from,
208, 753identification and characterization, 207, 316
HIV-1, insertion in vivo, analysis in bronchoalveolar lavage cells, 208,hepatitis A virus, primary cleavage site, identification and site-di-
359rected mutagenesis, effect on infectivity of HAV RNA transcripts,
II, human foamy virus, TATA box mutations, effect on infectivity and213, 213
gene expression, 206, 601infectious bronchitis virus 1a/1b, proteolytic processing, ORF 1a-
immediate-early 62, varicella-zoster virus, negative regulatory ele-encoding proteinase domain responsible for, characterization
ment binding transcriptional factor NF-Y in, identification, 214,and mutational analysis, 209, 420
256Potato mop-top virus
lymphoproliferative disease virus, LTR sequences influencing, identi-RNA 3, sequence analysis and gene content: evidence of heteroge-
fication, 208, 789neity of furovirus genomic organization, 206, 701
plus-strand, brome mosaic virus RNA-2, interaction with host pro-Potato spindle tuber viroid
teins, 214, 638pathogenicity and replicability, interdependence, 209, 60
Sendai virus, genomic and antigenomic, functional characterization,replication and symptom expression, suppression by pathogenicity
212, 163domain-stabilizing mutations, 208, 554
SV40 and cytomegalovirus, rabies virus DNA vaccine with, effect onPotato virus X
immune response in mouse, 209, 569–potyviral synergistic disease in transgenic tobacco, mediation by
TATA box, see TATA box5* proximal potyviral sequences, 206, 583
Prostaglandin E2Potexvirus
and arachidonic acid, release from HIV-infected mononuclear phago-coat protein, subcellular immunolocalization in infected Cheno-
cytes, relationship to viral replication and TNF-a and IL-2 pro-podium quinoa, 214, 314
duction, 208, 590Poxviruses
Protease inhibitordivergent, conservation of genomic organization: establishment of
HIV-1 escape mutant, infectivity, impairment after single point muta-genetic map of orf virus, 212, 698
tion in POL gene, 210, 212
Preprotoxin
Proteinase
M28p, processing to a/b heterodimeric protein toxin (Saccharo-
2A, picornavirus, stimulation of internal initiation of translation, mo-
myces cerevisiae K28), 213, 341
lecular mechanism, 213, 549
Primate foamy viruses
3C, foot-and-mouth disease virus
phylogenetic analysis by comparison of pol sequences, 207, 577 active-site residues, identification, 213, 581
Prohead-binding domain expression, effect on viral infection and gene expression, 212, 111
bacteriophage T3 packaging protein, fine structure analysis with hex- 3C, poliovirus, mediation of microtubule-associated protein 4 cleav-
apeptide analog, 211, 516 age, 211, 451
Proheads avian retroviral, Gag–Pol-encoded, expression in Escherichia coli
in defined system for in vitro bacteriophage l DNA packaging, 211, and production of proteinase PR(/IleGly), 207, 185
367 avian sarcoma leukemia virus, linked to adjacent Gag polyprotein,
Proline 137 enzymatic activity, 214, 439
adenovirus type 2 proteinase, mutation, effect on enzyme encapsida- cysteine, adenovirus type 2, encapsidation and activity, effects of
tion and activity, 209, 167 proline 137 mutation, 209, 167
Promoters domain responsible for proteolytic processing of infectious bronchitis
alfalfa mosaic virus subgenomic RNA 4 synthesis-associated, char- virus 1a/1b polyprotein, ORF 1a encoding, characterization and
acterization, 212, 663 mutational analysis, 209, 420
Bacillus subtilis phage f29, expression during infection cycle: tran- helper component, see Helper component–proteinase
scription regulation, 207, 23 HIV-1
core, hepatitis B virus, negative regulatory element, cell type-depen- enhancement by HIV-1 reverse transcriptase, 206, 387
dent regulation of activity, 214, 198 overexpression, associated increased intracellular cleavage of
Cp, Epstein–Barr virus, role in efficient superinfection and viral pro- Gag and reduction of viral infectivity, 206, 854
ductive cycle in Burkitt’s lymphoma, 206, 866 substrate specificity, effect of glycine substitution at position 48,
for cucumber necrosis virus 0.9-kb subgenomic RNA, deletion analy- 207, 475
sis, 214, 100 leader papain-like, mouse hepatitis virus strain A59, in vitro cleavage
–enhancer site identification, 209, 489
tyrosinase, hybrid LTRs containing, Moloney murine leukemia vi- NIa
rus-derived retroviral vectors with, tissue-specific gene expres- C-terminal 27-kDa, turnip mosaic potyvirus C5, self-cleavage site,
sion in mouse from, 214, 307 expression, purification, and identification, 213, 517
immediate early, human cytomegalovirus, stimulation in HL-60 recombinant, tobacco etch virus, expression and purification: bio-
cells by TNF-a, mediation via NF-kB induction, 208, 197 chemical analyses of full-length and naturally occurring trun-
Epstein–Barr virus, Fp, positive cis-regulatory elements, fine map- cated forms, 210, 194
ping, 206, 183 papain-like, autocatalytic processing of blueberry scorch carlavirus
equine herpesvirus 223-kDa protein, 207, 127
IE gene, octamer sequences, in transactivation of EHV-1 gene 12, role in adenovirus entry into host cells, 213, 494
213, 258 Proteinase inhibitors
Ro 31–8959, HIV-1 mutant with decreased sensitivity to, character-type 1, immediate-early, early, and late, expression, regulatory
function of ICP22 protein, 210, 273 ization, 206, 527
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Protein folding capsid
beet western yellows luteovirus, recombinant baculovirus-pro-paramyxovirus SV5 fusion protein, role of N-linked glycosylation, 209,
duced, assembly into virion-like particles in Bombyx mori cells250
and larvae, 213, 204Protein kinase
feline immunodeficiency virus, retroviral vector-transduced felinedsRNA-activated, PKR
T cells expressing, in vitro induction of FIV-specific cytotoxic Thuman, transfected into murine cells, stimulation of expression of
lymphocytes from chronically infected cat, 209, 390genes under control of HIV-1 or HTLV-I LTR, 214, 653
simian parvovirus and human parvovirus B19, amino acid homol-interferon-induced, direct interaction with HIV-1 Tat, 213, 413
ogy, 210, 314phosphorylating eIF-2 translation initiation factor, activation, effect
T  4 Nudaurelia capensis v virus, assembly, post-translationalof binding of influenza virus NS1 protein to dsRNA, 214, 222
cleavage, and specific encapsidation of mRNA in baculovirus
phosphorylation activity of herpes simplex virus type 1 and 2 140-
expression system, 207, 89
kDa RR1 protein, 207, 409
tobacco etch virus, determinants involved in cell-to-cell and long
truncated baculovirus homolog, pk2 gene encoding, expression and distance movement, 206, 1007
functional analysis, 206, 314
tobacco ringspot virus, and satellite RNA, expression in insect
Protein kinase C z cells, 213, 472
phosphorylation of human parainfluenza virus type 3 phosphoprotein, VP1, foot-and-mouth disease virus, 10-amino-acid linear sequence
identification of serine 333 as major site, 211, 561 containing B- and T-cell epitopes, conferral of protection in
Protein kinase R mouse, 212, 614
activation by HTLV-I Rex response element, 206, 913 VP2, African horse sickness virus, linear neutralization domain,
full-length and R-domain forms, RNA-binding activity: determination identification, 210, 391
of dissociation constants for VAi and TAR RNAs, 206, 511 VP7, rotavirus, effect of glycosylation on viral antigenicity, 209, 80
Protein priming capsid, human papillomavirus type 16, produced from recombinant
Semliki Forest virus, assembly into virus-like particles, 214, 349during in vitro RNA synthesis by virion-associated RNA polymerase
of infectious pancreatic necrosis virus, 208, 19 capsid, human papillomavirus type 16 and type 31, gene sequence
variation, 214, 664Proteins
capsid, red clover necrotic mosaic virus, role in long-distance viral2C, poliovirus, amino-terminal regions, mediated membrane binding,
movement in movement protein-transformed tobacco plants,role in viral RNA replication, 208, 540
212, 6073a, cucumber mosaic virus, potentiation of viral RNA cell-to-cell traf-
capsid, VP1 and VP2, Theiler’s virus, targeting by H-2D-restrictedficking in tobacco plants, 207, 345
cytotoxic lymphocytes in central nervous system of B10 mouse,6K mutant, Sindbis virus, pseudo-revertant correcting for aberrant
214, 91particle formation, identification of mutations mapping to E2 gly-
capsid, VP4–VP2, coxsackie A virus serotypes, sequence compari-coprotein ectodomain, 206, 1027
son, 212, 3019-kDa, encoded by antisense RNA derived from HIV-1 ENV gene,
capsid and nonstructural, goose parvovirus, amino acid sequencesrecognition in sera of HIV-infected individuals, 206, 196
and homologies with adeno-associated virus type 2, 210, 28320.5-K, encoded by E3 region of human adenovirus type 3 subgroup
cellularB, role in viral replication, 208, 226
binding to hepatitis C virus RNA 5*-noncoding region, role in viral25K, Autographa californica nuclear polyhedrosis virus, biosynthesis
replication and pathogenesis, 208, 723and localization in infected SF9 cells, 208, 279
binding to poliovirus RNA 5* noncoding region, role of stem–loop
33K, encoding genes, ovine adenovirus homologues for, sequence,
structure synergy, 206, 923
209, 400
coat
35-kDa major secreted, rabbitpox virus, mapping and role in patho-
alfalfa mosaic virus
genesis, 206, 591
N-terminal basic amino acids, role in infection initiation, 208,
54-kDa, adenovirus type 12 early region 1B, quaternary structure,
405
examination under denaturing and nondenaturing conditions,
role in regulation of plus and minus RNA synthesis, implications
207, 255
for viral life cycle, 208, 583
65-kDa, mouse hepatitis virus A59, processed from gene 1 polypro- beet necrotic yellow vein virus, accumulation in trans, regulation
tein, identification and characterization, 207, 316 by small cysteine-rich protein P14, 210, 73
82-kDa, porcine group C rotavirus gene 3-encoded, associated neu- cherry leafroll virus, and antisense RNA, transient expression, re-
tralizing epitope, identification, 208, 354 duction of viral accumulation in tobacco protoplasts, 208, 132
100K hexon assembly, encoding gene, ovine adenovirus homolog cowpea chlorotic mottle virus expressed in Escherichia coli and
for, sequence, 209, 400 in vitro-transcribed viral cDNA, in vitro viral assembly from, 207,
135-kDa, herpes simplex virus type 1 Vmw110 polypeptide multimeri- 486
zation and interaction with, identification of required viral se- CP1 and CP2, brome mosaic virus, amino-terminal basic residues,
quences, 209, 174 biological significance, 211, 42
140-kDa RR1, herpes simplex virus types 1 and 2, kinase autophos- cucumber necrosis virus, encoding gene, mutational analysis, 206,
phorylation activity and defective transphosphorylation, 207, 409 38
A38L, vaccinia virus, identification as 33-kDa integral membrane gly- Ectocarpus siliculosus virus, properties, 206, 520
coprotein, 214, 177 and genome-linked, tobacco vein mottling virus, interaction with
avian retrovirus long terminal repeat-binding, characterization, 206, viral polymerase in yeast cells, 214, 159
1 lettuce infectious yellows virus, amino acid sequence, 208, 99
bZip, interaction with bovine leukemia virus transactivator Tax, 214, maize dwarf mosaic virus, N-terminus, inhibition of viral transmis-
207 sion by aphid, 213, 676
potexviruses, subcellular immunolocalization in infected Cheno-sC, avian reovirus strain, induction of syncytia formation after expres-
sion in COS-7 cells, 208, 678 podium quinoa, 214, 314
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Prunus necrotic ringspot virus PE-5 isolate, amino acid sequence, rabies virus, association with cellular ezrin–radixin–moesin family
proteins, 206, 485208, 349
rice yellow mottle virus, mutagenesis, 206, 108 simian immunodeficiency virus, binding to soluble CD4 receptor
role in Capsicum L3 gene-mediated resistance against tobamovi- effects of mutations in env constant regions 3 and 4,, 210, 448
ruses, 209, 498 tick-born encephalitis complex viruses, comparative sequencing,
southern bean mosaic virus RNA, binding site, identification, 207, in investigation of mode of evolution and dispersal patterns in
562 northern hemisphere, 210, 152
tobacco mosaic virus V1 and V2, HIV-1, virus spread-related effect on replication effi-
assembly-deficient mutations, conferral of resistance, 208, 485 ciency in macrophages, 213, 70
gene encoding, role of single nucleotide change in induction of V3 domain, HIV-1 subtype D, G, and A/D recombinant, biological
severe chlorosis, 207, 234 and molecular characterization, 209, 136
ORF encoding, mutations in, effects on RNA accumulation and envelope, gE, varicella–zoster virus, immunodominant regions and
systemic movement, 212, 121 linear B cell epitopes, identification, 214, 531
turnip crinkle virus, binding to viral RNA, binding specificity and envelope, lactate dehydrogenase-elevating virus, membrane topo-
assembly interaction, 210, 82 graphy and N-glycosylation, 212, 512
turnip yellow mosaic virus, and overlapping p206-readthrough cod- envelope, SIV virus-like particles containing, assembly using bacu-
ing regions, functional studies, 206, 403 lovirus expression system, 214, 50
coliphage lO initiator, protection from proteolysis in assembly of external envelope, HTLV-II, antibodies against, rapid generation by
replication complex in vivo, 207, 179 growth of mouse plasmacytomas in SCID mouse, 214, 680
core, hepatitis C virus, differential subcellular localization, 213, 455 ezrin–radixin–moesin family, cellular, in corporation into rabies vi-
DNA-binding, see DNA-binding proteins rion and association in cell with envelope proteins, 206, 485
E F, measles virus, mRNA, preferential initiation at AUG2: role for long
Kunjin virus isolates, glycosylation status, 206, 49 untranslated region, 214, 628
Lelystad virus, characterization, 206, 155 fiber
E1A, adenovirus, induction of susceptibility to NK cell killing in human adenovirus subgenus D, encoding gene, characterization, 206, 564
cells, effects of Ad infection versus immortalization, 210, 421 adenovirus types Ad35p and Ad34a, encoding gene, organization
E1 and E2, attenuated Venezuelan equine encephalitis virus, func- and hemagglutinating capacity, comparison, 206, 686
tional association and implications of mutations for vaccine de- encoding genes, ovine adenovirus homologues for, sequence,
sign, 212, 102 209, 400
E1 and E2, HPV type 11, low-abundance RNA transcripts, identifica-
fusion
tion in latently infected respiratory tissues (human), 212, 285
Epstein–Barr virus nuclear antigen 2–estrogen receptor, transacti-
E1B, 54-kDa and 21-kDa, adenoviral, distinct modulation of p53 activ-
vation of viral and cellular genes and interaction with RBP-Jk,
ity in transcription and cell cycle regulation, 212, 543
214, 675
E1 P E4, human papilomavirus type 31b, cell differentiation-dependent
hepatitis B virus–mevalonate kinase overexpressed in humanexpression in epithelial cells bearing HPV-31b episomes, 206,
hepatoma, enzymatic properties, 208, 696679
and neuraminidase–hemagglutinin, paramyxovirus, promotion ofE1 P E4 and L1, human papillomavirus type 11, colocalization in
cellular fusion, associated HN domain, localization, 209, 457mouse xenograft system at multiple time points, 214, 259
Newcastle disease virus, intracellular maturation, effect of strainE2
differences in predicted amphipathic a-helix adjacent to fusioncottontail rabbit papillomavirus, immune response to, association
domain, 208, 827with tumor regression, 208, 298
paramyxovirus SV5hepatitis C virus, hypervariable region 1, human sera antibodies
assembly, intracellular transport, and fusion activity, role of N-to, blockage of viral attachment to tissue culture cells, 208, 653
linked glycosylation, 209, 250HPV type 16, and subdomains, characterization and expression in
cleavage mutants, induction of regulated and extensive syncy-insect cells, 211, 418
tium formation after expression in CV-1 cells, 209, 242Sindbis virus, associated amino acids conferring resistance to
pseudorabies virus immediate-early protein DNA-binding domainrelease inhibition in low-ionic-strength medium, identification,
and HSV-1 Vmw65, chimeric, inhibition of PRV replication, 210,210, 237
128E5, HPV type 16, expression, detection, and stable complex formation
Sendai virus, interaction with host cytoskeletal and lipid compo-with transmembrane proteins in COS cells, 211, 227
nents in infected BHK cells, 209, 701E6, HPV, type 16
Gag, HIV-1, associated increased intracellular cleavage induced bydirected mutations: abrogation of p53-mediated cell cycle arrest
protease overexpression, 206, 854correlated with p53 binding and degradation in vitro, 208, 111
Gag-p24, HIV-1, cell-dependent role in early infection phase, 212,mutational analysis: transformation function for human cells and
251degradation of p53 in vitro, 212, 535
green fluorescent, fusion to Rev and transdominant Rev protein, forE7, bovine papillomavirus type 4, T-cell responses during infection
analysis of Rev protein trafficking in living cells, 213, 439and epitope mapping, 206, 504
helicase-like and polymerase-like, brome mosaic virus, interaction,early, O, pseudorabies virus, functional homology with varicella-zos-
biochemical and genetic analysis, 214, 59ter virus ORF61 protein and HSV-1 ICPO, 209, 281
HIV-1, processing in CD4/ T cell lines, effect of interferon, 214, 379envelope
hostantigen, p37K, vaccinia virus, biochemical analysis, 213, 19
binding to mouse hepatitis virus genomic RNA, role of conservedhepatitis B virus, lacking cysteines in major antigenic region, se-
motif at 3* end of viral RNA, 214, 128cretion and antigenicity, 211, 535
interaction with plus-strand promoter of brome mosaic virus RNA-human endogenous retrovirus ERV-3, expression in human tis-
2, 214, 638sues: abundance in placental trophoblasts, 211, 589
Murray Valley encephalitis virus, antigenic variants, structural and host shutoff, HSV virion, inhibition of reporter gene expression in
absence of other viral gene products, 211, 491functional analysis, 211, 10
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IAP homologue, African swine fever virus, identification as late struc- matrix
tural polypeptide, 214, 670 Sendai virus, interaction with host cytoskeletal and lipid compo-
ICP0, HSV-1, functional homology with pseudorabies virus early pro- nents in infected BHK cells, 209, 701
tein O, 209, 281 simian immunodeficiency virus, conserved cysteine residues, mu-
ICP0 and ICP4, association with HSV-1, effect of host cell, 211, 209 tational analysis, 210, 501
ICP4, pseudorabies virus, feline immunodeficiency virus LTR-di- vesicular stomatitis virus
rected gene expression, inhibitory role of FIV LTR C/EBP site, aggregation reversibility and mediation by nucleation sites, role
208, 492 in viral assembly, 206, 28
ICP22, equine herpesvirus type 1, regulatory function, characteriza- assembly functions, effects of mutations at major phosphoryla-
tion, 210, 273 tion sites, 206, 894
ICP27, herpes simplex virus, acidic amino-terminal region, functional MDM2, expression in adenovirus early region 1-transformed human
homology with varicella-zoster virus ORF4 amino-terminal re- cells, effects of p53 at high levels, 210, 323
gion, 208, 376 membrane
IE2 E3–20.5K, human subgroup B adenovirus, containing O-linked and
human cytomegalovirus, mediated transcriptional activation, nega- complex N-linked oligosaccharides, characterization, 210, 335
tive regulation by retinoblastoma gene product, 208, 450 myristylated, encoded by vaccinia virus L1R open reading frame,
murine cytomegalovirus, role in viral growth and latency in infected as target of neutralizing monoclonal antibody 7D11, 211, 53
mouse, 209, 236
varicella–zoster virus ORF1-encoded, role in viral growth in vitro,
IHF, in defined system for in vitro bacteriophage l DNA packaging
206, 835
(Escherichia coli), 211, 367
membrane cofactor, function as measles virus receptor, role of N-immunogenic, Japanese encephalitis virus, double-subgenomic
glycans, 210, 479Sindbis virus recombinants expressing, induction of protection
minor capsid, parvovirus B19against lethal JEV infection in mouse, 212, 587
unique region-derived peptides, induction of neutralizing antibod-L
ies in rabbit, 206, 626hepatitis B virus, retention in 293 cells, role of C-terminal PreS1
VP1, localization on capsid surface, 211, 359sequence, 213, 57
mouse hepatitis virus strain A59, processing and viral replication,La Crosse virus, amino acid sequencing and comparison with
inhibition by cysteine proteinase inhibitor E64d, 208, 1polymerases from other Bunyaviridae, 206, 742
movementSendai virus, conserved domain I mutations, effect on transcription
bipartite geminivirus-associated, BR1 and BL1, role in viral hostand replication, 213, 352
range and pathogenicity, 207, 191Sendai virus RNA polymerase, alternative amino acids at single
site, production of multiple defects in RNA synthesis in vitro, cauliflower mosaic virus, identification of RNA-binding domain,
211, 577 206, 1145
rabies virus, in vitro-mutated, polymerase activity, 214, 522 tobacco mosaic virus, defective, and functional analog, effects on
L2, human papillomavirus type 6B, nuclear targeting and accumula- resistance and susceptibility in transgenic plants, 206, 307
tion, required sequences for, 213, 321 movement, red clover necrotic mosaic virus, transgenic tobacco
L2, N-terminus, bovine papillomavirus-4, vaccination of cattle with, plants, long-distance RCNMV movement, role of virion forma-
induced prevention of viral infection, 211, 204 tion, 212, 607
L and N, bunyavirus, transiently expressed, in transcription of recom- movement, tobamovirus and dianthovirus, functional homology, 213,
binant bunyavirus RNA template, 211, 133 38
large polymerase, vesicular stomatitis virus, interaction with P pro- Mx1 and MxA, role in inborn resistance against tick-borne Dhori
tein, role in viral transcription, 208, 821 virus in mouse, 211, 296
large surface, hepatitis B virus, myristylation, role in viral infectivity, MxA, purified, inhibition of vesicular stomatitis virus transcription,
213, 292 206, 545
leader, foot-and-mouth disease virus, critical amino acids, identifica- N, Lelystad virus, characterization, 206, 155
tion, 213, 140
Nef, HIV-1, downregulation of CD4 surface expression, role of CD4
leader and capsid, Theiler’s virus neurovirulent strains, analysis of
lck-binding domain, 207, 338
coding regions, 214, 550
NEF, HIV-1 and HIV-2 mutant phenotypes, manifestation, role of virusM
and host components, 213, 158Lelystad virus, characterization, 206, 155
nonstructuralmouse hepatitis virus CD4/ T-cell epitope, identification, 208, 173
NS2, bluetongue virus, African horsesickness virus, and epizooticM2, influenza A virus, cell surface expression, effects of M2 antibody,
hemorrhagic virus, structure and ssRNA-binding ability, 209, 624212, 411
NS3, hepatitis C virus, associated serine proteinase, in vitro assay,major, TP901–1 bacteriophage, virion positions and distribution
209, 52among lactococcal phages, 212, 595
nsP1, distribution in Semliki Forest virus-infected and nsP1-major capsid, VP2, infectious pancreatic necrosis virus, serotype-
transfected cells, 208, 610specific epitope, mapping, 209, 684
NSP3, rotavirus serotype G, comparative nucleotide and aminomajor DNA-binding, ICP130, equine herpesvirus type 1, characteriza-
acid sequence analysis, 207, 327tion and localization, 207, 380
rubella virus, identification, 206, 843major structural, Vp1, simian virus 40, assembly into disulfide-linked
simian parvovirus and human parvovirus B19, amino acid homol-postpentameric complexes in cell-free lystates, 207, 251
ogy, 210, 314major structural, VP2, infectious pancreatic necrosis virus, epitope
Sindbis virus, suppression of Japanese encephalitis virus subvirallocalization and strain variability, 214, 40
particle secretion in mammalian cells infected with SIN–JEVmajor tegument, VP8, bovine herpesvirus type 1, role in infection and
recombinants, 209, 155immunity, 206, 413
MAP-4, microtubule-associated, cleavage, mediation by poliovirus nonstructural, of unknown function, fish rhabdovirus VHSV, conserva-
tion of coding sequence among distant strains, 212, 7413C protease, 211, 451
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NS1 produced by mRNAs spliced into X region of human T-cell leukemia/
lymphotropic virus type II, expression and characterization, 209,influenza A virus, multimer formation in vitro and in vivo, 212, 422
445influenza virus, binding to dsRNA, effect on activation of protein
pVIII, encoding genes, ovine adenovirus homologues for, sequencekinase phosphorylating eIF-2 translation initiation factor, 214,
and fiber,, 209, 400222
Rb, retinoblastoma susceptibility, negative regulation of human cyto-minute virus of mice, constitutional expression of antisense RNA
megalovirus IE2 protein-mediated transcriptional activation,targeted against, inhibition of viral transcription, 206, 57
208, 450NS3–NS4–NS5, hepatitis C virus, linear B-cell epitopes, synthetic
readthrough, barley yellow dwarf luteovirus virion-associated, role inpeptide modeling, 206, 666
regulating efficiency of aphid transmission, 206, 954Nsm, nonstructural, tomato spotted wilt virus, induction of tubular
readthrough and virion, luteoviruses, N and C domain amino acidstructures in plant and insect cells, 214, 485
sequences, 206, 1129nuclear inclusion protein a, turnip mosaic potyvirus C5, C-terminal
reovirus mutant tsA279 with temperature-sensitive lesions in M2 and27-kDa protease domain self-cleavage site, expression, purifica-
L2 genes, deficient production, characterization, 207, 46tion, and identification, 213, 517
Rep, adeno-associated virus, inhibition of cellular and simian virusnucleocapsid
40 DNA replication, 207, 246
measles virus
Rep 68/78, adeno-associated virus, in analysis of minimum origin
high-level expression with replication-deficient adenovirus vec- requirements for linear duplex DNA replication in vitro, 209, 692
tor: induction of MHC-I-restricted CTL response and protec- Rep78, adeno-associated virus, covalent linkage to viral DNA in pre-
tion in murine model, 210, 456 formed virion, 214, 360
utilization in replication of Sendai virus defective interfering par- replicase, tomato bushy stunt virus, 33-kDa and 92-kDa, coordinate
ticle genome in vitro, 206, 777 expression and membrane association, 208, 365
vesicular stomatitis virus, interaction with P protein, role in viral replication
replication, 208, 821 AC1, bean golden mosaic geminivirus, NTP-binding domain, muta-
nucleoprotein interactor-1, interaction with influenza A virus nucleo- tional analysis, 211, 1
protein, 206, 116 E1, bovine papillomavirus type 1, required domains for origin-spe-
origin-binding, varicella–zoster virus, substitution for herpes simplex cific DNA binding and interaction with E2 transactivator, 211,
virus OBP in transient origin-dependent DNA replication assay 385
in Sf9 cells, 206, 655 p223, blueberry scorch carlavirus, autocatalytic processing by pa-
P pain-like proteinase, 207, 127
replicator, NS1, minute virus of mice, sequence motifs essential forhuman respiratory syncytial virus, transcriptional activity, effect of
nicking and covalent attachment to viral origin: identification ofphosphorylation of Ser232, 213, 405
linking tyrosine, 209, 122measles virus, phosphorylation, role of cellular casein kinase II,
retroelement reverse transcriptase-related, sigma rhabdovirus Dro-211, 218
sophila gene 3 encoding, nucleotide sequence, 213, 300Sendai virus, intracellular and cell-free phosphorylation, compari-
Rev, SIVmac239, activation domain, structural and functional analogyson, 208, 408
to HIV-1 Rev activation domain, 211, 290Sigma rhabdovirus of Drosophila gene 2 encoding, nucleotide se-
Rev and transdominant Rev, HIV-1, trafficking in living cells, analysisquence, 213, 300
with green fluorescent protein fusions, 213, 439vesicular stomatitis virus, hierarchal constitutive phosphorylation,
Shc, avian erythroblastosis virus v-erbB protein-binding site, identifi-effect on P1 to P2 conversion, 214, 189
cation, 206, 269p6.9, Autographa californica M nuclear polyhedrosis virus, cytocha-
simian immunodeficiency virus lymphocyte- and macrophage-tropiclasin-induced proteolysis in infected cells, 207, 1
strains, differential processing by macrophages, 206, 535P14, cysteine-rich, beet necrotic yellow vein virus, regulation of RNA
spike2 accumulation in cis and coat protein accumulation in trans,
murine coronavirus, role in cell-to-cell fusion, mutational analysis,210, 73
214, 453
p17, structural, African swine fever virus, gene mapping and se-
murine coronavirus JHMV, S1 subunit, role in neurovirulence for
quencing, 206, 1140
rat, 208, 67
p19 and p22, tomato bushy stunt virus, encoding genes, regulation transmissible gastroenteritis coronavirus, recombinant adenovirus
of viral spread, 213, 425 expressing, induction of antibodies against TGEV, 213, 503
p28 and p88 replication components of turnip crinkle virus, immuno- structural
detection, expression strategy, and complementation, 211, 525 channel catfish virus, identification by mass spectrometry, 206,
p53 1035
gene mutations, association with bovine leukemia virus-induced from luteoviruses, gene experiments, use of full-length infectious
leukemogenesis, 209, 676 cDNA clone of cucurbit aphid-borne yellows virus, 214, 150
high levels in adenovirus early region 1-transformed human cells, vaccinia virus, precursor, amino terminal peptide, role in proteo-
effects on cellular MDM2 expression, 210, 323 lytic processing, 207, 229; erratum, 209, 285; 207, 229
HPV, mediated cell cycle arrest, abrogation of, correlation with transmissible gastroenteritis virus, in in vitro antibody synthesis to,
p53 binding and degradation by E6 protein in vitro, 208, 111 T helper cells collaborating in, elicitation by viral nucleoprotein
interaction with HPV type 16 E6 protein in human cells in vitro, epitope, 212, 746
212, 535 surface, hepatitis B virus, expression regulation, key role of CCAAT
transcriptional activity and cell-cycle regulation, modulation by 54- element, 206, 1155
kDa and 21-kDa adenovirus E1B proteins, 212, 543 surface envelope, bovine lentivirus, identification of hypervariable
packaging, bacteriophage T3, fine structure of prohead-binding do- and conserved regions, 212, 728
main, analysis with hexapeptide analog, 211, 516 Tat, HIV-1
activation domain, zinc finger protein HT2A interacting with, identi-Pr160gag-pol, HIV-1, in vivo processing in acutely infected cultured
human T cells, 214, 624 fication (human), 209, 347
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activation in rodent cells, role of TAR sequences, 206, 690 Vpu, HIV-1
expression, effects on intracellular membrane trafficking pathwayand DNA sequence-specific transcriptional activators, functional
similarities, 206, 1150 in mammalian cells, 213, 639
induced CD4 degradation: role of alpha-helix structure in CD4encoding gene, enhancement of human herpesvirus type 6 replica-
tion, 211, 544 proximal cytoplasmic region in antigen sensitivity, 209, 615
v-Rel oncoprotein, Rev-T retrovirus, complexation with Rel-relatedinteraction with interferon-induced dsRNA-dependent kinase PKR,
213, 413 proteins in transformed cells, 207, 362
ZEBRA, capacity to disrupt Epstein–Barr virus latency, restorationtransactivation of HIV-2 LTR via TAR RNA element lacking dinucle-
otide bulge binding sites, 206, 673 by addition of heterologous activation regions, 211, 64
zinc finger, HT2A, interacting with activation domain of lentiviral TatTat0 HIV-1, infection and replication: genetic analyses of LTR and
tat mutations in primary and long-term human lymphoid cells, proteins, identification (human), 209, 347
Protein synthesis211, 157
Tax, HTLV-I, interactions with NF-kB2 and protein products p52 and vaccinia virus, block at intermediate stages, role in restricted viral
replication in CHO cells, 206, 984p100, 206, 1066
terminal, left early region of Streptococcus pneumoniae bacterio- Protein transport
Rous sarcoma virus envelope glycoprotein, lysosomally targeted, rolephage Cp-1 coding for, nucleotide sequence and transcription,
211, 21 of transient cell surface expression, 206, 353
Proteolysistomato bushy stunt virus, accumulation, effect of defective interfering
RNA, and implications for disease attenuation, 211, 324 associated processing of human cytomegalovirus glycoprotein B,
mediation by furin, 206, 746transmembrane
COS cells, stable complex formation with HPV type 16 E5 protein, coliphage lO initiator protein, in assembly of replication complex in
vivo, protection from, 207, 179211, 227
Moloney murine leukemia virus, cysteine mutations on, analysis, cytochalasin D-induced, p6.9 in Autographa californica M nuclear
polyhedrosis virus-infected cells, 207, 1211, 285
transport, in mammalian cell secretory pathway, effects of HIV-1 Vpu helper component–proteinase-mediated, role in tobacco etch potyvi-
rus genome amplification, 209, 268protein, 213, 639
TYA, regions necessary for Ty1 virus-like particle structure formation, infectious bronchitis virus 1a/1b polyprotein, ORF 1a encoding pro-
teinase domain responsible for, characterization and mutationalanalysis, 212, 69
TYA particle-forming, mapping on Ty1 virus-like particle with immu- analysis, 209, 420
in mammalian cell secretory pathway, effects of HIV-1 Vpu protein,nological techniques, 207, 59
UL6, HSV-1, association with viral capsid, 206, 465 213, 639
microtubule-associated protein 4, mediation by poliovirus 3C prote-UL37, herpes simplex virus type 1, association with tegument of
purified virions, 206, 1055 ase, 211, 451
rice tungro bacilliform virus reverse transcriptase, 208, 207V, simian virus 5, identification as structural component and associa-
tion with nucleocapsid, 208, 121 simian immunodeficiency virus gp160, effects of mutations in env
constant regions 3 and 4, 210, 448varicella-zoster virus ORF 4-encoded, acidic amino-terminal region,
role in transactivation and functional homology with herpes sim- tomato black ring nepovirus RNA-1-encoded polyprotein, functional
characterization, 206, 362plex virus ICP27 amino-terminal region, 208, 376
v-erbB, avian erythroblastosis virus Shc protein-binding site, identifi- vaccinia virus, role of structural protein precursor amino terminal
peptide, 207, 229; erratum, 209, 285; 207, 229cation, 206, 269
viral, cis-acting, role in replication of coronavirus defective-interfering Protoxins
M28, dsRNA, nucleotide sequence (Saccharomyces cerevisiae K28),RNA, 209, 428
VP1, hepatitis A virus, proposed gene, encoding of protein larger 213, 341
Provirusthan protein observed in HAV-infected cells and virions, 213,
671 infectious clones of chimpanzee foamy virus generated by long PCR,
based evidence for close functional relatedness to human foamyVP2, infectious bursal disease virus, recombinant herpesvirus of tur-
key expressing, induction of protection against IBDV virulent virus, 214, 685
Proviruseschallenge in chicken, 211, 481
VP3, bluetongue virus, chimeric, synthesis and interactions with VP7 caprine arthritis–encephalitis virus, complete, erratic GrA hypermu-
tation in, sequence, 209, 297protein to assemble into virus core-like particles, 214, 593
VP4, human rotavirus ST3, independent neutralization epitopes, iden- HIV-1, virtually full-length, of diverse subtypes, recovery from primary
virus cultures using PCR, 213, 80tification, 206, 148
VP7, bluetongue virus, interactions with chimeric VP3 molecules to HIV group O, highly defective: role of local sequence determinants in
GrA hypermutation during negative-strand viral DNA synthesis,assemble into virus core-like particles, 214, 593
VP8*, rotavirus isolate 993/83, sequence analysis: identification of 208, 601
Mtv-6, endogenous, structure and biological activity, 206, 395virus isolated from calf feces as pigeon rotavirus, 210, 231
VpG, feline calcivirus, role in infectivity of RNA transcripts derived Prunus necrotic ringspot virus
PE-5 isolate RNA 3, nucleotide sequence, 208, 349from cloned full-length copy of viral genome, 210, 383
Vpr, HIV-1 Pseudomonas aeruginosa
derived single-stranded RNA phage PP7, nucleotide sequence: rela-domains involved in subcellular localization, analysis, 212, 331
function, role of conserved dipeptide Gly75 and Cys76, 210, 495 tionship to coliphages and conservation of regulatory RNA struc-
ture, 206, 611incorporation into virion, N-terminal acidic domain residues essen-
tial for, identification, 207, 297 Pseudorabies virus
DNA, latently transcribed regions, altered dinucleotide content, impli-role in efficient viral replication in mononuclear phagocytes, 206,
935 cations for latent RNA expression and DNA structure, 209, 358
early protein O, functional homology with varicella-zoster virus ORF61stability and incorporation into viral particles, role of carboxy-termi-
nal domain, 214, 647 protein and HSV-1 ICPO, 209, 281
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ICP4, feline immunodeficiency virus LTR-directed gene expression, in coronavirus infectious bronchitis virus strains, evidence, 213, 569
homologous, vaccinia virus DNA, fidelity, 209, 688inhibitory role of FIV LTR C/EBP site, 208, 492
live attenuated Bartha vaccine strain, avirulence of, role of UL21 intrachromosomal, mediation by polyomavirus large T antigen, 206,
227gene mutations, 212, 466
replication, inhibition by chimeric trans-gene product repressing tran- in luteovirus evolution: evidence for recombination due to base-pair-
ing between genomes of distinct viruses, 206, 1129scription of immediate-early genes, 210, 128
Pseudotypes Red clover necrotic mosaic virus
and tobacco mosaic tobamovirus, movement proteins, functional ho-Epstein–Barr virus and HIV-1, lack of formation in productively coin-
fected B lymphoblastoid cells, 209, 643; erratum, 212, 757 mology, 213, 38
Regulatory elementsPurine nucleoside triphosphates
effect on double-stranded RNA bacteriophage f6 in vitro transcrip- conserved composite, Oct-1–NFI synergistic interaction at, role in
activation of epithelial-specific enhancer of HPV type 16, 207,tion, 207, 400
Puumala virus 77
negativeinfection in human monocytes/macrophages, effects of interferon-a
and cell differentiation, 206, 8 binding transcription factor NF-Y, identification in varicella-zoster
immediate-early 62 promoter, 214, 256
hepatitis B virus core promoter, cell type-dependent regulation ofQ
activity, 214, 198
ReovirusesQuaternary structure, see also Molecular structure
adenovirus type 12, early region 1B 54K protein, examination under avian
growth in primary chicken embryo tendon cells and fibroblasts,denaturing and nondenaturing conditions, 207, 255
comparison, 207, 117
S1133, endogenous enzymatic activities: identification of viral cap-R
ping protein, 206, 1017
baboon, syncytium-inducing, characterization, 212, 752Rabbitpox virus
major secreted 35-kDa protein, mapping and role in pathogenesis, mutant tsA279, with temperature-sensitive lesions in M2 and L2
genes, characterization as defective in transmembrane trans-206, 591
Rabies virus port and deficient in viral protein production, 207, 46
serotype 3, persistent infection in B-cell hybridoma, eradication byanti-glycoprotein monoclonal antibodies neutralizing, pH depen-
dence, 210, 400 passage in medium with anti-reovirus antibodies, 212, 272
Replicaseglycoprotein gene, long 3* noncoding region lacking pseudogene
properties, 206, 718 cocksfoot mottle virus, translation as part of polyprotein by 01 ribo-
somal frameshift, 207, 566immune effector mechanisms for protection, 214, 398
L protein, in vitro-mutated, polymerase activity, 214, 522 cymbidium ringspot virus, full-length gene, transgenic tobacco plants
expressing, viral resistance in, characterization, 212, 240nucleic acid vaccines against, immune responses in mouse, 209,
569 mediated resistance to alfalfa mosaic virus infection in transformed
tobacco plants, 207, 467nucleoprotein gene, genetic polymorphism, 209, 526
virion, incorporation of cellular ezrin–radixin–moesin family proteins, pepper mild mottle tobamovirus, encoding gene, 54-kDa region, Ni-
cotiana benthamiana transformed with, resistance responsesand association of ERM proteins with viral envelope proteins,
206, 485 against viral infection, 211, 170
tomato bushy stunt virus, associated proteins, coordinate expressionReactivation
polyomavirus in mouse, effects of incomplete immunocompetence, and membrane association, 208, 365
Replication212, 268
Reassortment associated complex in coliphage lO, assembly in vivo, protection of
Clp initiator protein from proteolysis, 207, 179genomic, rice dwarf Phytoreovirus, 212, 724
interspecific, role in virus evolution, 207, 334 avian influenza A virus strains, inhibition by 4-guanidino-2,4-dideoxy-
2,3-dehyro-N-acetylneuraminic acid, 212, 323in nature, among viruses related to hantavirus pulmonary syndrome,
evidence: complete nucleotide sequence of M and S sequences avirulent avian influenza virus in embryonated chicken eggs, muta-
tion to virulent form during, associated molecular changes, 206,of California isolates (deer mouse), 206, 973
Receptor-binding domain 755
bovine herpesvirus 4 in vitro, effect of DNA synthesis dependencehuman adenovirus type 2 fiber, localization of antigenic sites, 214,
110 on S phase of cell cycle, 213, 328
coronavirus defective-interfering RNA, role of cis-acting viral protein,Recombinants
African cassava mosaic virus, initiation of rolling circle DNA replica- 209, 428
cymbidium ringspot virus satellite RNA mutants, 206, 1092tion, associated strand nicking within conserved nonanucleotide
motif, 206, 707 double-stranded RNA viruses, interference by production of N-termi-
nal fragments of capsid polypeptides, 214, 215Sindbis virus, double-subgenomic, expressing Japanese encephalitis
virus immunogenic proteins, induction of protection against le- equine infectious anemia virus in macrophages, reduction, correla-
tion with uracil incorporation into viral DNA, 210, 302thal JEV infection in mouse, 212, 587
Sindbis virus–Japanese encephalitis virus, infected mammalian feline immunodeficiency virus, role of C/EBP binding site in long
terminal repeat, 208, 492cells, suppression of JEV subviral particle secretion by SIN vec-
tors, 209, 155 foot-and-mouth disease virus in macrophage cell cultures, restriction
after Fc receptor-mediated adsorption, 207, 503Recombination
bovine viral diarrhea virus genotypes 1 and 2, effects on onset of hepatitis A virus cytopathic variants, rapid, associated genomic re-
gions: infectious cDNA clone, 212, 686postvaccinal mucosal disease, 212, 259
brome mosaic virus genetic RNA, facilitation by foreign complemen- hepatitis C virus, role of cellular proteins binding 5*-noncoding region
of viral RNA, 208, 723tary sequences, 208, 370
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HIV-1 and in vitro packaging system, dsRNA bacteriophage f6 in, polymer-
ase activity, 211, 320BaL and IIIB strains in primary human neuroblasts, 210, 221
wheat dwarf geminivirus DNA, implications of DNA bending in largegag gene mutant in various cell lines, characterization, 212, 251
intergenic region, 208, 303integrase-defective, in human primary macrophages and T cells,
Resistance, see also Drug resistance; Multidrug resistance208, 242
bovine viral diarrhea virus in MDBK mutant cell line due to block inin intestinal cells, restriction, genetic control by gag–pol region
viral entry, 208, 565of HIV-1 genome, 207, 160
coat protein-mediated, tobacco mosaic virus, conferrence by PM2in macrophages, efficiency, virus spread-related effect of envelope
assembly defective mutants, 208, 485V1 and V2 regions, 213, 70
cymbidium ringspot virus in transgenic tobacco plants expressingin mononuclear phagocytes, role of vpr, 206, 935
full-length viral replicase gene, characterization, 212, 240in vitro, Nef-mediated enhancement, determination at level of viral
developmental, in fourth instar Trichoplusia ni orally inoculated withDNA formation, 212, 451
Autographa californica M nuclear polyhedrosis virus, 209, 384relationship with arachidonic acid and prostaglandin E2 production
HIV-1 to proteinase inhibitors: viral mutant with decreased sensitivityin infected monocytes/macrophages, 208, 590
to Ro 31–8959, 206, 527Tat0, and infection: genetic analyses of LTR and tat mutations in
inborn, against tick-borne Dhori virus in mouse, role of Mx1 andprimary and long-term human lymphoid cells, 211, 157
MxA, 211, 296T-lymphotropic NL4–3 isolate in promyelocytic and T-cell lines,
partial, to attenuated poliovirus Sabin 1 strain in HEp-2c cell clones206, 641
cured of persistent poliovirus infection, 212, 309HIV-1 and HIV-2 in human lymphocytes and macrophages, inhibition
against pepper mild mottle virus infection in Nicotiana benthamiana,by polymerase substrate depletion, 211, 554
effects of transformation with 54-kDa region of viral replicaseHIV-1 and SIV, in CD4/ T cell lines, effect of interferon, 214, 379
gene, 211, 170human adenovirus type 3 subgroup B, role of 20.5-K protein, 208,
replicase-mediated, alfalfa mosaic virus infection in transformed to-226
bacco plants, 207, 467human herpesvirus type 6 , enhancement by HIV-1 tat gene, 211,
retroviral infection, correlation with Friend murine leukemia virus Fv4544
env expression by hematopoietic cells in transgenic and bonehuman papillomavirus type 1A DNA, stimulation by mulimerized AT-
marrow chimeric mice, 208, 75rich palindromic sequence, 214, 301
tobacco mosaic virus infection, effects of defective movement protein
molluscum contagiosum virus, analysis in human foreskin grafts to
and functional analog in transgenic plants, 206, 307
skin of athymic mouse, 213, 655
against tobamoviruses, Capsicum L3 gene-mediated, role of coat
mouse hepatitis virus RNA, role of conserved motif at 3* end of viral
protein, 209, 498
genomic RNA, 214, 128
Respiratory syncytial virus
Orgyia pseudotsugata baculovirus DNA
groups A and B, chimeric and truncated G proteins, antigenic analy-
genes influencing, 212, 650 sis, 209, 70
lef-3 gene essential for, identification and sequence and transcrip- human, cold-passaged attenuated strain, F and L gene mutations,
tional analysis, 210, 372 identification, 208, 478
parvoviral DNA, role of initiator protein and sequence homology with phosphoprotein P
prokaryotic rolling circle replication initiators, 209, 122 bacterial expression and identification of Ser237 as site of phos-
potato spindle tuber viroid phorylation by cellular casein kinase II (human), 205, 93; erra-
and pathogenicity, interdependence, 209, 60 tum, 209, 284
and symptom expression, suppression by pathogenicity domain- transcriptional activity, role in casein kinase II-mediated phosphor-
stabilizing mutations, 208, 554 ylation (human), 205, 104; erratum, 209, 284
pseudorabies virus, inhibition by chimeric trans-gene product re- Respiratory system
pressing transcription of immediate-early genes, 210, 128 HPV type 11 latent infection in, low-abundance RNA transcripts for
related plant circovirus gene, poly(A) addition site mapping and poly- viral E1 and E2 proteins in, identification (human), 212, 285
adenylation signal analysis in, 211, 345 Response elements
Rous sarcoma virus, necessary role of suboptimal src 3* splice site, interferon-stimulated, in 2–5A synthetase gene promoter, in vivo ac-
206, 1099 tivity, 211, 113
Sendai virus L protein, effect of mutations in conserved domain I, Rex, HTLV-I, activation of 2*,5*-oligoadenylate synthetase and p68
213, 352 kinase, 206, 913
simian immunodeficiency virus Restriction fragments
effects of mutations in env constant regions 3 and 4, 210, 448 BamHI-I2, -Q2, and -L, of Marek’s disease virus, from transformed
massive, requirement for quasispecies development in vivo, 208, and persistently infected cells, viral cDNAs mapping to, isolation
644 and characterization, 213, 590
variant population, role in progression to AIDS in infected ma- Reticuloendotheliosis virus
caques, 207, 528 strain A, SU protein maturation and translocation, effect of mutations
Sindbis virus, and tissue tropism, in Aedes albopictus, 212, 1 in CWLF motif conserved cysteine residues, 206, 885
tobacco etch potyvirus, role of helper component–proteinase-medi- Retroelements
ated proteolysis, 209, 268 reverse transcriptase, related protein, sigma rhabdovirus of Drosoph-
tomato bushy stunt virus, role of replicase proteins p33 aand p92, ila gene 3 encoding, nucleotide sequence, 213, 300
208, 365 Retrotransposition
turnip crinkle virus, p28 and p88 proteins involved in, immunodetec- in amplification of endogenous HERV-H retroviral elements in human
tion, expression strategy, and complementation, 211, 525 genomic DNA, 206, 164
vesicular stomatitis virus, role of P protein phosphorylation and inter- Retrotransposons
action with L and N proteins, 208, 821 Ty1, virus-like particle, structure
immunological analysis, 207, 59vesicular stomatitis virus RNA, required cis-acting sequences in ter-
mini of VSV defective interfering particle RNAs, 206, 760 TYA protein regions necessary for formation, analysis, 212, 69
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Retroviral elements intra- and intermolecular nonenzymatic ligations within transcripts
derived from peach latent mosaic viroid, 212, 705endogenous, human, ERV9, mobilization during primate evolution,
213, 271 Rice dwarf virus
Retroviruses, see also Endogenous retroviruses; Oncoretroviruses high-resolution genome typing and genomic reassortment events,
avian, long terminal repeats, transcription regulatory elements, mini- 212, 724
review, 206, 1 Rice tungro bacilliform virus
contaminant defective, production, analysis of avian leukosis virus- reverse transcriptase, proteolytic processing and activation, 208, 207
based packaging cell lines for, 209, 671 Rice yellow mottle virus
defective, MAIDS-associated, establishment of leukemic T-cell lines infectious full-length cDNA clone, synthesis and coat protein muta-
from inoculated mice, 206, 555 genesis, 206, 108
fragment from Sphenodon, isolation and characterization, 210, 206 RNA
human endogenous 1, tomato black ring nepovirus, polyprotein encoded by, proteolytic
clones HERV(K)27 and (K)67, expression in human teratocarci- activity, functional characterization, 206, 362
noma cells, 208, 733 1 and 2, lettuce infectious yellows virus, nucleotide sequence, 208,
ERV-3, envelope protein expression: abundance in placental tro- 99
phoblasts, 211, 589 2
HERV-H spliced sequences in human genomic DNA: evidence for beet necrotic yellow vein virus, accumulation in cis, regulation by
amplification via retrotransposition, 206, 164 small cysteine-rich protein P14, 210, 73
S71-related sequences with full-length pol genes, identification, peanut clump virus, P39 gene in vitro translation by leaky scanning
209, 550 mechanism, 208, 215
Moloney murine leukemia virus-derived, with hybrid LTRs containing soil-borne wheat mosaic virus, spontaneous deletion sites, analy-
murine tyrosinase enhancer/promoter, tissue-specific gene ex- sis, 209, 213
pression from, 214, 307 3
murine C-type, from Chinese TSZ complex, biological characteriza- potato mop-top virus, sequence analysis and gene content: evi-
tion and molecular cloning, 212, 367 dence of heterogeneity of furovirus genomic organization, 206,
neuropathogenic, NT40, generation from Friend murine leukemia vi- 701
rus, 214, 239
Prunus necrotic ringspot virus PE-5 isolate, nucleotide sequence,
neurotropic, CasBrE, perinatal infection in mouse, prevention by inoc-
208, 349
ulation with Friend murine leukemia virus, 206, 372
adenovirus, early and late, mutations altering accumulation, identifi-
and pararetroviruses, packaging strategy, comparison, review, 213,
cation in Ad-encoded single-stranded DNA-binding protein, 212,
1
91
replication-defective, in one-step virofection procedure, 211, 234
alphaherpesvirus, latent expression, implications of altered dinucleo-
Rev-T, v-Rel oncoprotein, complexation with Rel-related proteins in
tide content in latently transcribed regions of viral DNA, 209,
transformed cells, 207, 362
358
simian type D, SRV-Pc, from baboon, isolation and characterization,
antisense207, 292
cherry leafroll virus, and coat protein, transient expression, reduc-transmissible, in Epstein–Barr virus-producer B95–8 cells, identifica-
tion of viral accumulation in tobacco protoplasts, 208, 132tion and characterization, 209, 374
HIV-1 ENV gene-derived, 19-kDa protein encoded by, recognitionvectors, see Vectors, retroviral
in sera of HIV-infected individuals, 206, 196Reverse transcriptase, see RNA-directed DNA polymerase
minute virus of mice, NS-1 transactivator protein-targeted, consti-Revertants
tutional expression, inhibition of viral transcription, 206, 57Sindbis virus 6K protein mutant pseudo-revertant correcting for aber-
Aura virus, nucleotide sequence, 208, 621rant particle formation, identification of mutations mapping to
barley yellow dwarf virus, replication, gene products and cis-actingE2 glycoprotein ectodomain, 206, 1027
elements involved in, identification, 212, 186Ribonuclease H
binding activity of full-length and R-domain forms of interferon-induc-and reverse transcriptase, domains of human foamy virus, molecular
ible RNA-dependent protein kinase R: determination of dissocia-biological characterization, 213, 97
tion constants for VAi and TAR RNAs, 206, 511Ribonucleoside-diphosphate reductase
brome mosaic virus, genetic recombination, facilitation by foreignbovine herpesvirus 1, subunits UL40 and UL39, expression studies,
complementary sequences, 208, 370and sequence analysis of UL39, UL38, and UL37, 212, 734
C4, simian immunodeficiency virus, inactivating mutations, V3 muta-herpes simplex virus
tions compensating for, 213, 179type 1, subunits, intracellular localization of subunits during infec-
cellular, small species, metabolism during productive subgroup Ction of cultured cells, 213, 615
adenovirus infection, 206, 100type 2, large subunit ICP10, intracellular internalization and associ-
circularly permuted, role in bacteriophage f29 DNA packaging, 207,ated signaling pathways, 210, 345
442Ribonucleotide reductase, see Ribonucleoside-diphosphate reduc-
citrus tristeza virustase
genomic, sequence analysis, 208, 511Ribosomal frameshifting
subgenomic, characterization in infected tissues, 208, 57601, cocksfoot mottle virus, putative replicase translation as part of
cucumber mosaic viruspolyprotein by, 207, 566
cell-to-cell trafficking in tobacco plants, potentiation by viral 3ahuman T-cell leukemia virus type 2, frequency, modulation by gag
protein, 207, 345gene translation efficiency, 208, 312
Ribosomes helper virus strains Fny and Sny, and associated proteins, accumu-
lation in tobacco and zucchini squash, differential effects ofinternal entry site, see Internal ribosomal entry sites
satellite RNA, 208, 58Ribozymes
hairpin, HIV-1 pol gene-targeted, in vitro and in vivo characterization, cucumber necrosis virus, 0.9-kb subgenomic, promoter for, deletion
analysis, 214, 100206, 381
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cymbidium ringspot virus, accumulation, role of 3* terminal putative HIV-1
5* regions, nonsufficiency for encapsidation, implications for HIV-stem–loop structure, 214, 269
defective 1 packaging signal, 212, 718
alternative splicing, role of 5* splice sites and competing subopti-citrus tristeza virus Israeli VT strain, identification, 208, 383
endogenous retroviral, efficient transmission by infectious parti- mal 3* splice sites, 213, 373
gag–pol region of genome, in genetic control of viral replicationcles produced on avian retroviral vector packaging cell line,
207, 271 restriction in intestinal cells, 207, 160
low-abundance E1 and E2 protein transcripts, HPV type 11, identifica-multiple species, identification in plants infected with citrus tristeza
virus, 214, 264 tion in latently infected respiratory tissues (human), 212, 285
messengerdefective-interfering
in broad bean mottle virus, de novo generation, 212, 574 altered editing in measles virus hamster neurotropic strain, 207,
555coronavirus, replication, role of cis-acting viral protein, 209, 428
cucumber necrosis virus capped, avian reovirus S1133, endogenous enzymatic activities
required for synthesis of, 206, 1017accumulation in infected host plant, host effects and essential
sequences, 210, 41 dicistronic, containing internal ribosome entry segments, in analy-
sis of molecular mechanism of picornavirus 2A proteinase-medi-dimers formed during coinfection with CNV cDNA clone syn-
thetic transcripts, characterization and biological activity, 207, ated stimulation of internal initiation of translation, 213, 549
Ebola virus glycoprotein, editing by EBO polymerase and T7 and282
cymbidium ringspot tombusvirus, dimer generation, 207, 510 vaccinia virus polymerases, 214, 421
host cell, cleavage by influenza A virus RNA polymerase subuniteffect on accumulation of tomato bushy stunt virus proteins and
implications for disease attenuation, 211, 324 PB2, 208, 38
intermediate, vaccinia virus, translation block, role in restrictedinfluenza virus A/WSN, providing protection from lethal infection,
isolation from murine lung and characterization: subsets of inoc- viral replication in CHO cells, 206, 984
measles virusulum DI RNAs, 210, 9
mouse hepatitis virus, as expression vector in generation of pseu- antisense sequences complementary to viral nucleoprotein N
and hemagglutinin H genes, cure of persistently MV-infecteddorecombinant MHV expressing hemagglutinin–esterase, 208,
319 cells, 207, 168
F protein, preferential initiation at AUG2: role for long untrans-rubella virus, generated during serial undiluted passage, charac-
terization, 206, 216 lated region, 214, 628
transcription and replication efficiency, role of cis-acting ele-Sendai virus: functional characterization of genomic and antigeno-
mic promoters, 212, 163 ments in genomic termini, 208, 800
spliced into X region of human T-cell leukemia/lymphotropic virustomato bushy stunt virus, accumulation in infected host plant, host
effects and essential sequences, 210, 41 type II, proteins produced by, expression and characterization,
209, 445Dengue type 4 virus growth-restricted mutants, genomic 5* noncod-
ing region deletions in, construction, 207, 68 src, suboptimal 3* splice site, role in Rous sarcoma virus replica-
tion, 206, 1099double-stranded
adenosine deaminase specific for, induction by interferon-a and T  4 Nudaurelia capensis v virus capsid protein, expression,
post-translational cleavage, and encapsidation in baculovirusIFN-g in human cells, 210, 508
bacteriophage f6 system, 207, 89
mouse hepatitis virusin in vitro packaging and replication system, polymerase activity,
211, 320 evolution during chronic infection, 209, 337
genomic, conserved motif at 3* end, role in host protein bindingin vitro transcription, effects of purine nucleoside triphosphates
and calcium, 207, 400 and viral RNA replication, 214, 128
packaging, see RNA packagingbinding of influenza virus NS1 protein to, effect on activation of
protein kinase phosphorylating eIF-2 translation initiation factor, pestivirus, translation initiation, role of internal ribosome entry, 206,
746214, 222
Diadromus pulchellus reovirus genome segments, sequence anal- poliovirus, 5* noncoding region, cellular protein binding, role of stem–
loop structure synergy, 206, 923ysis, 210, 109
infectious bursal disease virus strains, genomic segments, termi- pregenomic, duck hepatitis B virus, accumulation, role of preC region
sequences, 207, 549nal sequences, 209, 10
and interferon-b, role in activation of apoptotic Fas antigen-encod- RNA-2 mutants, brome mosaic virus, plus-strand promoter, interac-
tion with host proteins, 214, 638ing gene upon influenza virus infection, 209, 288
M28, nucleotide sequence (Saccharomyces cerevisiae K28), 213, rotavirus nonstructural protein NSP3 with binding activity for, compar-
ative nucleotide and amino acid sequence analysis, 207, 327341
Trichomonas vaginalis virus T1 Rous sarcoma virus, dimerization in vitro and in vivo, 212, 47
satellitecDNA sequence analysis, 206, 773
identification in infected protozoan, 208, 189 cucumber mosaic virus
helper virus strains Fny and Sny, effects on viral RNA and associ-feline calcivirus, transcripts derived from cloned full-length copy of
viral genome, infectivity, role of VpG protein, 210, 383 ated protein accumulation in tobacco and zucchini squash,
208, 58Helicoverpa armigera stunt virus, genomic, nucleotide sequence,
208, 84 hypervariable region variation, role of helper virus and initial
sequence context, 206, 765hepatitis C virus, 5*-noncoding region, cellular protein-binding, role
in viral replication and pathogenesis, 208, 723 cymbidium ringspot virus, mutants, replication, 206, 1092
tobacco mosaic virus, accumulation, effects of deletion andhigh-affinity ligands, to HIV-1 integrase, isolation from random pool,
209, 327 frameshift mutations in coat protein and 5* ORFs, 212, 121
tobacco ringspot virusHIV, expression in transition from latent to productive infection, single
cell transcript analysis, 206, 16 and capsid protein, expression in insect cells, 213, 472
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replication initiation effectiveness of linear and circular RNA, substrate depletion by mycophenolic acid, inhibition of HIV-1 and
HIV-2 replication in human lymphocytes and macrophages, 211,208, 832
554tomato black ring virus, specificity in association with helper virus,
RNA-directed RNA polymerase213, 87
activity of dsRNA bacteriophage f6 in in vitro packaging and replica-trace amount associated with tobacco ringspot virus, stimulation
tion system, 211, 320of increase by nonaccumulating satellite RNA mutants, 209, 470
alfalfa mosaic virus, interaction with template, effect of oxidation ofsingle-stranded
vicinal hydroxyl groups of template, 213, 650binding by nonstructural NS2 protein of bluetongue virus, African
associated activity of in vitro-mutated rabies virus L protein, 214,horsesickness virus, and epizootic hemorrhagic virus, 209, 624
522phage PP7, from Pseudomonas aeruginosa, regulatory structures,
association with virions of tomato spotted wilt virus virions, 207, 308conservation, 206, 611
bacteriophage T7, recombinant vaccinia virus encoding, constructionSouthern bean mosaic virus, coat protein binding site, identification,
and transient expression in mammalian cells, 210, 202207, 562
bluetongue virus U.S. serotypes, sequence analysis and antigenicsubgenomic
epitope mapping, 214, 280associated with cherry leafroll virus infections, description, 211,
coxsackie A virus serotypes, sequence comparison, 212, 3033
Helicoverpa armigera stunt virus larger genomic RNA, nucleotideequine arteritis virus, transcription, UV inactivation and translation
sequence, 208, 84inhibition studies, 213, 364
infectious pancreatic necrosis virus virion-associated, role in protein-
simian hemorrhagic fever virus, sequence analysis, 207, 543
primed RNA synthesis in vitro, 208, 19
TAR plant virus-associated, highly conserved motifs, as tags for specific
HIV-1, role in Tat activation in rodent cells, 206, 690 detection of carmovirus-related RdRp genes, 207, 312
HIV-2, lacking dinucleotide bulge binding sites, role in LTR trans- Sendai virus, L protein subunit, alternative amino acids at single site,
activation by HIV-1 Tat protein, 206, 673 production of multiple defects in RNA synthesis in vitro, 211,
template, recombinant bunyavirus, transcription by transiently ex- 577
pressed bunyavirus proteins, 211, 133 subunit PB2, influenza A virus, cleavage of host cell mRNA and tri-
3*-noncoding, tick-borne encephalitis virus, sequence analysis, meric enzyme function, 208, 38
based hypothesis of evolutionary relationships among strains, tobacco vein mottling virus, interaction with viral coat protein and
213, 169 genome-linked protein in yeast cells, 214, 159
tick-borne encephalitis virus infectious transcripts, generation in RNA hybridization
days by RT-PCR, 214, 611 in detection of herpes simplex virus sequences in trigeminal ganglia
tobacco etch potyvirus, genome amplification, role of helper compo- of latently infected mouse, 206, 633
nent–proteinase-mediated proteolysis, 209, 268 RNA packaging
tobacco vein mottling virus 5* proximal potyviral sequences, media- bacteriophage f6
tion of potato virus X/potyviral synergistic disease in transgenic acquisition of fourth genomic segment, 212, 204
multiple copies of reduced-size genomic segments, 212, 213tobacco, 206, 583
bacteriophage f29, antisense oligonucleotides targeting, inhibitiontranscripts, hepatitis A virus, infectivity, effect of site-directed muta-
of viral assembly, 211, 568genesis of viral polyprotein primary cleavage site, 213, 213
bovine leukemia virus genomic RNA in vivo, essential RNA stem–transcripts derived from peach latent mosaic viroid, intra- and inter-
loop structure, identification, 211, 434molecular nonenzymatic ligations within, 212, 705
HIV-1, signal for, implications of nonsufficiency of RNA 5* regionsturnip crinkle virus, binding to coat protein, binding specificity and
for encapsidation, 212, 718assembly interaction, 210, 82
strategy in retroviruses and pararetroviruses, comparison, review,VA genes, human and simian adenoviruses, phylogenetic inferences
213, 1from, 207, 32
in vitro system, polymerase activity of dsRNA bacteriophage f6 in,varicella-zoster virus gene 63 transcript, mapping, 209, 218
211, 320vesicular stomatitis virus, encapsidation, replication, and budding
RNA polymerase, see DNA-directed RNA polymerase; RNA-directedinto infectious defective interfering particles, determination of
RNA polymeraserequired cis-acting sequences, 206, 760
RNA replication
RNA-binding domain
measles virus, efficiency, role of cis-acting elements in genomic
cauliflower mosaic virus movement protein, identification, 206, 1145
termini: rescue of synthetic MV minireplicons, 208, 800
RNA-directed DNA polymerase poliovirus, role of 2C protein-mediated membrane binding, 208, 540
HIV-1 Semliki Forest virus, associated nonstructural protein nsP1, localiza-
enhancement of HIV-1 proteinase activity, 206, 387 tion in virus-infected and nsP1-transfected cells, 208, 610
foscarnet resistance-associated mutations, 212, 58 Sendai virus defective interfering particle genome in vitro, utilization
mutations at multiple sites in, generation of resistance to 1-[(2- of measles virus nucleocapsid protein, 206, 777
hydroxyethoxy)methyl]-6-(phenylthio)thymine, 210, 186 tobacco necrosis virus, role of ORF 1 and 2, 212, 222
identification in S71-related human endogenous retroviral se- tobacco ringspot virus satellite RNA, initiation, effectiveness of linear
quences, 209, 550 and circular RNA, 208, 832
retroelement, related protein, sigma rhabdovirus of Drosophila gene RNA synthesis
3 encoding, nucleotide sequence, 213, 300 alfalfa mosaic virus, role of coat protein, implications for viral life
and ribonuclease H, domains of human foamy virus, molecular bio- cycle, 208, 583
logical characterization, 213, 97 alfalfa mosaic virus in vitro, effect of oxidation of vicinal hydroxyl
rice tungro bacilliform virus, proteolytic processing and activation, groups of template 3* end, 213, 650
208, 207 alfalfa mosaic virus subgenomic RNA 4 in vivo, sequences control-
ling, characterization, 212, 663Sphenodon endogenous virus, associated domains, sequence analy-
sis, 210, 206 broad bean mottle virus defective-interfering RNAs de novo, 212, 574
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infectious pancreatic necrosis virus, protein-primed in vitro, role of Satellite panicum mosaic virus
and other plant satellite viruses, structural comparison, 214, 571virion-associated RNA-directed RNA polymerase, 208, 19
minus- and plus-strand, differentiation: polymerase activity of dsRNA Satellite tobacco mosaic virus
and other plant satellite viruses, structural comparison, 214, 571bacteriophage f6 in in vitro packaging and replication system,
211, 320 Satellite tobacco necrosis virus
and other plant satellite viruses, structural comparison, 214, 571mouse hepatitis virus strain A59, and viral protein processing, inhibi-
tion by cysteine proteinase inhibitor E64d, 208, 1 Saumarez reef virus
and TYU and CFA viruses: different evolutionary rates in genus Flavi-Sendai virus RNA in vitro, multiple defects, production by alternative
amino acids at single site in viral L protein, 211, 577 virus, 206, 1133
SecretionRNA viruses
double-stranded, ScVL1 and ScVLa, replication, interference by pro- associated pathways in mammalian cells, proteolysis and protein
transport, effects of HIV-1 Vpu protein, 213, 639duction of N-terminal fragments of capsid polypeptides, 214,
215 hepatitis B virus, role of N-linked glycosylation, 213, 660
SELEXinterferon-a-producing cells responding to, frequency, 204, 1; erra-
tum, 206, 1159, 207, 342 in isolation of high-affinity RNA ligands to HIV-1 integrase from ran-
dom pool, 209, 327Ro 31–5140
herpes simplex virus type 2 DNA polymerase- and thymidine kinase- Self-ligation
intra- and intermolecular, nonenzymatic, within transcripts derivedinhibiting, synergistic effects of ganglionic infections, 206, 263
Ro 31–8959 from peach latent mosaic viroid, 212, 705
Semliki Forest virusHIV-1 mutant with decreased sensitivity to, characterization, 206, 527
Ross River virus nonstructural protein nsP1, distribution in SFV-infected and nsP1-
transfected cells, 208, 610geographic distribution in Australia and Pacific Islands, 212, 20
Rotaviruses recombinant, human papillomavirus type 16 capsid proteins pro-
duced from, assembly into virus-like particles, 214, 349993/83 isolate from calf feces, identification as pigeon rotavirus
based on VP8* sequence analysis, 210, 231 Sendai virus
CD4/ T cells specific for, prevalence after intranasal inoculation inbovine, G type 6, VP7-specific monoclonal antibodies, in selection
of neutralization-resistant rotavirus variants, 209, 80 mouse, 210, 179
defective interfering particles, genome synthesis in vitro utilizinggroup A, human and porcine, virulence and host range restriction,
associated genes, identification, 209, 274 measles virus nucleocapsid protein, 206, 777
fusion, hemagglutinin–neuraminidase, and matrix proteins, interac-human
G types 2 and 3, VP7-specific monoclonal antibodies, in selection tion with host cytoskeletal and lipid components in infected BHK
cells, 209, 701of neutralization-resistant rotavirus variants, 209, 80
ST3 strain, independent neutralization epitopes for, identification genomic and antigenomic promoters, functional characterization,
212, 163on VP4 trypsin cleavage products, identification, 206, 148
murine infection in infant mouse, protection conferred by immunization with
human parainfluenza virus type 1, 212, 13infection and protection against reinfection in mouse, resolution,
effector functions of antibody and CD8/ cells, 214, 387 infection in mice, antibody-forming cell response, kinetics in different
anatomical locations, 207, 287single oral immunization in neonatal mouse, subsequent long-
term production of rotavirus antibodies and protection against L polymerase protein, conserved domain I mutations, effect on tran-
scription and replication, 213, 352reinfection, 211, 474
strains EC, EHP, EL, and EW, homologous, infection in mouse L protein, alternative amino acids at single site, production of multiple
defects in RNA synthesis in vitro, 211, 577model, analysis, 207, 143
porcine, group C, gene 3-encoded 82-kDa proteins, identification of P protein, intracellular and cell-free phosphorylation, comparison,
208, 408neutralizing epitope on, 208, 354
rhesus and UK strains, infection in murine L cells, enhancement by Serine
residue 232, human respiratory syncytial virus P protein, phosphory-dansylcadaverine and cytochalasin D, 212, 429
serotype G, nonstructural protein NSP3 gene, comparative nucleo- lation, effect on protein transcriptional activity: accessory role
Ser237, 213, 405tide and amino acid sequence analysis, 207, 327
Rous sarcoma virus residues in polyomavirus middle-T antigen, role in viral-mediated
oncogenic transformation, 208, 26envelope glycoprotein, lysosomally targeted, transport, role of tran-
sient cell surface expression, 206, 353 Ser 333, human parainfluenza virus type 3 phosphoprotein, identifica-
tion as major site for protein kinase C z phosphorylation, 211,integrase, conserved central domain, activities and substrate speci-
ficity, 206, 448 561
Serine protease inhibitors, see Serpinsreplication, necessary role of suboptimal src 3* splice site, 206, 1099
RNA dimerization in vitro and in vivo, 212, 47 Serine proteinase
hepatitis C virus NS3, in vitro assay, 209, 52Rubella virus
defective-interfering RNAs generated during serial undiluted pas- Serine/threonine protein phosphatase
role in tobacco mosaic virus-mediated programmed cell death, 207,sage, characterization, 206, 216
E2 glycoprotein, secreted forms, expression and characterization in 460
SerpinsSf9 cells, 206, 736
nonstructural proteins, identification, 206, 843 vaccinia virus, B13R and B22R genes, characterization, 206, 136
Serum
hepatitis C virus hypervariable region 1-specific antibodies, blockageS
of viral attachment to tissue culture cells, 208, 653
Shope fibroma virusSaccharomyces cerevisiae
HSV-1 transcription, activation by VP16 DNA-binding derivitives lack- encoding of dual-specificity tyrosine/serine phosphatase essential
for viral viability, 206, 572ing carboxy-terminal acidic activation domain, 209, 19
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Sigma rhabdovirus major structural protein Vp1, assembly into disulfide-linked postpen-
tameric complexes in cell-free lystates, 207, 251Drosophila, gene 2 and 3, nucleotide sequence, 213, 300
Signal transduction natural strains, presence in human choroid plexus and ependymoma
associated activity of herpes simplex virus type 2 ribonucleotide tumors, 212, 710
reductase large subunit ICP10, 210, 345 Sindbis virus
Simian foamy virus 6K protein mutant, pseudo-revertant correcting for aberrant particle
chimpanzee, infectious proviral clones generated by long PCR, based formation, identification of mutations mapping to E2 glycoprotein
evidence for close functional relatedness to human foamy virus, ectodomain, 206, 1027
214, 685 and Aura virus, organizational and sequence similarity, 208, 621
and related primate foamy viruses, phylogenetic analysis by compari- double-subgenomic recombinants expressing Japanese encephalitis
son of pol sequences, 207, 577 virus immunogenic proteins, induction of protection against le-
SFV-Gg, isolation from gorilla, functional and phylogenetic relation- thal JEV infection in mouse, 212, 587
ship to human and primate foamy viruses, 207, 217 –Japanese encephalitis virus recombinants, infected mammalian
Simian hemorrhagic fever virus cells, suppression of JEV subviral particle secretion by SIN vec-
subgenomic RNAs, junction sequences, and 5* leader, sequence tors, 209, 155
analysis, 207, 543 mutant resistant to release inhibition in low-ionic-strength medium,
Simian immunodeficiency virus isolation and identification of E2 protein amino acids conferring
attenuated, lymph nodes of macaque inoculated with, limited viral resistance, 210, 237
spread and rapid immune response, 213, 535 replication and tissue tropism in Aedes albopictus, 212, 1
constant region 4, inactivating mutations in, V3 mutations compen- Sin Nombre virus
sating for, 213, 179
naturally occurring genetic reassortment, 214, 602
diverse isolates, CD4-expressing macaque cell line infectable by,
SIV, see Simian immunodeficiency viruscharacterization, 213, 386
Soil-borne wheat mosaic virusenv constant regions 3 and 4, effects of mutations, 210, 448
Oklahoma isolate, RNA2, spontaneous deletion sites, analysis, 209,and HIV-1, replication in CD4/ T cell lines, effect of interferon, 214,
213379
Southern bean mosaic virusand HIV-1 and -2, poly(A)signal, conservation of hairpin structure,
bean strain, nucleotide sequence, 206, 287207, 276; erratum, 209, 284; 207, 276
RNA, coat protein binding site, identification, 207, 562–HIV-1-infected rhesus monkey, development of HIV-1 Env-specific
Species specificitycytotoxic T-cell responses, 208, 770
ectromelia virus and vaccinia virus interferon-g-binding proteins,isolate 251, envelope glycoprotein, monoclonal antibodies against,
208, 762specificity and neutralizing capacity, 211, 339
Sphenodon endogenous viruslymphocyte- and macrophage-tropic strains, proteins, differential pro-
cessing by macrophages, 206, 535 isolation and characterization, 210, 206
lymphocyte-tropic, persistent infection in rhesus monkey brain, 213, Spicules
600 role in formation of vaccinia virus envelopes, analysis with condi-
matrix protein, conserved cysteine residues, mutational analysis, tional lethal mutant, 214, 494
210, 501 Spinal cord
microglial-associated, selection of homogeneous env quasispecies mouse chronically infected with neurotrophic coronavirus, astrocyte
in brain after serial passage, 212, 458 activation in, 213, 482
neutralization by chimeric macaque/human Fab molecules, 207, 495 persistent lymphocyte-tropic SIV infection (rhesus monkey), 213, 600
partially attenuated nef deletion mutant, cellular immune response Spleen necrosis virus
of infected rhesus monkeys, 212, 392 improved retroviral packaging lines derived from, 208, 234
quasispecies development in vivo, requirement of massive viral repli- Splicing
cation and clearance, 208, 644 alternative, HIV-1 RNA, role of 5* splice sites and competing subopti-
related particles containing envelope proteins, assembly using bacu- mal 3* splice sites, 213, 373
lovirus expression system, 214, 50
HERV-H endogenous retroviral sequences in human genomic DNA,
SIVmac239 Rev protein, activation domain, structural and functional
206, 164
analogy to HIV-1 Rev activation domain, 211, 290
Rous sarcoma virus RNA transcripts: role of suboptimal src 3* splice
variant virus populations, replication, tropism, and cytopathic proper-
site in viral replication, 206, 1099
ties of, association with AIDS progression in infected macaques,
Spodoptera frugiperda207, 528
–Autographica californica nuclear polyhedrosis virus expressionSimian retrovirus
system, in assembly of SIV virus-like particles containing enve-type D, SRV-Pc, from baboon, isolation and characterization, 207,
lope proteins, 214, 50292
Squash leaf curl virusSimian varicella virus
movement proteins BR1 and BL1, role in viral host range and patho-genome, configuration and terminal sequences, 207, 154
genicity, 207, 191Simian virus 5
Squirrel monkey retrovirusV protein, identification as nucleocapsid-associated structural com-
B95–8, cDNA, nucleotide sequence, 209, 374ponent binding two Zn atoms, 208, 121
long terminal repeat, direct repeats in, human sequence-specificSimian virus 40
DNA-binding proteins interacting with, identification, 211, 316and cytomegalovirus, promoters, rabies virus DNA vaccine with, ef-
SSPE, see Subacute sclerosing panencephalitisfect on immune response in mouse, 209, 569
Stalk domainDNA replication, inhibition by adeno-associated virus rep gene, 207,
246 human parainfluenza type 2 virus hemagglutinin–neuraminidase
protein, binding by cell fusion-inhibiting monoclonal antibody,large T antigen, epitope recognizing MHC-I H-2Kb antigen-restricted
CTL clones, identification, 208, 159 206, 1117
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Stat1–IRF-1 pathway Newcastle disease virus, depression by mutations in fusion glyco-
protein cytoplasmic domain, 210, 264as mechanism for interferon-b-resistant cell response to interferon-
g, 211, 113
Stem–loop structure
T3* terminal, role in accumulation of cymbidium ringspot viral RNA,
214, 269
essential for bovine leukemia virus genomic RNA packaging in vivo, TAATGARAT motifs
identification, 211, 434 herpes simplex virus ICP4 and ICP0 genes, positive and negative
role in poliovirus RNA 5* noncoding region binding by cellular pro- regulation, 207, 107
teins, 206, 923 TATA box
Strain differences and cAMP-response element, role in herpes simplex virus type 1
effect on infectious pancreatic necrosis virus major structural protein latency-associated transcript expression in murine trigeminal
epitopes, 214, 40 ganglia, 210, 141
Newcastle disease virus, predicted amphipathic a-helix adjacent to Tax protein
fusion domain, effect on fusion protein intracellular maturation, human T-cell lymphotrophic virus, and NF-kB/IkB transcription com-
208, 827 plex, molecular interactions, 214, 3
SIV lymphocyte- and macrophage-tropic strains for protein pro- T cells
cessing, 206, 535 CD4/
Strand breaks HIV-1 and SIV replication in, effect of interferon, 214, 379
single, in mature bacteriophage T7 DNA, 211, 329 and monocytes, HIV-1-infected, viral DNA synthesis, comparison,
Strand nicking 206, 731
African cassava mosaic virus recombinants within conserved nona- mouse hepatitis virus M protein epitope recognizing, identification,
nucleotide motif, role in initiation of rolling circle DNA replica- 208, 173
tion, 206, 707 role in CD8/-mediated cure of persistent lymphocytic choriomen-
Streptococcus pneumoniae ingitis virus infection in mouse, 212, 244
bacteriophage Cp-1, left early region coding for terminal protein and Sendai virus-specific, prevalence after intranasal inoculation in
DNA polymerase, nucleotide sequence and transcription, 211, mouse, 210, 179
21 CD40/0 and CD80/0 single-knockout and double-knockout mouse,
Streptococcus thermophilus polyomavirus persistence and reactivation, 212, 268
temperate, bacteriophage, characterization and genetic relationship CD8/, and antibodies, effector functions in resolution of rotavirus
with lytic phages, 212, 632 infection and protection against reinfection in mouse, 214, 387
Stress cytotoxic, see Cytotoxic T cells
cellular, see Cellular stress response herpes simplex virus-specific, in murine female genital tracts after
Subacute sclerosing panencephalitis genital HSV-2 infection, analysis, 212, 481
affected brain tissue, derived measles virus and wild-type virus L herpesvirus saimiri-transformed, interleukin-2 and IL-4 expression
genes, nucleotide sequence comparison, 208, 795 (human, monkey), 208, 418
Substrate recognition HIV-1 protease inhibitor-escape mutant infectivity, inhibition by single
HIV-1 protease, effect of glycine substitution at position 48, 207, 475 point mutation in POL gene, 210, 212
Subterranean clover stunt virus HIV NF-kB-independent promoter domain activity and Sp1 phosphor-
nucleotide sequencing: affinities with geminiviruses, 207, 354 ylation, induction by okadaic acid (human), 208, 753
Superantigens integrase-defective HIV-1 replication (human), 208, 242
pORF(sag), mouse mammary tumor virus, role in promotion of tumori- and monocyte macrophages, HIV-1 tropism, genetic determinants,
genic potential of hyperplastic mammary epithelial cells, 211, 206, 646
84 murine leukemia virus-specific, effects of immune transfer on viral
Superinfection infection in rat, 211, 408
Epstein–Barr virus in group I Burkitt’s lymphoma cells, role of Cp responses to bovine papillomavirus type 4 E7 protein during infection
viral promoter expression and relationship to EBV productive and epitope mapping, 206, 504
cycle, 206, 866 response to partially attenuated simian immunodeficiency virus nef
Survival deletion mutant (rhesus monkey), 212, 392
long-term, E-55/ murine leukemia virus persistently infected mouse, retroviral vector-transduced, expressing feline immunodeficiency vi-
effects of non-H-2-linked genes, 211, 507 rus capsid protein, in vitro induction of FIV-specific cytotoxic T
Susceptibility lymphocytes from chronically infected cat, 209, 390
tobacco mosaic virus infection, effects of defective movement protein Tegument
and functional analog in transgenic plants, 206, 307 purified herpes simplex virus type 1 virions, association of viral UL37
SV40, see Simian virus 40 protein with, 206, 1055
Symptoms Temperature
potato spindle tuber viroid infection, and viroid replication, suppres- effect on late gene and polyhedrin expression in AcNPV mutant-
sion by pathogenicity domain-stabilizing mutations, 208, 554 infected Sf9 cells, 209, 90
Syncytia formation, see also Cell fusion; Membrane fusion sensitivity of Sabin type 3 poliovirus, correlation with paralysis dose
baboon reovirus inducing, characterization, 212, 752 in transgenic mouse and neurovirulence in cynomolgus monkey,
human cytomegalovirus-induced in glioblastoma-derived cells, effect 210, 160
of viral glycoprotein B mutation, 209, 580 Terminase
induction in defined system for in vitro bacteriophage l DNA packaging, 211,
by avian reovirus sC protein after expression in COS-7 cells, 208, 367
678 Theiler’s murine encephalomyelitic virus
in CV-1 cells expressing paramyxovirus SV5 mutant fusion pro- growth in murine macrophage cell lines, effect of state of differentia-
tion, 209, 437teins, 209, 242
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Theiler’s murine encephalomyelitis virus Tobacco necrosis virus
ORF 1 and 2, expression, sufficiency for satellite RNA replication,persistent and neurovirulent strains, leader and capsid coding re-
gions, analysis, 214, 550 212, 222
Tobacco ringspot virusTheiler’s virus
capsid proteins VP1 and VP2, targeting by H-2D-restricted cytotoxic capsid protein, and satellite RNA, expression in insect cells and 3D
structure of TobRV-like particles, 213, 472lymphocytes in central nervous system of B10 mouse, 214, 91
Thogoto virus satellite RNA
replication initiation, effectiveness of linear and circular RNA, 208,baculovirus-related glycoprotein, immune protection abilities, 213,
249 832
trace amount, stimulation of increase by nonaccumulating satelliteThreonine
residues in polyomavirus middle-T antigen, role in viral-mediated RNA mutants, 209, 470
Tobacco vein mottling virusoncogenic transformation, 208, 26
Thymidine kinase –potato virus X synergistic disease in transgenic tobacco, mediation
by 5* proximal potyviral sequences, 206, 583deficient mutants of infectious laryngotracheitis virus, generation,
209, 304 RNA-dependent RNA polymerase, interaction with viral coat protein
and genome-linked protein in yeast cells, 214, 159and DNA polymerase, herpes simplex virus type 2, drugs or muta-
tions inhibiting, synergistic effects on ganglionic infections, 206, Tobamoviruses
Capsicum L3 gene-mediated resistance against, role of coat protein,263
encoding gene, Cotia virus, nucleotide sequence and amino acid 209, 498
Tomato aspermy virussequence homology with other poxvirus TK genes, 210, 67
gene deletion, attenuation of channel catfish herpesvirus and effect and related cucumoviruses, phylogenetic analysis, 207, 334
Tomato black ring nepoviruson infectivity, 209, 658
HSV-1, Tat-inducible gene expression, protection of acyclovir-treated RNA-1-encoded polyprotein, proteolytic activity, functional character-
ization, 206, 362CD4 cells from HIV-1 spread by conditional suicide and reverse
transcription inhibition, 206, 495 Tomato black ring virus
satellite RNA, specificity in association with helper virus, 213, 87Thymocytes
Epstein–Barr virus de novo infection in, associated replicative gene Tomato bushy stunt virus
defective interfering RNAs, accumulation in infected host plant, hosttranscription: simultaneous expression of BZLF-1 and repressor
RAZ (human), 208, 685 effects and essential sequences, 210, 41
protein, accumulation, effect of defective interfering RNA and implica-Tick-borne encephalitis virus
infected murine macrophages, effects on requirements for nitric ox- tions for disease attenuation, 211, 324
replicase proteins, coordinate expression and membrane associa-ide synthesis, 212, 174
infectious transcripts, generation in days by RT-PCR, 214, 611 tion, 208, 365
spread, regulation by nested genes functioning in cell-to-cell move-3*-noncoding region, sequence analysis, based hypothesis of evolu-
tionary relationships among strains, 213, 169 ment and host-dependent systemic invasion, 213, 425
Tomato golden mosaic virusTick-born encephalitis complex viruses
mode of evolution and dispersal patterns in northern hemisphere, BL1 and BR1 genes, virus and host-specific adaptations, 214, 330
complementable and noncomplementable host adaptation defects,210, 152
Tissues 212, 263
Tomato spotted wilt virusSindbis virus distribution in Aedes albopictus, 212, 1
TNF-a, see Tumor necrosis factor a nonstructural Nsm protein, induction of tubular structures in plant
and insect cells, 214, 485Tobacco etch virus
capsid protein determinants involved in cell-to-cell and long distance virions, associated RNA-dependent RNA polymerase activity, 207,
308movement, 206, 1007
–potato virus X synergistic disease in transgenic tobacco, mediation Toxins
a/b heterodimeric protein, processing from M28p (Saccharomycesby 5* proximal potyviral sequences, 206, 583
recombinant NIa proteinase, expression and purification: biochemi- cerevisiae K28), 213, 341
Transactivationcal analyses of full-length and naturally occurring truncated
forms, 210, 194 equine herpesvirus 1 gene 12 via octamer sequences in EHV IE
gene promoter, 213, 258replication and genome amplification, requirement for helper compo-
nent–proteinase-mediated proteolysis, analysis, 209, 268 HIV-2 LTR by HIV-1 Tat protein via TAR RNA element lacking dinucle-
otide bulge binding sites, 206, 673Tobacco mosaic virus
coat protein gene, role of single nucleotide change in induction of varicella-zoster virus, role of ORF 4 protein acidic amino-terminal
region, 208, 376severe chlorosis, 207, 234
defective movement protein and functional analog, effects on resis- viral and cellular genes, by Epstein–Barr virus nuclear antigen 2–
estrogen receptor fusion proteins, 214, 675tance and susceptibility in transgenic plants, 206, 307
disassembly, role of carboxylate groups, confirmation by site-di- Transactivators
E2, bovine papillomavirus type 1, complexation with E1 replicationrected mutagenesis, 206, 724
epitopes, kinetic and functional mapping using biosensor technol- protein, mapping of required E1 domains for, 211, 385
IE1, AcNPVogy, 213, 462
mediated programmed cell death, role of serine/threonine protein expression during viral infection in Sf9 cells, 209, 99
temperature-sensitive, altered transactivation and DNA-bindingphosphatase, 207, 460
and red clover necrotic mosaic dianthovirus, movement proteins, activities, 209, 90
Tax, bovine leukemia virus, interaction with bZip proteins, 214, 207functional homology, 213, 38
resistance to, conferrence by PM2 coat protein assembly-defective VP16, herpes simplex virus type 1, DNA-binding derivitives lacking
carboxy-terminal acidic activation domain, transcriptional activ-mutants, 208, 485
satellite, deletion and frameshift mutants, characterization, 212, 121 ity, 209, 19
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Transcription Transcriptional analysis
Bombyx mori nuclear polyhedrosis virus pol gene, 206, 435AcNPV, enhancer function of homologous region 1a, 208, 742
feline herpesvirus type 1 genome short segment, and insertionalactivation by HSV-1 VP16 DNA-binding derivitives lacking carboxy-
mutagenesis of ORF US8.5, 208, 704terminal acidic activation domain in yeast, 209, 19
Transcription factor elementsactivity of HPV type 31b enhancer, regulation via synergistic interac-
in bovine immunodeficiency virus LTR, identification, 209, 604tion of AP1 with cellular factors, 211, 184
Transcription factorsassociated activity of human respiratory syncytial virus P protein,
E2F, free and heteromeric forms, induction of herpes simplex virus,effect of phosphorylation of Ser232, 213, 405
213, 624avian reovirus S1133, associated endogenous enzymatic activities,
NF-kB206, 1017
down-regulation by interferon-a-induced inhibition of murine cyto-Bacillus subtilis phage f29, regulation: expression of viral promoters
megalovirus immediate-early gene expression, 211, 251throughout infection cycle, 207, 23
HIV, independent promoter activity, induction by okadaic acid inbovine herpesvirus-1 3*-coterminal UL1–UL3.5 gene cluster ORFs,
T lymphocytes, 208, 753analysis, 213, 28
induction in human cytomegalovirus-infected HL-60 cells, media-differentiation-dependent, epidermodysplasia verruciformis-associ-
tion of TNF-a-stimulated HCMV immediate early enhancer/pro-ated human papillomavirus type 5 in benign lesions, 214, 245
moter, 208, 197double-stranded RNA bacteriophage f6 in vitro, effects of purine
NF-kB/IkB complex, and human T-cell lymphotrophic virus Tax pro-nucleoside triphosphates and calcium, 207, 400
tein, molecular interactions, 214, 3Epstein–Barr virus replicative genes during de novo infection of hu-
NF-kB2, and protein products p52 and p100, interactions of HTLV-Iman thymocytes: simultaneous BZLF-a and RAZ expression,
Tax protein with, 206, 1066208, 685
NF-Y, negative regulatory element binding, identification in varicella-equine arteritis virus subgenomic RNA, UV inactivation and transla-
zoster immediate-early 62 promoter, 214, 256tion inhibition studies, 213, 364
SP1hepatitis B virus surface protein, regulation, key role of CCAAT ele-
binding site for, identification on hepatitis B virus large surfacement, 206, 1155
antigen promoter, 208, 399HTLV-I, activation: Tax interactions with NF-kB2 and protein products
phosphorylation and NF-kB-independent HIV promoter domain ac-p52 and p100, 206, 1066
tivity in T lymphocytes , induction by okadaic acid, 208, 753human respiratory syncytial virus, role of phosphoprotein P phos-
Transformationphorylation by casein kinase II, 205, 104; erratum, 209, 284
fibroblasts by insertionally activated c-erB, resistance to, phenotype
left early region of Streptococcus pneumoniae bacteriophage Cp-1
dominance in avian and murine species, 212, 277
coding for terminal protein and DNA polymerase, 211, 21
HPV type 16 E7 gene, potential in BHK cells, correlation with expres-
lymphoproliferative disease virus, efficiency, LTR sequences re-
sion levels, 207, 260
quired for, identification, 208, 789
long-term quail fibroblast culture by chimeric jun oncogene, 207, 321
mdr3 gene in P388 cells, activation, role of mouse mammary tumor oncogenic, polyomavirus-mediated, role of middle-T antigen do-
virus LTR and mdr3 gene sequence, 210, 244 mains, 208, 26
measles virus mRNA, efficiency, role of cis-acting elements in geno- quail fibroblasts, induction by avian myeloblastosis virus v-myb weak
mic termini: rescue of synthetic MV minireplicons, 208, 800 transcriptional activation, 208, 467
minute virus of mice, inhibition by constitutive expression of anti- Translation
sense RNA targeted against NS-1 transactivator protein, 206, bovine viral diarrhea virus, initiation, role of internal ribosome entry
57 site in 5* noncoding region, 206, 750
Orgyia pseudotsugata multinucleocapsid nuclear polyhedrosis virus cocksfoot mottle virus putative replicase, as part of polyprotein by
lef-3 gene, analysis, 210, 372 01 ribosomal frameshift, 207, 566
recombinant bunyavirus RNA template by transiently expressed equine arteritis virus subgenomic RNA, inhibition studies, 213, 364
bunyavirus proteins, 211, 133 human T-cell leukemia virus type 2 gag gene, efficiency, modulation
regulation, analysis with human polyoma JC virus, review, 213, 283 of ribosomal frameshifting frequency, 208, 312
regulatory elements, avian retroviral long terminal repeats, minire- internal initiation, picornavirus 2A proteinase-mediated stimulation,
view, 206, 1 molecular mechanism, 213, 549
Sendai virus L protein, effect of mutations in conserved domain I, measles virus F mRNA, preferential initiation at AUG2: role for long
213, 352 untranslated region, 214, 628
vesicular stomatitis virus peanut clump virus RNA 2 P39 gene by leaky scanning mechanism
inhibition by purified MxA protein, 206, 545 in vitro, 208, 215
role of P protein phosphorylation and interaction with L and N Translation initiation factor
proteins, 208, 821 eIF-2, protein kinase phosphorylating, activation, effect of binding of
Transcriptional activators influenza virus NS1 protein to dsRNA, 214, 222
avian myeloblastosis virus v-myb oncogene-induced transformation Translocation
of quail fibroblasts, 208, 467 oncoretroviral SU protein, effects of mutations in conserved cysteine
DNA sequence-specific, and HIV-1 Tat, functional similarities, 206, residues in CWLC motif, 206, 885
1150 Transmembrane transport
human cytomegalovirus IE2 protein, negative regulation by retino- associated defect in reovirus mutant tsA279 with temperature-sensi-
blastoma gene product, 208, 450 tive lesions in M2 and L2 genes, characterization, 207, 46
Transmissible gastroenteritis virusNFI, synergistic interaction with Oct-1 at conserved composite regu-
latory element, role in Oct-1 activation of epithelial-specific en- antibodies against, induction by recombinant adenovirus expressing
hancer of HPV type 16, 207, 77 TGEV spike protein, 213, 503
nucleoprotein epitope, elicitation of T helper cells collaborating in inOct-1, activation of epithelial-specific enhancer of HPV type 16 via
vitro antibody synthesis to three major structural viral proteins,synergistic interaction with NFI at conserved composite regula-
tory element, 207, 77 212, 746
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polyprotein-encoding gene 1, nucleotide sequence, 206, 817 papilloma, regression, association with immune response to cotton-
tail rabbit papillomavirus E2 protein, 208, 298Transphosphorylation
herpes simplex virus type 1 and 2 140-kDa RR1 protein defective in, plasmacytomas, growth in SCID mouse, rapid generation of antibod-
ies against HTLV-II external envelope protein by, 214, 680207, 409
Transport thymic lymphomas, feline leukemia virus-induced, long terminal re-
peat alterations in, in vivo selection, 206, 661herpes simplex virion along exocytic pathway, detection of envelope
glycoconjugate intermediate forms during, 214, 619 thymic lymphosarcoma, experimentally induced, occurrence of feline
leukemia virus variants (cat), 214, 584Transposons
IFP2, lepidopteran, movement in insect cells, assay with baculovirus urinary tract, BK virus productive infection, effect of DNA rearrang-
ments, 214, 273genome as target DNA, 211, 397
TCl4.7, Cyptophlebia leucotreta, identification in Cydia pomonella Tumor surveillance
implications of CTLs isolated from healthy seropositive individualsgranulosis virus after coinfection of C. leucotreta larvae with
CpGV and C. leucotreta granulosis virus, 207, 369 specific for peptide epitopes from Epstein–Barr virus nuclear
antigen 1, 214, 633Trichomonas vaginalis virus T1
double-stranded RNA, cDNA sequence analysis, 206, 773 Turnip crinkle virus
coat protein, binding to viral RNA, binding specificity and assemblyT. vaginalis infected with, satellite double stranded RNA in, identifica-
tion, 208, 189 interaction, 210, 82
p28 and p88 replication components, immunodetection, expressionTrigeminal ganglia
herpes simplex virus type 1 infections strategy, and complementation, 211, 525
Turnip mosaic virus C5latency-associated transcript expression in, role of cAMP-re-
sponse element and TATA box (mouse), 210, 141 NIa C-terminal 27-kDa protease, self-cleavage site, expression, puri-
fication, and identification, 213, 517synergistic effects of viral polymerase- and thymidine kinase-inhib-
iting drugs or mutations (mouse), 206, 263 Turnip yellow mosaic virus
genomic coding density: roles of overlapping coat protein and p206viral detection by in situ DNA PCR and RNA hybridization in latently
infected mouse, 206, 633 readthrough coding regions, 206, 403
TyrosinaseTrophoblasts
placental, abundant expression of endogenous retroviral envelope enhancer/promoter, hybrid LTRs containing, Moloney murine leuke-
mia virus-derived retroviral vectors with, tissue-specific geneprotein (human), 211, 589
Tropism, see also Neurotropism expression in mouse from, 214, 307
Tyrosinebunyavirus: evidence for G1 glycoprotein-mediated entry pathway
common to California serogroup, 214, 339 linking sequence motifs in minute virus of mice replicator protein
NS1 essential for nicking and covalent attachment to viral origin,cell, HTLV-II, susceptibility of human CD4/ and CD8/ lymphocyte
subpopulations in vitro and in vivo, 210, 441 identification, 209, 122
phosphorylation, phospholipase C-g1, by vaccinia virus growth fac-murine leukemia virus, for macrophages, microglia, and cerebral
vascular cells, correlation with neuropathogenicity, 214, 239 tor, 214, 21
Tyrosine/serine phosphatasetissue
oncogenes, analysis with c-erb transformation resistance in avian encoded by myxoma virus and Shope fibroma virus, properties and
role in viral viability, 206, 572and murine fibroblasts, 212, 277
Sindbis virus in Aedes albopictus, 212, 1 Tyuleniy virus
and SRE and CFA viruses: different evolutionary rates in genus Flavi-variant SIV population, role in progression to AIDS in infected ma-
caques, 207, 528 virus, 206, 1133
Tubular structures
tomato spotted wilt virus-infected plant and insect cells, induction
Uby viral nonstructural Nsm protein, 214, 485
Tumorigenesis
bone, enhancement by Akv murine leukemia virus in hMT-c-fos-LTR Ultraviolet light
transgenic mouse, 206, 85 inactivation of equine arteritis virus subgenomic RNA transcription,
lymphatic, enhancement by Akv murine leukemia virus in myc-k 213, 364
transgenic and wild-type mice, 206, 93 Ultraviolet radiation
Tumor necrosis factor a measles virus inactivation by, effects on CD46-dependent presenta-
HIV-induced, regulation of arachidonic acid and prostaglandin E2 tion to murine MHC class I-restricted CTLs and MHC class II-
release from HIV-infected mononuclear phagocytes, 208, 590 restricted helper T cells, 212, 255
stimulation of human cytomegalovirus immediate early enhancer/ Uracil
promoter in HL-60 cells, mediation via NF-kB induction, 208, incorporation into equine infectious anemia virus DNA, correlation
197 with reduced viral replication in macrophages, 210, 302
Tumors Uracil–DNA glycosylase
HSV-1, expression, characterization, and inhibition by 6-(p-n-octylani-bovine leukemia virus-induced leukemogenesis in cattle and sheep,
lino)uracil, 211, 307relationship with p53 tumor-suppressor gene mutations, 209,
Uukuniemi virus676
glycoproteins G1 and G2, homodimeric association, 211, 241choroid plexus, detection of natural simian virus 40 strains, 212, 710
ependymoma, detection of natural simian virus 40 strains, 212, 710
hepatoma, hepatitis B virus core antigen mutations, accumulation in
VT-cell epitopes, 212, 151
intracranial melanoma, experimental, treatment with neuroattenu-
ated HSV-1 mutant (mouse), 211, 94 V2 domain
multicentric lymphomas, feline-leukemia virus-induced, genetic de- HIV-1, T-cell line-tropic, amino acid changes, effects on gp120 func-
tion, 206, 878terminants, 214, 431
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V3 loop K3L0 and E3L0 mutants, infected L929 cells, interferon sensitivity
patterns, 210, 254HIV-1 gp120
derived multibranched peptide constructs, inhibition of viral infec- L1R open reading frame, myristylated membrane protein encoded
tion via CD4 interaction, 206, 457 by, as target of neutralizing monoclonal antibody 7D11, 211, 53
derived synthetic peptides enhancement of cell binding and infec- and orf virus, genome comparisons: establishment of genetic map
tion, minimal sequence requirements, 206, 807 of orf virus, 212, 698
restriction of viral entry of T-cell tropic strains in macrophages, proteolytic processing, role of structural protein precursor amino
209, 696 terminal peptide, 207, 229; erratum, 209, 285; 207, 229
variant R3H of macrophage-tropic clone, amino acid substitutions, recombinant encoding bacteriophage T7 RNA polymerase, construc-
role in adaptation to growth in transformed T-cell lines, 210, 490 tion and transient expression in mammalian cells, 210, 202
HIV-1 synthetic peptides, from different viral strains, induction of replication restriction in CHO cells, occurrence at stage of viral inter-
cross-reactive cytotoxic T lymphocytes, 211, 261 mediate protein synthesis, 206, 984
Vaccination, see also Immunization; Inoculation serpin genes B13R and B22R, characterization, 206, 136
bovine papillomavirus-4 L2 N-terminus, induced protection against –T7 polymerase system, and Ebola virus polymerase, editing of
viral infection in cattle, 211, 204 Ebola virus glycoprotein mRNA, 214, 421
bovine viral diarrhea virus, subsequent onset of mucosal disease, Vaccinia virus growth factor
effects of genetic recombination between viral genotypes 1 and in tyrosine phosphorylation of phospholipase C-g1, 214, 21
2, 212, 259
Vagina
DNA expressing HIV-1 Env and noninfectious HIV-1 particles, in-
HSV-2 infection, subsequent HSV-specific antibody-secreting cell re-duced antibody response in mouse, 209, 147
sponse (mouse), 206, 234with double-subgenomic Sindbis virus recombinants expressing Jap-
Variantsanese encephalitis virus immunogenic proteins, induced protec-
antigeniction against lethal JEV infection in mouse, 212, 587
Chlorella virus PBCV-1, large deletions in 330-kb genome, proper-against feline rhinotracheitis, with recombinant feline herpesvirus-1
ties, 214, 413with deletion in genes for glycoprotein gI and gE, 214, 12
Murray Valley encephalitis virus envelope protein, structural andwith high-dose attenuated Borna disease virus, induced protection
functional analysis, 211, 10against Borna disease in weanling rat, 206, 426
CTL escapeVaccines
clone Y-4, in identification of SV40 tumor antigen H-2Kb-restrictedAfrican horse sickness virus: identification of linear neutralization
determinant, 208, 159domain in protein VP2, 210, 391
lymphocytic choriomeningitis virus, biologic activity in vivo, 211,attenuated Venezuelan equine encephalitis virus, implications of mu-
443tations in E1 and E2 proteins in design of, 212, 102
lymphocytic choriomeningitis virus and vaccinia virus, generationDNA, against rabies virus, immune responses in mouse, 209, 569
and molecular characterization, 210, 29equine herpesvirus type 1 recombinant glycoprotein gp14, various
formulations, protective effects against EHV-1 challenge infec- feline leukemia virus, occurrence in experimentally induced thymic
tion in murine model, 208, 500 lymphosarcomas in cat, 214, 584
poliovirus influenza A viruses, selection by egg fluids and cells of chorioallan-
oral live, neurovirulence test using poliovirus-sensitive transgenic toic membrane of embryonated chicken eggs, 211, 302
mice, 206, 1075 influenza virus neuraminidase, with decreased sensitivity to 4-gua-
Sabin type 2, grown under different cell culture conditions, genetic nidino-Neu5Ac2en, generation and characterization, 214, 475
stability and mutant selection, 209, 366 Varicella-zoster virus
Sabin type 3 gene 63, transcript mapping and regulatory activity, 209, 218
microevolution in cell culture and implications for quality control, glycoprotein gH:gL complex, cell surface expression and fusion,
211, 377 analysis by laser scanning confocal microscopy, 210, 429
temperature-sensitive derivitives, neurovirulence in poliovirus- immediate-early 62 promoter, negative regulatory element binding
sensitive transgenic mouse and cynomolgus monkey, testing transcriptional factor NF-Y in, identification, 214, 256
methods, 210, 160
ORF1 membrane protein, role in viral growth in vitro, 206, 835
pseudorabies virus, live attenuated Bartha strain, avirulence of, role
ORF4 protein, acidic amino-terminal region, role in transactivationof UL21 gene mutations, 212, 466
and functional homology with herpes simplex virus ICP27Vaccinia virus
amino-terminal region, 208, 376A38L gene product, identification as 33-kDa integral membrane gly-
ORF61 protein, functional homology with pseudorabies virus earlycoprotein, 214, 177
protein O, 209, 281cytotoxic T-cell escape variants, generation and molecular character-
origin-binding protein, substitution for herpes simplex virus OBP inization, 210, 29
transient origin-dependent DNA replication assay in Sf9 cells,DNA, homologous recombination fidelity, 209, 688
206, 655DNA ligase, residues essential for covalent catalysis, mutational
Varicella–zoster virusanalysis, 211, 73
gE envelope protein, immunodominant regions and linear B cell epi-and ectromelia virus, interferon-g-binding proteins, species specific-
topes, identification, 214, 531ity, 208, 762
prototypic and aberrant nucleocapsids, computer modeling, 214, 321envelope
Variola virusorganization and relationship to structure of intracellular mature
major and minor strains, inverted terminal repeats, topography, 211,virions, 214, 503
350role of spicules in formation, analysis with conditional lethal mu-
Vascular cellstant, 214, 494
envelope antigen p37K, biochemical analysis, 213, 19 cerebral, murine leukemia virus tropism for, correlation with neuropa-
thogenicity enhancement: virus-induced neurodegeneration of–HPV recombinants, induction of serum IgG, IgM, and mucosal IgA
antibodies after immunization in mouse, 206, 174 rat, 214, 239
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Vectors human papillomavirus type 6 and 16 virus-like particles in Schizosac-
charomyces pombe, 206, 126adenoviral
human papillomavirus type 16 virus-like particles, by capsid proteinsAd type 5-based, helper-independent, foreign gene expression,
produced from recombinant Semliki Forest virus, 214, 349analysis with firefly luciferase and bacterial b-galactosidase
genes as reporters, 210, 226 influenza A virus, effects of M2 antibody, 212, 411
replication-deficient, in measles virus nucleocapsid protein, high- simian virus 40, postcapsomeric stage, role of disulfide bonds, 207,
level expression: induction of MHC-I-restricted CTL response 251
and protection in murine model, 210, 456 SIV virus-like particles containing envelope proteins, using baculovi-
double-subgenomic Sindbis virus recombinants expressing Japa- rus expression system, 214, 50
nese encephalitis virus immunogenic proteins, induction of pro- strategy in retroviruses and pararetroviruses, comparison, review,
tection against lethal JEV infection in mouse, 212, 587 213, 1
expression tobacco mosaic virus coat protein into virus-like particles, role in
in construction of improved retroviral packaging lines derived from coat protein-mediated resistance, 208, 485
spleen necrosis virus, 208, 234 turnip crinkle virus, role of RNA cooperative binding by coat protein,
mouse hepatitis virus defective-interfering RNA, in generation of 210, 82
pseudorecombinant MHV expressing hemagglutinin–esterase, vesicular stomatitis virus
208, 319 matrix protein functions, effects of mutations at major phosphoryla-
retroviral tion sites, 206, 894
avian, cell line packaging, infectious particles produced on, effi- role of matrix protein aggregation reversibility and mediation by
cient transmission of defective retroviral endogenous RNA, 207, nucleation sites, 206, 28
271 wild-type HIV-1, inhibition by matrix-deficient gag mutant, 208, 808
Harvey murine sarcoma virus with MDR1 as selectable marker, Viral attachment
virus production and gene transduction efficiency, 208, 621 hepatitis C virus to tissue culture cells, blockage by antibodies in
replication-competent, construction with human foamy virus and human sera specific to envelope protein E2 hypervariable region
subsequent direction of high-level foreign gene expression in 1, 208, 653
BHK-21 cells, 210, 167 Viral binding
replication-defective, in one-step virofection procedure, 211, 234 differential role of HSV-1 and HSV-2 glycoprotein C, effect on sero-
transduced feline T cells expressing feline immunodeficiency virus type differences in cell tropism, 214, 29
capsid protein, in vitro induction of FIV-specific cytotoxic T lym- Viral budding
phocytes from chronically infected cat, 209, 390 Sindbis virus 6K protein mutant pseudo-revertant correcting for aber-
vaccinia virus recombinant encoding bacteriophage T7 RNA poly- rant particle formation, identification of mutations mapping to
merase, for transient expression in mammalian cells, 210, 202 E2 glycoprotein ectodomain, 206, 1027
Venezuelan equine encephalitis virus Viral clearance
attenuated mutants with lethal mutations in PE2 cleavage signal and
lymphocytic choriomeningitis virus in mouse with persistent infec-
second-site suppressor mutation in E1, pathogenicity in mouse
tion, role of interferon g, 212, 244
and growth in mosquito cells, 212, 102
simian immunodeficiency virus, and massive viral replication, re-
induced disease, progression, effects of specific glycoprotein muta-
quirement for quasispecies development in vivo, 208, 644
tions (mouse), 206, 994
Viral disassembly
neuroinvasion via olfactory system and trigeminal nerve (mouse),
tobacco mosaic virus, role of carboxylate groups, confirmation by208, 662
site-directed mutagenesis, 206, 724Vesicular stomatitis virus
Viral dispersalIndiana serotype, P proteins, interaction with L and N proteins, effi-
tick-born encephalitis complex viruses, patterns in northern hemi-ciency in cells expressing recombinant proteins, 208, 821
sphere, 210, 152infection in murine olfactory neuroepithelium and entry in central
Viral entrynervous system, early events, 209, 257
adenovirus into host cells, role of protease, 213, 494matrix protein, assembly functions, effects of mutations at major
bovine herpesvirus type 1, modulatory function of glycoprotein D,phosphorylation sites, 206, 894
207, 429M protein aggregation, reversibility and mediation by nucleation
bovine viral diarrhea virus, blockage in resistant MDBK mutant cellsites, implications for viral assembly, 206, 28
line, 208, 565P protein, hierarchal constitutive phosphorylation, effect on P1 to P2
G1 glycoprotein-mediated pathway common to California serogroup:conversion, 214, 189
bunyavirus tropism, 214, 339transcription, inhibition by purified MxA protein, 206, 545
HIV-1Viral assembly, see also Encapsidation; Packaging
in choriocarcinoma cells, role of membrane CD4 and Fc receptors,bacteriophage f29, inhibition by antisense oligonucleotides tar-
208, 784geting viral pRNA essential for DNA packaging, 211, 568
T-cell line tropic strains in macrophages, and cell fusion, restrictionbacteriophage T7 procapsid, associated abortive DNA packaging in
by V3 loop, 209, 696vivo, 210, 409
measles virus into polarized epithelial cells through apical plasmabaseplate, bacteriophage P2 genes involved in, sequences, 213, 109
membrane, 210, 91bluetongue virus into core-like particles, by interactions of BTV chim-
mouse hepatitis virus A59 into polarized murine epithelial kidneyeric VP3 molecules with VP7 protein, 214, 593
cells, 210, 54coliphage lO replication complex in vivo, proteolysis of initiator pro-
vesicular stomatitis virus into murine central nervous system, earlytein during, protection from, 207, 179
events, 209, 257cowpea chlorotic mottle virus in vitro from coat protein expressed
Viral growthin Escherichia coli and in vitro-transcribed viral cDNA, 207, 486
Amsacta moorei entomopoxvirus in Lymantria dispar cells, effectshepatitis B virus small envelope proteins lacking cysteines in major
antigenic region, 211, 535 of viral inhibitors, 211, 462
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attenuated Venezuelan equine encephalitis virus with lethal muta- Viral stability
tions in PE2 cleavage signal and second-site suppressor muta- HIV-1 and SIV in CD4/ T cell lines, effect of interferon, 214, 379
tion in E1, in mosquito cells, 212, 102 HIV-1 Vpr, and virion incorporation of Vpr into viral particles, role of
murine cytomegalovirus in mouse, role of IE2 protein, 209, 236 carboxy-terminal domain, 214, 647
Theiler’s murine encephalomyelitic virus in murine macrophage cell Viral transmission
lines, effect of state of differentiation, 209, 437 barley mild mosaic virus by fungal and mechanical means, strain
varicella–zoster virus in vitro, role of ORF 1-encoded membrane characterization, 212, 383
protein, 206, 835 barley yellow dwarf luteovirus by aphids, efficiency, role of virion-
Viral hemorrhagic septicemia virus associated readthrough protein, 206, 954
distant strains, maintenance of sixth functional cistron coding for cell-to-cell, role in maintenance of reovirus serotype 3 persistent
nonstructural protein of unknown function, 212, 741 infection in B-cell hybridoma, 212, 272
G and N cDNA-derived protein sequences, stimulation of leukocyte HIV-1 subtype D, G, and A/D recombinant in Sweden, biological and
proliferation with individual fish variation (Onchorynchus my- molecular characterization, 209, 136
kiss), 212, 348 maize dwarf mosaic virus by aphid, inhibition by N-terminus of MDMV
Viral movement coat protein, 213, 676
cauliflower mosaic virus, associated protein, identification of RNA- Nilaparvata lugens reovirus to brown planthopper via rice plant, 207,
binding domain, 206, 1145 303
cell–cell related events, study using sequence distances between HIV-1 env
genes from individuals infected from same source, 211, 198brome mosaic virus 3a gene encoding, coding changes, effects
on host range of viral systemic infection, 214, 464 Virions
nested genes functioning in, regulation of tomato bushy stunt virus associated RNA polymerase of infectious pancreatic necrosis virus,
spread, 213, 425 role in protein-primed RNA synthesis in vitro, 208, 19
cowpea chlorotic mottle bromovirus, cell-to-cell, host specificity, role bovine papillomavirus, fate after infection of cultured cells, 214, 167
of 3a gene, 206, 276 enveloped viruses, incorporation of cellular ezrin–radixin–moesin
cucumber mosaic virus, complementation in transgenic tobacco ex- family proteins, and association of ERM proteins with viral enve-
pressing CMV 3a gene, 209, 188 lope proteins, 206, 485
long-distance, red clover necrotic mosaic virus in movement protein- hepatitis A virus, observed VP1 protein, comparison with protein
transgenic plants, role of virion formation, 212, 607 encoded by proposed VP1 gene, 213, 671
satellite tobacco mosaic virus, effects of deletion and frameshift mu- herpes simplex virus, envelope, glycoconjugate intermediate forms,
tations in coat protein and 5* ORFs, 212, 121 detection during virion transport along exocytic pathway, 214,
tobacco etch virus in plants, cell-to-cell and long distance, effects 619
of capsid protein mutations, 206, 1007 HIV-1, incorporation of Vpr into viral particles, role of Vpr C-terminal
Viral persistence domain, 214, 647
implications of CTLs isolated from healthy seropositive individuals lactococcal temperate bacteriophage TP901–1, major proteins, posi-
specific for peptide epitopes from Epstein–Barr virus nuclear tions and relationships in, 212, 595
antigen 1, 214, 633 lymphocytic choriomeningitis virus glycoprotein complex dissocia-
measles virus tion from, pH dependence and kinetics, 209, 3
hamster neurotropic and Philadelphia 26 strains, comparison, 207, preformed, adeno-associated viral DNA in, covalent linkage to viral
555 Rep78 protein, 214, 360
in immortalized murine macrophage cell line, 207, 12 red clover necrotic mosaic virus, formation, role in long-distance viral
movement in movement protein-transgenic tobacco plants, 212,Viral processing
607HIV-1 and SIV in CD4/ T cell lines, effect of interferon, 214, 379
vaccinia virus, intracellular mature, structure, relationship to vacciniaViral receptors
envelope organization, 214, 503CD4, –HIV-1 gp120 covalently crosslinked complexes, monoclonal
Virofectionantibodies raised against, identification of gp120 complex-de-
pendent epitope, 211, 583 one-step procedure for using replication-defective retrovirus vectors,
211, 234human poliovirus receptor gene, transgenic mice carrying, in neurovi-
rulence test for oral live poliovaccines, 206, 1075 Viroids, see Peach latent mosaic viroid; Potato spindle tuber viroid
Virulencemeasles virus, membrane cofactor protein function as, role of N-
glycans, 210, 479 avian influenza virus, associated mutation arising in avirulent form
during replication in embryonated chicken eggs, associated mo-Viral release
lecular changes, 206, 755measles virus from polarized epithelial cells through apical plasma
membrane, 210, 91 neurologic, murine coronavirus JHMV, for rat, localization of determi-
nant on S1 subunit, 208, 67Sindbis virus from CEF cells, inhibition in low-ionic-strength medium,
mutant resistant to, isolation and identification of E2 protein porcine rotavirus, associated genes, identification in gnotobiotic pig-
let model, 209, 274amino acids conferring resistance, 210, 237
Viral spread vaccinia virus, effects of Mr 38.5K and Mr 40K intracellular polypep-
tides in murine intranasal model, 206, 136related effect of HIV-1 envelope V1 and V2 regions on viral replication
efficiency in macrophages, 213, 70 Virus–host interactions
herpes simplex virus type 1 Vmw110 polypeptide with cellular 135-SIV, in lymph nodes of macaques inoculated with attenuated virus,
213, 535 kDa protein, required viral sequences, identification, 209, 174
implications of interferon-independent ICAM-1 early expression bytomato bushy stunt virus, regulation by nested genes functioning in
cell-to-cell movement and host-dependent systemic invasion, West Nile virus in quiescent nonproliferating fibroblasts, 208,
437213, 425
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W X-ray crystallography
bluetongue virus type 1 core particle, 210, 217
West Nile virus
early induction of interferon-independent virus-specific ICAM-1 ex-
Ypression in quiescent nonproliferating fibroblasts, implications
for virus–host interaction, 208, 437
YeastWheat dwarf geminivirus
fission, HPV type 6 and 16 virus-like particle assembly (Schizosac-large intergenic region, DNA bending in, 208, 303
charomyces pombe), 206, 126Woodchuck hepatitis virus
HPV type 6a virus-like particles, assembly in Saccharomyces cerevis-DNA, integration in B3N locus in woodchuck hepatocellular carci-
iae, 209, 506noma, recurrence, 214, 229
X
Z
Xenografts
Zincsystem in mouse, human papillomavirus type 11 E1 P E4 and L1 pro-
binding by simian virus 5 V protein, 208, 121teins, colocalization at multiple time points, 214, 259
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